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Throughout the course of pregnancy, lactation and involution, mammary tissue
embarks on a programme of proliferation, differentiation and de-differentiation; the
terminal differentiation events enable expression of the tissue's physiological functions
of biosynthesis and secretion, while involution leads to reductive remodelling process
in which the tissue returns to a less differentiated state. The following study describes
how PK-A (cAMP dependent protein kinase) activity and the expression of generic
C- and R-subunits are developmentally regulated in the rat mammary gland
throughout the pregnancy/lactation/involution cycle.
A polyclonal antibody was raised against a synthetic peptide corresponding to a juxta-
C terminal region of the catalytic subunitof PK-A. Immunotitration-inhibition studies
were performed, which showed no discernible difference in its potency or titre against
mammary tissue C-subunit preparations regardless of the physiological state of the
donor animal. Immunoinhibition studies were also performed against mammary tissue
sampled throughout pregnancy and lactation. A small proportion of mammary tissue's
PK-A activity was found to be non-immunoinhibitable; this appeared to be
proportional to the level of total PK-A activity present and independent of the tissues
physiological state. Non-immunoinhibitable/non-immunoprecipitable PK-A activity
was also demonstrated in preparations of C-subunit purified from pregnant and
lactating sheep mammary tissue. It therefore appeared that mammary tissue contained
a subpopulation of C-subunit molecules not recognised by the antibody. It was further
demonstrated that PK-A C-subunit was susceptible to deactivation by a factor present
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within soluble mammary tissue extracts. Deactivation was linear with respect to time,
required PK-A dissociation and was temperature sensitive. Deactivation also appeared
to be partially inhibited by moderate concentrations of MgATP.
"Expressed" and "total" activities of PK-A were measured in extracts of rat
mammary tissue sampled throughout pregnancy and lactation. Expression of the genes
encoding the catalytic subunit (C-subunit) isoforms Ca and C/3 was examined by
northern blotting, as a function of mammary development, to determine relative levels
of their respective mRNAs. The content of C-subunit protein (all isoforms) was also
estimated immunochemically and related to levels of C-subunit catalytic activity and
of mRNAs. It was found that C-subunit isoform mRNAs are expressed coordinately
during mammary development and that a marked decline in expression, per cell, at
around parturition is parallelled by a fall in total PK-A activity. The expressed
activity of PK-A underwent characteristic changes throughout pregnancy and
lactation, reaching a peak late into pregnancy. The PK-A activity ratio reached a peak
in early lactation. C-subunit protein mass closely parallelled total PK-A activity
throughout pregnancy and lactation, thereby demonstrating the constancy of C-subunit
specific activity during these developmental events. Regulatory subunits (R-subunits)
were probed with the photoaffinity label 8-azido-[32P]cAMP; both particulate and
cytosolic fractions of mammary tissue were examined. The abundance of RII as a
proportion of total R-subunit increased throughout pregnancy and lactation in both
cellular compartments. Litter removal from mid-lactating rats abruptly interrupts the
expression of differentiated function in mammary tissue. Accompanying this, total and
expressed PK-A activities were diminished after 24 and 48h; C-subunit mass also
decreased but not in proportion to total activity such that specific activity was reduced
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in comparison with nursing rats. These effects were apparently not transcriptionally
driven, since the levels of Ca mRNA remained unaltered. Furthermore, these changes
were accompanied by a decline in the amount of R-subunit which was proportionally
greater than that of the C-subunit. A cAMP-binding protein of 37-38kDa, thought to
be derived from the proteolytic cleavage of RI or RII, became more prominent in
both tissue fractions following litter removal. The relative abundance of R-subunit
isoforms remained unaltered by litter removal in soluble cytosolic tissue extracts; both
RI and RII isoforms were coordinately down-regulated. However in the particulate
fraction there was an apparent preferential down-regulation of the RI isoform, leading
to a noticeable increase in the RII:RI ratio possibly reflecting the association of the
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List of abbreviations
The abbreviations used throughout this thesis are those described as "accepted" in the
instructions to authors of the Biochemical Journal (Biochem.J. (1994) 297, 1-15.)-
Exceptions, together with abbreviations used commonly throughout this thesis are as
follows:
ATP Adenosine 5' triphosphate
cAMP Adenosine 3', 5'-cyclic monophosphate
BSA Bovine serum albumin
cpm Counts per minute
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IgG Immune gamma globulins
Kj Equilibrium dissociation constant of a inhibitory compound
KLH Keyhole limpet haemocyanin
M Molar
MES 2-[N-morpholino] ethane-sulphonic acid
fj. (prefix) Micro (10"6x)
m (prefix) Milli (10"3 x)
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MOPS 3-[N-morpholino] propane-sulphonic acid
PAGE Polyacrylamide gel electrophoresis
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PK-A Cyclic-AMP dependent protein kinase (also known as protein kinase A)
PMSF Phenylmethylsulphonyl fluoride
RI Regulatory subunit of PK-A (see above), type I isoform
RII Regulatory subunit of PK-A (see above), type II isoform
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1.1 Mammary gland development
1.1.1 Introductory comments
The mammary gland is a unique organ, not only in its secretory products but in its ability
to complete an entire cycle of growth and differentiation each time it is called upon to
provide nutrition for a new set of offspring. In its most fully differentiated state, that of
full lactation, the gland possesses vast numbers of lobulo-alveolar structures, which
consist principally of specialised secretory epithelial cells, committed to milk formation
and secretion and an extracellular matrix (ECM) which maintains the structures in a
functional conformation (Walker et al, 1989 and Talhouk et al, 1992). In a single day it
may produce considerably more than its own weight of secretion; in energetic terms, as
many joules per day as it contains in its own mass (Knight & Peaker, 1982a). A
satisfactory lactation, vital to reproductive and in the case of the dairy cow, economic
success, can only be expected when the mammary gland has reached a complete state of
development, both in terms of the number of cells and in their ability to synthesize and
secrete milk.
The mammary gland grows slowly during embryonic and juvenile life and does not
mature until the reproductive system begins to function at puberty. Therefore unlike most
organs which have completed morphogenesis by the time ofbirth and whose subsequent
development is mainly the enlargement or replication of pre-existing structures, the
mammary gland undergoes most of its morphogenesis in the sub-adult and adult animal.
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The structural and functional development of the mammary gland may be divided into
several stages:
(1) foetal development, development of a rudimentary ductal system at birth.
(2) Growth during puberty, ductal growth and elongation.
(3) Mammogenesis, the growth and differentiation of mammary ductal and alveolar
tissue.
(4) Lactogenesis the onset of copious milk secretion around parturition.
(5) Lactation, the continuing production ofmilk.
(6) Involution, the return of the gland to the less differentiated state at cessation of
lactation.
In this chapter the hormonal control of mammary development during pregnancy,
lactation and involution will be considered in coordination with other events in the
female reproductive cycle. The focus will be upon the hormonal controls as they are
understood in the rodent, although comparative studies in other species may also be
discussed.
1.1.2. Foetal development
Development begins in the foetus, in which parenchymal structures are derived from the
ectoderm (which also gives rise to the skin). This early stage of development leading to
the formation of a rudimentary system of ducts at birth, is independent of hormonal
influences, although in the male rat, androgens have been shown to suppress ductal
growth during the later stages of foetal development. However development does require
the presence of stromal tissues, which may provide stimulatory growth factors as well as
physical support for the developing parenchymal structures.
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1.1.3 Development during puberty
From birth to the beginning of sexual maturity, inmostmammalian species the mammary
gland consists of a nipple and a rudimentary ductal system. At the onset ofpuberty in the
female, enhanced oestrogen secretion causes further developments and refinement to the
ductal system and stromal elements. The critical role ofoestrogen in regulating mammary
development is demonstrated by the observation that in rodents ovariectomy prior to
puberty suppresses mammary development and that this inhibition is reversed by
administration ofoestrogen (Forsyth, 1989 and 1991). In some species including humans,
puberty is also associated with an accumulation of lipids in the fat cells, such that
eventually 85% of the mammary gland is fat tissue.
1.1.4 Development during pregnancy
The mammary gland also undergoes cycles ofproliferation, differentiation, function and
regression during the adult reproductive cycle, with the final stages of secretory lobular
development taking place during pregnancy and lactation. This final maturation of the
lobulo-alveolar elements, sometimes called terminal differentiation is brought about by
the hormonal milieu of pregnancy. Underlining the importance of development during
pregnancy, normally referred to as mammogenesis, it has been estimated that 60% of all
mammary growth takes place during first pregnancy in the rat (Griffith & Turner, 1961)
78% in the mouse (Brookreson & Turner, 1959) and sheep (Anderson, 1975) and 98%
in the hamster (Sinha et al, 1970). The total DNA content of the mammary gland shows
an increase throughout pregnancy, indicating growth which continues until day 10 or 12
of lactation (Munford, 1963).
During the first half ofpregnancy the gland grows by branching of the ductal system and
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budding of the alveoli (reviewed by Daniel & Silberstein, 1987). Thus the parenchyma
successively replaces the fat pad or stroma which becomes more and more reduced and
disappears completely by the end ofpregnancy. Where the first lobuloalveoli form, their
lumina are devoid of secretory proteins and remain flattened. Close inspection of the
glandular cells during early pregnancy shows poor cytoplasmic organisation. Cells
contain a few protein granules enclosed by vacuoles and lipid droplets of various sizes
scattered throughout the cytoplasm indicating the onset of secretory activity.
Differentiation continues throughout pregnancy with lobulo-alveolar development
completed by the second half ofpregnancy. The cytoplasm of the secretory cells shows
increased activity; enlarged it contains numerous fat globules and Golgi filled with
protein granules. The alveolar lumina remain narrow until parturition although filled with
protein granules.
1.1.5 Development during lactation
At this stage mammary epithelial cells, having acquired the full complement of
intracellular enzymes and proteins, begin to meet the prodigious demands of milk
synthesis and secretion. The onset of copious milk secretion or lactogenesis is a gradual
process which begins at parturition and, in the rat, normally continues for 20-25 days.
Differentiated milk-secreting cells can be histologically identified by their large size and
by the polarisation of membrane organelles. They also contain abundant endoplasmic
reticulum located basally and Golgi-derived vesicles in the apex of the cell. Evidence of
secretory activity is seen as a highly folded apical membrane, fat droplets in the cytosol
and casein micelles in secretory vesicles (review by Pitelka & Hamamoto, 1983).
As already discussed above, most mammary gland growth occurs during pregnancy.
4
However the degree to which growth is complete at parturition and the relative
contributions of cell number and the secretory activity to milk yield throughout lactation
varies between species (Knight & Peaker, 1982a). In rats, cell proliferation may account
for as much as three quarters of the increase in daily milk yield leading up to peak
lactation with the remainder being accounted for by greater cellular activity (Knight et
al, 1984). Following peak lactation, the volume ofmilk produced by the mother gradually
declines until milk removal ceases and the offspring are finally weaned. The maintenance
ofmilk secretion during the later stages of lactation depends on the number of secretory
cells lost, the extent of replacement (if any) and the retention of synthetic capacity of the
cells. In the rat decreasing cellular activity is entirely responsible for the decline in milk
yield (Knight et al, 1984).
The population of cells responsible for the mammary growth during lactation have not
yet been fully defined. Mammary growth may occur as a result of proliferation of all
differentiated cells (discussed by Knight & Peaker, 1982a), in which case the dogma that
proliferation and differentiation are mutually exclusive may be incorrect. It is possible
that cells can de-differentiate in order to proliferate as histological evidence exists,
showing the presence of secretory products in mitotic cells (Franke & Keenan, 1979 and
Traurig, 1967). Alternatively proliferation may arise from the presence of a stem-cell
population (Medina & Smith, 1990), although this latter possibility has not yet been
conclusively demonstrated.
1.1.6 Mammary involution
At weaning the mammary gland undergoes a reductive remodelling process termed
involution, during which it gradually returns to a less differentiated state. Milk synthesis
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ceases and there is a significant collapse of lobulo-alveolar structures (Walker et al,
1992). The process of involution is dominated by two major events: a loss of epithelial
cells by programmed cell death and a proteolytic degradation of the extracellular matrix,
which ordinarily maintains the alveolar structures in a functional conformation (Talhouk
et al, 1992).
The process is rapid in the rat, in which formation ofnewmilk stops within 8-1 Oh ofpup
removal. The morphological changes that characterise involution are elegantly described
by Helminen & Ericson (1968); within 24h of the onset of involution changes in the
rough endoplasmic reticulum, Golgi vesicles and secretory vesicles are observed, plus
a marked decline in the activity of enzymes associated with milk synthesis. There also
follows a marked increase in the activity of free lysosomal enzymes and
metalloproteinases (Jones, 1967 and 1968). By 48h there is extensive morphological
evidence of autophagic activity by the lysosomes within the epithelial cells accompanied
by leucocytic infiltration of the tissue and a substantial decrease in both casein and
mRNA and its transcription (Levy, 1963, Greenbaum et al, 1963 and Teyssot &
Houdebine, 1981). After 3 days macrophages take over the task of removing fragmented
epithelial cells and involution is well on its way to completion.
1.2 Control ofmammary growth during pregnancy
The control ofmammary gland growth is a complex process involving factors intrinsic
to the gland (local factors) and the whole animal (systemic control) as well as external
influences such as environment, climate and diet. In vivo mammogenesis requires sex
steroids, a lactogenic hormone (either prolactin or placental lactogen) and probably one
or more unknown growth factors. In addition interactions between the mammary
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epithelial elements and the stroma in which they are situated are clearly of importance
although poorly understood. Precisely how all these hormones and growth factors
function in a concerted manner to regulate mammary development during pregnancy,
remains the subject of continuing investigation.
1.2.1 Hormonal controls
Pregnancy creates a hormonal milieu that triggers extensive development ofmammary
gland in preparation for lactation. Evidence for multiple hormonal involvement in the
induction of mammary growth became available from the classical ablation and
replacement experiments performed in the 1950's (Lyons, 1958., Lyons et al, 1958., and
Nandi, 1958). These early in vivo studies demonstrated the effect of a combination of the
hormones oestrogen, progesterone, adrenal steroids, prolactin and growth hormone in
inducing lobulo-alveolar development of the mammary gland in triply operated virgin
rats (hypophysectomised-ovariectomized-adrenalectomised). Both Nandi and Lyons were
able to stimulate ductal proliferation by injection of oestrogen, deoxycorticosterone
acetate and growth hormone. However addition of progesterone, prolactin and
prednisalone to this regime were required in order to produce full lobuloalveolar
development typical of the late pregnant animal. Only prolactin and adrenal steroids were
apparently required formilk secretion. The effect of these hormones in combination with
insulin, upon the ultrastructure and differentiation ofmammary epithelial cells has been
confirmed in vitro (review by Topper & Freeman, 1980).
The injection of oestrogen and progesterone into experimental animals causes
developmental changes in the mammary gland comparable to those observed during
pregnancy. However both oestrogen and progesterone are without effect upon
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hypophysectomised animals (Lyons et al, 1958) calling into question the direct mitogenie
role of oestrogen upon mammary epithelial cells. Furthermore, oestradiol failed to
stimulate proliferation when added to the medium ofprimary cell cultures (Yang et al,
1980 and Imagawa et al, 1982) or whole-gland cultures (DuBois & Elias, 1984). In
contrast more recent reports have indicated that in mixed cultures ofmammary epithelial
and stromal cells, epithelial proliferation may be enhanced by oestradiol (McGath, 1983
and Haslam, 1986). Further work using plastic implants capable of delivering bioactive
oestradiol (17-P) molecules in situ have allowed investigation into the possible direct
effects of this classical ductal mitogen. When implanted into the mammary tissue of
ovariectomized rats, oestradiol stimulated local end bud formation, while contra lateral
gland were unaffected (Silberstein & Daniel, 1982). The authors concluded that oestrogen
may act directly as a ductal mammogen, however since the animals were not
hypophysectomised, it is possible that oestrogen stimulated the release of a pituitary
factor such as growth hormone. If so, oestradiol must also be acting to sensitise the gland
locally, since contra lateral glands were unaffected, and could therefore be said to have
a direct (non-systemic) action on the mammary gland. Alternatively oestrogen may be
acting to stimulate the release of a local agent promoting synthesis of an unidentified
ductal mitogen.
There is some evidence that GH and prolactin could act independently of oestrogen at the
level of the growing gland. Both growth hormone and prolactin can stimulate mammary
epithelial cell growth in vivo (Yang et al, 1980a and DuBois & Elias, 1984). Using
unprimed, ovariectomized animals it has been demonstrated that bovine and mouse GH
placed in slow release implants, stimulates local end bud formation. Contra lateral glands
were unaffected, indicating GH did not act systemically. Prolactin was similar to GH in
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its ability to stimulate end bud growth.
In addition to the above, placental lactogen is secreted in appreciable quantities during
pregnancy and is the major contributor to lactogenic activity during gestation (Forsyth,
1986). Placental lactogen, has both GH and prolactin like biological activities and levels
are higher in animals carrying a large number of foetuses, resulting in a greater degree
ofmammary growth, appropriate to the needs of the young (Flint et al, 1985 and Knight
& Peaker, 1982b). In rodents, coitus results in bi-daily prolactin surges which are
replaced by rising placental lactogen levels. Both the mouse and the rat show different
forms ofplacental lactogen between early (up to day 12) and late pregnancy (Robertson
& Friesen, 1981).
1.2.2 Growth factors
The inability of classical mammogens to stimulate morphogenesis or even normal levels
ofDNA synthesis in end buds in vitro indicates that other factors may act in conjunction
with these hormones. Studies indicate that a variety of growth factors are also involved
in the hormonal regulation of mammary development. These include the insulin-like
growth factor (IGF-1), epidermal growth factor (EGF), mesenchyme-derived growth
factor (MDGF), platelet-derived growth factor (PDGF), fibroblast growth factor (FGF),
pituitary-derived mammary growth factor (PMGF) and the transforming growth factors
(TGF-a and TGF-P). These growth factors may facilitate developmental processes of the
parenchymal and stromal elements of the mammary tissues in development of the
parenchyma.
One growth factor which has received particular attention is EGF, with the discovery that
EGF receptor levels, in whole mouse mammary gland, vary according to their
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physiological state (Edery et al, 1985). Receptor levels are relatively high in virgin
animals but rise during early pregnancy; levels then steadily decline throughout the
remainder ofpregnancy and into lactation. Such observations are consistent with a role
for EGF in ductal development, but do not establish a causal relationship. This is made
somewhat difficult by the fact that EGF has no focal source. However valuable
information has been gleaned from the use of primary cell cultures and slow release
implants. Using serum supplemented media in collagen gel cultures Yang and co-workers
(1980) demonstrated that EGF and agents which raise intracellular cAMP levels, strongly
stimulated mammary epithelial proliferation. Using the same culture system but
employing serum free media Nandi and co-workers (1984) demonstrated that a
combination of insulin, EGF, transferrin, BSA and cholera toxin stimulated cellular
proliferation up to 10 fold. Deletion experiments showed that insulin and EGF were
absolute requirements for cellular proliferation. Later studies (Imagawa et al, 1985) have
shown that EGF was able to synergise with prolactin and progesterone at low
concentrations (lng/ml) to stimulate growth. Slow release implants have also been used
to demonstrate the in vitro effects of EGF on ductal growth in the regressed glands of
ovariectomized virgin mice (Daniel & Silversein, 1985). It was found that EGF
stimulated end bud growth in a dose dependent manner. By comparison insulin , PDGF,
transferrin and TGF-P had no effect.
However when EGF receptor activity was examined by autoradiographic analysis in 5
week old mice most receptor activity was found in the stroma adjacent to the end buds.
Few if any receptors were seen in the luminal epithelium. These observations are
supported by the finding that receptor levels measured in a mammary fibroblast cell line
were 100 fold greater than those measured in a mammary epithelial cell line COMMA-
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ID (Danielson et al, 1984). The presence of relatively high levels ofEGF receptors on
stroma suggests that it is the primary target site. However since it is well established that
stimulation of EGF receptors leads to their rapid down regulation, the absence of
epithelial receptors in the parenchyma may reflect stimulation by EGF. Therefore EGF
or an EGF-like peptide may be a natural ductal mitogen.
1.2.3 The role of cyclic AMP
It is now widely accepted that regulation of mammary growth involves a complete
interplay between systemic and locally produced modulators, and that classical ductal
mammogens alone cannot support/stimulate ductal growth. Therefore attention is now
focused on identifying other possible, locally synthesized growth regulators and the
receptor-mediated pathways through which they operate. Levels ofcAMP in both rat and
mouse mammary gland are known to increase during the intense cellular proliferation of
pregnancy, an observation consistent with it having a mitogenic role (Greenbaum et al,
1971). Agents which raise intracellular cAMP levels are known to stimulate mammary
epithelial proliferation in vitro (Yang et al, 1980). Cholera toxin implants irreversibly
activate receptor associated adenyl cyclase, strongly stimulate end bud growth and so
demonstrate that a recognised intracellular effector can orchestrate all events for ductal
growth (Silberstein et al, 1984). Cyclic AMP may activate the pathway through which
ductal growth is stimulated, but since the classical ductal mammogens such as oestrogen
do not act through an adenyl cyclase-coupled receptor pathway this may be indicative of
an as yet unidentified cAMP mediated pathway.
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1.2.4 Stromal interactions
The requirement for a stromal matrix for maximal ductal development is apparent from
the inability of mammary epithelia to form ducts and end buds in vitro. Even when
cultured in a floating collagen gel, which optimises the potential for spatial organisation
(Yang et al, 1980a) epithelial cells form thin walled tubes and spiked cul-de-sacs. Fatty
stroma appears to be necessary for organotropic growth, as demonstrated by studies in
which mammary fat pad was artificially enriched with type I collagen (Daniel et al,
1984). Into these fragments ofmammary duct were transplanted which grew as described
above in collagen gels, but on reaching the fatty stroma, normal end buds appeared.
However the need for specific mammary stroma has been largely discounted with the
demonstration that adult ducts can grow in ectopic locations as well as in the mammary
fat pad (Horhino, 1967 and 1971).
1.2.5 The extracellular matrix (ECM)
Culture models ofmammary epithelial function indicate that cell-matrix interactions are
necessary for lactation and survival of alveolar cells in vivo. Details of these studies are
discussed in section 1.3.3.
1.3 Control ofmammary tissue development during lactation
As discussed above, pregnancy is important in nurturing the necessary growth and
structural development of the gland in preparation for lactation. Although growth of the
gland continues beyond pregnancy in some species, including the rat (see Knight &
Peaker, 1982a for review) the terminal purpose ofmammary development remains the
synthesis and secretion ofmilk, and is the subject of this section. Lactation is a complex
12
physiological process involving the manufacture and secretion of several hundred milk
components. To date, the production of only a few of them has been examined
experimentally. Species differences in the hormonal requirements add to the complexity
of the problem.
1.3.1 Control of milk synthesis
The function of the fully differentiated mammary epithelial cell is the synthesis and
secretion ofmilk. The major components ofmilk, apart from water, are lactose, fats and
milk proteins. In most species, lactose is the predominant milk carbohydrate and is
synthesised within the Golgi complex by lactose synthase, which consists of galactosyl
transferase and the specifier protein a-lactalbumin (see Kuhn, 1983b and Leong, 1990
for review of lactose synthesis). Although lactose, and other milk solids appear in the
gland well before the onset of lactation (Fleet et al, 1975) the major increase in the rate
of lactose synthesis occurs around the time of parturition when copious milk secretion
is triggered by a combination of progesterone withdrawal and increasing levels of
circulating prolactin (see Kuhn, 1983a for review). During lactation, the prime regulator
of lactose synthesis is the concentration of glucose in the Golgi, rather than the activity
of lactose synthase (Faulkner & Peaker, 1987). The mechanism ofmilk protein synthesis
is essentially identical to that of all secreted proteins in eukaryotic cells. Milk protein
genes are under transcriptional, translation and post-translational control by prolactin and
other hormones. The majority of studies have centred on casein, the most abundant
protein produced by the mammary gland; although the induction ofmilk proteins is not
coordinately regulated and casein mRNA expression can occur in the absence of a-
lactalbumin and whey acidic protein (WAP) mRNA expression in vitro (Lee et al, 1984
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and 1985). Effects on gene expression are chronically, rather than acutely, regulated, for
although casein mRNA induction occurs within one hour of prolactin addition in vitro,
marked increases in mRNA levels do not occur until several hours later (Matusik &
Rosen, 1978). This induction is the consequence of an enhanced rate of gene
transcription, with prolactin also acting to stabilise the synthesised transcript and increase
the mRNA half life (Teyssot & Houdebine, 1980 and 1981). Increased levels ofmRNA
tend to result in an increased rate of protein synthesis (Houdebine & Gaye, 1975),
although there are exceptions to this rule such as in the pseudopregnant rabbit
(Houdebine, 1976). A level of post-translational control has been demonstrated in
lactating mice expressing foreign milk protein genes where increased milk protein
synthesis in vitro was not matched in vivo (Wilde et al, 1992). Caseins once synthesised
are also susceptible to intracellular degradation during secretion (Wilde et al, 1992)
although this process appears to be inversely related to the differentiative state of the
tissue (Wilde et al, 1989) and may be more important in tempering net protein secretion
in mammary tissue from pregnant animals.
Fatty acids are synthesised in the cytoplasm of milk secreting cells by acetyl-CoA
carboxylase and fatty acid synthase, with palmitate being the predominant fatty acid in
milk. However, it is triglycerides which make up nearly all milk fat. In the rat, half the
mammary glands requirement is met by circulating lipoproteins, the remaining half from
de novo synthesis within the gland. Glucose is the major precursor of fatty acid in the
lactating rat mammary gland; while acetate is the primary precursor in the ruminant
mammary gland (Laarveld et al, 1985). At peak lactation (10-15 days post partum) the
mammary gland of the rat utilises 30mmol of glucose per day (Williamson & Robinson,
1977) of which about 20mmol is used for lipogenesis, primarily for fatty acid and
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triglyceride synthesis ( Williamson, 1980). The rate of mammary lipogenesis is
stringently regulated according to the level and type of substrate available to the gland
(Munday & Hardie, 1987). Prolactin is involved in the long-term control of lipogenic
enzymes, acting on sheep mammary explants to activate and increase the total level of
acetyl-CoA carboxylase (Barber et al, 1991), the key regulatory enzyme which catalyses
the first reaction committed to fatty acid synthesis. Prolactin is also required for the
induction of fatty acid synthase (Speake et al, 1975). Pyruvate dehydrogenase (PDH) is
another important regulatory enzyme in the lactating rat mammary gland. The PDH
complex is a multienzyme complex which catalyses the oxidative decarboxylation of
pyruvate to acetyl-CoA and is located in the mitochondrial matrix space. The overall
reaction is essentially irreversible and regulates the supply of acetyl-CoA which is
available for oxidation or fatty acid synthesis. Short term regulation of fatty acid
synthesis is achieved by Insulin, which changes the activities of (PDH), acetyl-CoA
carboxylase and glucose uptake.
In addition to hormonal regulation of lipogenesis, medium-chain fatty acids (and ketone
bodies), which are present in rat milk, inhibit lipogenesis, at least in vitro, as a
consequence of a direct inhibition of glycolysis (Heesom et al, 1992). Furthermore, fatty
acids may equally modulate the activity of acetyl-CoA. This acute regulation ofmilk fat
synthesis might offer an additional mechanism ofmodulating the activities of lipogenic
enzymes.
1.3.2 Hormonal requirements of lactation
Parturition results in a marked change in the hormonal milieu and is characterised by
falling levels ofprogesterone as a result of placental loss, and in some species, including
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the rat, placental lactogen. At the same time there is an increase in the circulating levels
of prolactin, oestrogens, oxytocin and adrenal corticoids, these factors taken together
stimulate the onset of copious milk secretion.
In addition, insulin is a very basic hormonal requirement of lactation. The response of in
vitro systems to lactogenic agents is often dependent upon or enhanced by insulin. For
example Topper & Freeman (1980) found insulin to be essential for the stimulation of
milk protein synthesis by prolactin and Cortisol in mammary explants from mid-pregnant
mice. Circulating levels of insulin decrease during lactation, however mammary tissue
is able to function at lower insulin concentrations by increasing its receptor concentration
(Flint, 1982) and remains a highly insulin-sensitive and insulin-responsive tissue (Burnol
et al, 1983 and Jones et al, 1984a, b). In some tissues insulin can produce profound
decreases in cAMP concentrations (and thus PK-A activities) through activation of a
phosphodiesterase. For example, insulin is able to antagonize hormone-activated lipolysis
in adipose tissue, via its activation of a membrane-associated cGMP-inhibited
phosphodiesterase (PDE 3), which leads to a reduction in cAMP, a decrease in PK-A
activity, and a lowering of the phosphorylation and thereby activity of the hormone-
sensitive lipase, the rate-limiting enzyme in the regulation of lipolysis (Elks et al, 1985;
Beebe et al, 1985 and Manganiello et al, 1995).
The importance of prolactin has been demonstrated by studies in which prolactin
secretion was specifically inhibited by administration of ergot-alkaloid bromocriptine
(Cowie et al, 1980). Hormones other than prolactin are also important in maintaining
lactation, in ruminants growth hormone is a potent lactogenic hormone (Cowie et al,
1980), however the effect upon rodents is much more modest.
In the rat, prolactin is the predominant galactopoietic hormone, with its effects being
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modified by growth hormone; treatment with both bromocriptine and anti-growth
hormone serum being required to fully inhibit milk secretion (Madon et al, 1986).
Established lactation, or galactopoiesis requires insulin, glucocorticoid, prolactin and
thyroid hormones. In addition oxytocin is required for milk let-down. This hormone is
released from the posterior pituitary lobe by suckling of the young via a neuroendocrine
reflex. Although both prolactin and oxytocin are secreted in response to suckling young
the physiological roles of these two hormones are quite different. Prolactin acts on the
mammary epithelial cells to stimulate the production and secretion of milk into the
alveolar lumina. Oxytocin acts on the myoepithelial cells facilitating ejection of the milk
from alveoli into ducts and mammary sinuses, thus becoming available to the young.
1.3.3 The extracellular matrix
Culture models ofmammary epithelial function indicate that cell-matrix interactions are
necessary for lactation and for the survival of alveolar epithelial cells in vivo. Since the
alveolus is present in the pregnant and lactating animal only, it is possible that the major
function of basement membrane in this tissue is to contribute to differentiation and to
maintain survival, but only until the cessation of lactation.
Evidence that the basement membrane is important in maintaining cell phenotype has
largely been provided by cell culture models in which mammary epithelial cells were
removed from mid- to late pregnant animals and placed in conventional cell culture. Cells
cultured in this way grew in monolayers and quickly lost their ability to lactate, unable
to synthesize milk protein in response to lactogenic hormones (Emermann et al, 1977 and
Lee et al, 1984). However some epithelial characteristics are retained such as prolactin
receptors (Streuli, 1994).
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The introduction of the EHS matrix has significantly advanced the lactational culture
model (Li, et al, 1987). This is a reconstituted basement membrane isolated from the
murine Engelbreth-Holm-Swarm tumour (Kleinman et al, 1986) and allows cells isolated
as whole alveoli from pregnant mammary glands to retain their morphology and to
secrete milk proteins. Even trypsinized cells from monolayer cultures will form alveolar-
like structures which are capable of secreting milk into the central lumen (Streuli et al,
1991). Furthermore, these cells could be made to express P-casein after several days
culture with prolactin, a function that was blocked by an anti-P,-integrin antibody,
indicating that direct cell-matrix interactions were essential for milk protein expression
(Streuli et al, 1991). The basement membrane has therefore been shown to provide
signals for differentiation that are absent when cells are plated out in monolayers. The
EHS culture model has also been used to confirm the role of the basement membrane in
mammary cell survival. In culture, mouse mammary cells grown on plastic or collagen
I undergo apoptosis. Culture on EHS matrix, results in a 15-fold suppression of
apoptosis, suggesting that mammary cell survival is controlled by the cell-matrix
interaction, and that in the absence of a correctmatrix the cells die by apoptosis (Edwards
& Streuli, 1995).
1.3.4 Local control of milk secretion
In addition to systemic control by circulating hormones, the rate ofmilk secretion by the
mammary gland is modulated locally by changes in the frequency and completeness of
milk removal. More frequent removal ofmilk from a gland produces an increased rate
ofmilk secretion, as when hourly milk removal (Linzell & Peaker, 1971) is compared to
twice daily milk removal (Henderson et al, 1983). These effects are rapidly reversed
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when the gland is returned to twice daily milking (Henderson et al, 1983). The increase
in milk secretion has been shown to result from the removal of amilk constituent, which
acts upon secretory epithelial cells limiting milk secretion. The feedback inhibitor of
lactation of FIL (Addey et al, 1991) has been identified in a fraction of goat whey
proteins of molecular weight 10-30kDa (Wilde et al, 1987). This fraction inhibited
lactose and casein synthesis in rabbit mammary explants and inhibited milk accumulation
in lactating rabbits when introduced into the gland (Wilde et al, 1987).
As well as systemic and local controls, mammary development and lactation are also
subject to external influences such as environment, climate, diet and the number of
suckling young (see Knight & Peaker, 1982a for review).
1.3.5 The role of cAMP
The mitogenic role of cAMP in mammary development has been discussed (section
1.2.3). Several reports have addressed the question of the role of cAMP mediated
mechanisms in acute regulation of aspects of mammary tissue metabolism (Wilde &
Kuhn, 1981., Clegg, 1988 and Clegg & Ottey, 1990). The conclusion to which they point
is that this tissue is refractory to the usual cascade of events initiated by an increase in
cAMP. Thus neither cytosolic phosphorylation events nor the activities of several
enzymes, including lactose synthase and acetyl-CoA carboxylase, are influenced by
raising the concentration ofcAMP inmammary tissue preparations (Wilde & Kuhn, 1981
and Clegg et al, 1986). One possibility to explain these altered responses is that the
cAMP-dependent protein kinase (PK-A) itself has distinctive properties in mammary
tissue, some evidence to this effect has already been reported (Takhar & Munday, 1992).
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1.4 Control ofmammary gland involution
Involution of the mammary gland and the accompanying loss of epithelial cells is a
consequence of events triggered by the cessation of lactation. However the nature of the
cellular signals induced by these events which eventually trigger the epithelial cell death
and the involution remain to be elucidated.
1.4.1 Hormonal controls
The phases ofmammary gland development and function are under stringent hormonal
control, some of these hormones also have a critical role in maintenance of lactation and
retard involution. In most experimental studies, mammary involution is initiated when
animals are in the height of their lactation, usually by removal of the litter. In this way
the role of the suckling stimulus and lactogenic hormones in maintaining lactation can
be demonstrated.
The role of suckling was elegantly demonstrated by (Selye, 1931) who showed that
mammary gland of a lactating rat could be maintained in a secretory state after ligating
galactophores, provided suckling was allowed to continue. Further studies showed that
prolactin, administered daily to lactating rats, segregated from their litters, retarded
mammary involution (Hooker & Williams, 1940). More recently Richards & Benson
(1971) examined in a comprehensive fashion the involution inhibitory effects ofoxytocin
and the anterior pituitary hormones administered singly and in combination. In doing so
they demonstrated that both oxytocin and prolactin would retard mammary involution in
the rat (Richards & Benson, 1971). However, close inspection of the secretory cells
showed that despite the maintenance of lobuloalveolar structure, cell organelles did go
through some involutionary changes when oxytocin alone was administered. More recent
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experiments show that a combination ofGH, prolactin and ACTH were needed in order
to maintain both structure and function of secretory alveoli (Richards & Benson, 1971).
Others have also shown that hydrocortisone and prolactin inhibit mammary gland
regression when injected in high doses into rodents (Ossowski et al, 1979).
1.4.2 Apoptosis and programmed cell death (PCD)
It has been shown that during involution the majority of secretory epithelial cells die by
apoptosis, a form of programmed cell death (Walker et al, 1989., Strange et al, 1992.,
Bielke et al, 1995). Programmed cell death has been recognised in a number of
developmental and remodelling events in tissues and to tumour regression in response
to treatment with chemotherapeutic agents (for review Fesus et al, 1991). Furthermore
it has been recently recognised that similar gene products which were previously
associated with proliferation may also be involved in regulation of programmed cell
death. For instance, c-myc (Even et al, 1992) and p53 (Lowe et al, 1993 and Symonds et
al, 1994) which have been identified as regulators of the G1 phase of the cell cycle are
also important regulators of cell death, both in vitro and in vivo.
1.4.3 The role of cyclic AMP
Apoptosis may also be triggered by cellular signal transducers such as cAMP. Cyclic
AMP can be substituted for glucocorticoid in triggering apoptosis in lymphoid cells
(Dowd & Miesfeld, 1992), and is a major second messenger molecule that regulates the
activity ofprotein kinase A (PK-A). In the nucleus the catalytic subunit ofPK-A exerts
its action at least in part, bymodulating the activity of transcription factors such as CREB
(Montminy & Bilezikjian, 1987) CREM (Foulkes et al, 1991) and AP-1 (Abate et al,
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1991). AP-1 is a classical G1 marker ofproliferating cells. It is a transcription factor and
may consist of dimeric complexes between different Fos and Jun family members as well
as ATF/CREB family members (Hai & Curran, 1991). The synthesis of AP-1 or its
activity in cells can be induced by a wide variety of growth factors and intracellular
signals mediated by protein kinase C, protein kinase A and many oncogene products. In
mouse mammary gland a transient activation of nuclear PK-A occurs very early after
weaning (24h) and peaks at day 1 and 2 of involution (Marti et al, 1994 and 1995). This
coincides with a rise of c-fos, junB, junD and to a lesser extent c-jun mRNA levels and
a transient induction of AP-1 (cfos/junD) DNA binding activity are apparent within 4
days of involution (Marti et al, 1994 and 1995).
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Table 1.1 Regulators of the mammary development, lactation and involution
Development
Fetal Puberty Pregnancy


















1.5 Abnormal mammary growth (breast cancer)
1.5.1 Introductory comments
Breast carcinoma is the most common malignancy in women in North America and
Western Europe, and in the UK carries a higher rate ofmortality than any othermalignant
disease (Forrest, 1986). Despite advances in treatment and screening, only modest
increases in survival have been achieved. One major problem in trying to reduce the
morbidity and mortality from breast cancer is the lack of a clear understanding of the
natural history and molecular pathology of the disease.
It is now acknowledged that both normal proliferative and tumorigenic processes have
many molecular features in common including expression of growth factors (Varmus,
1989 and Cross & Dexter, 1991), extracellular matrix components and proteinases
(Liotta, 1991 and Matisian, 1990), intracellular oncogene and protooncogene products
(Cantley et al, 1991), tumour suppressor gene products (Marshall, 1991) and genes
associated with proliferation.
Furthermore the normal ontogenic growth so far described in the branching
morphogenesis of the mammary gland is relevant to cancer biology. The growth of the
end bud through adipose stroma provides a useful model for tissue invasion, while ductal
elongation must be seen as rapid and aggressive even when compared with highly
malignant tissue, its growth is tightly regulated by tissue-level homeostatic factors. Even
more directly, in the rat the mammary end bud is the target tissue for certain carcinogens.
1.5.2 Mitogenic control
Many of the mammary mitogens and mammogens so far described in the development
ofmammary tissue are also involved in mitogenic signal transduction in human breast
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cancer cells. In this context they are discussed here. The steroid hormone 17P-oestradiol
has been established as a preeminent breast epithelial cell mitogen and an etiological
factor in the development of human breast cancer (Davidson & Lippmann, 1989). The
oestrogen receptor directly controls transcription of genes required for proliferation, such
as thymidine kinase and myc. In addition oestrogen is able to stimulate proliferation
through autocrine and paracrine loops, inducing synthesis and secretion of polypeptide
growth factors TGF-ce, IGF-1 and PDGF (Lippmann & Dickson, 1990). Oestrogens
accelerate the rate ofprogression ofbreast cancer cells through the G1 phase of the cell
cycle. Increased transit rate might result from increased degradation of the mitotic cyclin,
cyclin B1 (Thomas & Thomas, 1994), or increasing the expression of calmodulin
(Rasmussen & Means, 1987) and/or cyclin Dl. Cyclin D1 is a critical determinant of the
GS transit time in human breast cancer cells (Musgrove et al, 1994). Aberrant expression
of cyclin Dl is observed in many human breast cancer cell lines, and may contribute to
neoplastic growth (Keyomarsi & Pardee, 1993). Progestins, IGF-1 and insulin also
stimulate cyclin Dl expression in breast cancer cells and accelerate progression through
the cell cycle (Musgrove et al, 1993).
The polypeptide growth factors EGF, TGF-a and IGF-I and II, basic fibroblast growth
factor (bFGF) and insulin also stimulate breast cancer growth in tissue culture (Lippmann
& Dickson, 1990). Gene related to the EGF receptor include the c-erbB2 (neu or HER2),
c-erbB3 and c-erbB4, which are expressed in breast cancer tissues and associated with
poor prognosis.
The ubiquitous calmodulin protein regulates many calcium-sensitive cellular processes
via the formation of a calcium-calmodulin complex. Essential to cell proliferation it
serves to activate an extensive number of calmodulin sensitive enzymes involved in
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growth regulation. Intracellular cAMP and calcium, cell cycle progression, DNA
replication and mitosis are all subject to regulation by calmodulin.
Finally, with the finding that prolactin receptors are present in both normal and neoplastic
tissue (Field et al, 1993), prolactin has recently been proposed to act as a local growth
factor stimulating mammary tumours (Mershon et al, 1995).
1.5.3 Cross-Talk
The extent to which interactions occur between steroid hormones, polypeptide growth
factors and cAMP responsive pathways in breast cancer cells remains to be fully
understood. The induction of progesterone receptor synthesis by oestrogen is well
characterised. However another important clinical observation is the inverse relationship
which exists between oestrogen and EGF receptor levels found in most tumours,
indicating that mitogenic signals may be initiated either by intracellular oestrogen or by
the transmembrane EGF receptor pathway. Tumours which express mainly EGF receptor
activity are associated with poor differentiation, metastasis and low survival rates. The
two pathways were therefore thought to be independent. However there is evidence that
EGF activates some mitogenic signals through the oestrogen receptor pathway (Ignar-
Trowbridge et al, 1992).
Receptor phosphorylation provides a mechanism for crosstalk between responses
initiated by steroid hormones, polypeptide growth factors and cAMP, protein kinase C
or calmodulin. The oestrogen receptor is phosphorylated on at least 6 serine residues
(LeGoff et al, 1994), of which some are catalysed by PK-A and PK-C. However both
oestrogen and progesterone receptors have been found to exist as phosphoproteins in vivo
(Moudgil,1990). Furthermore ligand binding has been shown to increase receptor
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phosphorylation (Denner et al, 1990). It is possible that a change in phosphorylation state
might alter its ability to activate gene transcription. Some reports have even suggested
that phosphorylation of steroid hormone receptors can increase their binding to specific
DNA sequences (Denner et al, 1989). Treatment of immature rat uterine cells grown in
primary culture with estradiol, IGF-1, or agents which raise cAMP, resulted in a
significant increase in intracellular progesterone receptor (Aronica & Katzenellenbogen,
1991. and Cho et al, 1994). More recent studies using transient transfection of uterine
cells with a simple oestrogen-responsive reporter gene, have shown that agents which
raise cAMP are able to stimulate oestrogen receptor-mediated transcription (Aronica &
Katzenellenbogen, 1993).
Multiple interrelated processes initiate growth in human breast cancer cells. A more
complete understanding of these mitogenic signal transduction pathways might provide
the basis for the development of therapeutic strategies for intervention of human tumour
growth in vivo.
1.5.4 The role of cyclic AMP
There has recently been a profusion of papers describing how cAMP might influence
breast cancer proliferation through a variety ofmechanisms (see section 1.7 for greater
detail). Cyclic AMP is reported to regulate cell growth via the cAMP dependent protein
kinase or PK-A (Krebs, 1972), which depending upon the cell type can inhibit or activate
the MAP kinase cascade through certain phosphorylation events (see section 1.7.1).
However the regulatory subunits (R-subunit) of this kinase have also been the focus of
much investigation. There are two major types of PK-A, type I and type II which are
distinguished by their R-subunits, RI and RII (see section 1.6.2). Human breast cancer
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cell lines express predominantly type I PK-A and this differential pattern of expression
has also been correlated with neoplastic growth. The cAMP analogue, 8-C1 cAMP, as
been used in numerous studies to inhibit the growth of human breast cancer cell lines in
culture, associated with down regulation of the type I PK-A and decreased ras proto-
oncogene protein expression. In mouse mammary cells, inhibition of cell growth was
correlated with the ability of 8-C1 cAMP to decrease the amount of type I PK-A mRNA.
The reduction in the level of type I PK-A with respect to type II PK-A by 8-C1 cAMP
reduced growth rate in these cells and antagonised the proliferation induced by the
polypeptide growth factor TGF-a (Ciardiello et al, 1990).
Cyclic AMP also plays a critical role in breast cancer cell proliferation by modulating the
activity of oestrogen and progesterone receptors. The cyclic nucleotide can also induce
expression of prolactin receptors, an effect that might be mediated through cAMP
dependent activation of the oestrogen receptor pathway (Aronica & Katzenellenbogen,
1993 and Cho et al, 1994). Hence the steroid hormone and polypeptide growth factors
mitogenic signalling pathways are influenced by intracellular cAMP in human breast
cancer cells.
1.6 The cAMP dependent protein kinase or protein kinase A (PK-A)
1.6.1 Introduction
The second messenger cAMP was first observed as a heat stable factor which could be
generated by treatment of a particulate subcellular fraction obtained from rat liver with
adrenaline. Production required the presence of ATP and the factor could induce
activation of the cytosolic enzyme glycogen phosphorylase. Subsequently the active
principle was identified as cAMP. Since the Nobel prize winning work of Sutherland and
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co-workers, who first developed the concept of cAMP as a intracellular second
messenger ofhormone action, many of the signal transduction mechanisms surrounding
cAMP have been characterised.
The discovery ofcAMP was quickly followed by the demonstration that most eukaryotic
cells possess a plasma-membrane associated enzyme adenylate cyclase, which can
produce cAMP from ATP and that activity of this enzyme could be regulated by various
hormones.
With the discovery of the cAMP dependent protein kinase (PK-A) it was quickly realised
that, at least in mammalian cells, PK-A was the major if not only, intracellular receptor
for cAMP. In holoenzyme form (R2C2), PK-A exists as a tetrameric structure composed
of two catalytic subunits (C-subunit) bound to, and inhibited by a regulatory subunit
dimer (R-subunit). PK-A is activated and inactivated as follows:
R2C2 + 4cAMP ^ R2(cAMP)4 + 2C
Inactive Active
Cyclic AMP binds to the R-subunits of the protein kinase and the equilibrium outlined
above, shifts to the right hand side, releasing free C-subunit both physically and
functionally from inhibition by the R-subunits. In its free state active C-subunit mediates
protein phosphorylation which is the primary mechanism of cAMP action in mammalian
cells. Cyclic AMP is hydrolysed by cAMP phosphodiesterases allowing the equilibrium
to shift back to the left hand side, and C-subunit to reassociate with the R-subunits. The
cAMP-specific (Type IV) phosphodiesterases (PDEs) are a diverse family of proteins,
the regulation ofwhich is beyond the scope of this thesis (see Bolger, 1994 for review).
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Cyclic AMP is synthesised by adenylyl cyclases which convert ATP to cAMP and are
controlled dynamically by a variety of hormones, neurotransmitters and other regulatory
molecules (see Tang & Gilman, 1992 for review). Adenylyl cyclase catalytic subunit is
activated or inhibited by the heterotrimeric GTP-binding proteins Gs and G, respectively.
G-proteins are a diverse family of proteins, the a-subunit of which is responsible for
activation or inhibition of adenylyl cyclases (see Gilman, 1995 for review). Therefore
PK-A is responsive to hormones which bind to and activate the ^-adrenergic class of
receptor which are physically coupled to Gs, causing activation of adenylyl cyclase and
increased synthesis of cAMP.
In order that the unmodified form of the protein substrate can be regenerated, a
phosphoprotein phosphatase catalyses a dephosphorylation reaction (see Cohen, 1993 for
review). Thus the steady state, phosphorylation-dephosphorylation equilibrium between
an active and inactive form of a protein is dynamically regulated by protein kinases,
phosphoprotein phosphatases and their respective effectors. Together these constitute a
cyclic cascade system and can provide the cell with an efficient and sensitive control
mechanism that has potential for amplification and cooperativity of response (Figure 1.1).
One of the superficially puzzling aspects of the use of a second messenger system such
as cAMP is that, while many cells possess the components of the system, each responds
in a unique way to a rise in intracellular cAMP; such that in liver cells it promotes
gluconeogenesis and glycogen breakdown, while in the adrenal cortex it promotes
increased steroid release. It appears that many different effector hormones can induce
different responses, all via PK-A.
These varied effects may reflect differences in intracellular responses to cAMP and, since
all the actions are mediated by PK-A, it follows that PK-A must act upon different target
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substrates in each cell type. Different patterns of expression of target proteins for PK-A
phosphorylation may help explain how different tissues are able to respond uniquely to
increases in intracellular cAMP. This hypothesis is dependent upon the broad substrate
specificity of PK-A, as exemplified by the promiscuous phosphorylation of numerous
proteins in tissue homogenates. Thus the way in which a cell responds to a rise in
intracellular cAMP will be determined by available substrates within that cell. Despite
the apparent wide range ofpotential protein substrates in cells, it is clear that, in general
there are only a small number of true target proteins in any given hormone sensitive
tissue. Some restriction is obviously achieved by appropriate compartmentalisation of
cellular proteins, but there are also some structural criteria which are also important. The
enzymewill only phosphorylate serine or threonine residues present within a random coil
i.e. those present in a P-sheet, P-turn or a-helix are not phosphorylated. A consensus
sequence has also been identified as RRX&/TY or RXXRXXS/TY where Y is a
hydrophobic residue (Zetterqvist et al, 1990. and Taylor et al, 1993).
1.6.2. Modulation of PK-A activity
Cyclic AMP itself can influence PK-A expression; negative feedback ofPK-A activity
can be achieved by down-regulation of the level of C-subunit (Hemmings, 1986 and
Schwoch, 1987) presumably by a protease with particular efficiency against free C-
subunit (Alhanaty & Shaltiel, 1979). It can also be achieved by increasing the level ofR-
subunit relative to C-subunit as confirmed by the identification ofRIa as the extinguisher
of cAMP-induced gene responses (Boshart et al, 1991 and Jones et al, 1991). A
consensus cAMP responsive element has been identified within the RIa promoter






























Figure 1.1 Schematic view of PK-A activation and protein phosphorylation
as well as the compensatory increase in RI in cells over expressing C-subunit (Uhler &
Mcknight, 1987).
The ratio ofR-subunits to C-subunit in terminally differentiated tissues has been reported
to be approximately 1.0. This has been demonstrated in a number of species of heart
(Corbin et al, 1977) several tissues from adult rabbits (Hofmann et al, 1977) and in the
postnatal developing rat liver (Wittaack et al, 1983) and rat brain (Lohmann et al, 1978).
This suggests that the two subunits are coordinately regulated. However Uno et al (1984)
analysing yeast mutants with altered cAMP metabolism, determined that the subunits of
protein kinase A were not encoded by the same gene locus, suggesting the possibility that
the levels of regulatory and catalytic subunits could be independently regulated. There
are several reports in the literature indicating that at least under certain circumstances in
some cells there are greater amounts of R-subunit than C-subunit. Richards & Rolfes
(1980) reported that ovarian granulosa cells from immature, hypophysectomised rats
could be stimulated by oestrogen and follicle-stimulating hormones to express a 10-20
fold increase in the level of type II R-subunit with little or no increase in the levels of
either type I R-subunit or C-subunit activity. Conversely, treatment of neuroblastoma-
glioma hybrid cells with dibutyryl cAMP or addition of reagents that elevate intracellular
cAMP have been shown to result in selective increase in the type I R-subunit with no
change in type II or C-subunit levels (Walker et al, 1979 and Lohmann et al, 1983). More
recently Ekanger et al (1989) demonstrated that R-subunit transiently exceeds that of C-
subunit before a period of intense cellular proliferation in the regenerating rat liver. In
this instance both RIa and Rlla were over expressed.
In addition to the R-subunits, another class of endogenous proteins that inhibit the C-
subunit are the protein kinase inhibitors (PKI's). PKI's are small extremely potent
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inhibitors of C-subunit, possessing nanomolar Kj values (White-House & Walsh, 1983
and Van Patten et al, 1991). The inhibition of the C-subunit is very specific, as other
protein kinases are not inhibited by PKI's (Kemp et al, 1988 and Van Patten et al, 1992).
Three PKI isoforms are known to exist, PKIa (Olsen & Uhler 1991a., 1991b and Van
Patten et al, 1991) PKipi (Van Patten et al, 1991 and Scarpetta & Uhler, 1993) and
PKip2 (Scarpetta and Uhler, 1993). The a and p isoforms are products of distinct genes
(Olsen & Uhler, 1991a., 1991b., Van Patten et al, 1991 and 1992) whereas PKipi and
P2 are splice varients of the same genes (Scarpetta & Uhler, 1993). Both PKIa and PKip
are able to inhibit C-subunit with equal efficiency (Van Patten et al, 1992). The PKI
protein and related peptides, containing the pseudosubstrate sequence RRNAI (Scott et
al, 1985) have been used to study phosphorylation by PK-A C-subunit as described else
where in this thesis (Olsen & Uhler, 1989). However, despite a wealth of structural and
biochemical studies a clear physiological role of the PKI's in the cAMP signal
transduction pathway has not yet been elucidated.
1.6.3 PK-A isoenzymes and structural variation
The earliest recognition ofPK-A diversity was based on the elution characteristics of the
enzyme during ion-exchange chromatography on columns of DEAE cellulose (Corbin
et al, 1975). It is now well recognised that two readily distinguishable forms of the
regulatory subunits exist (RI and RII) and that these associate with C-subunit to
constitute the two major isoenzymes of PK-A, namely type I and type II. Tissue
distribution studies have shown that most types of mammalian cells contain both
isoenzymes, although the relative proportions of each vary markedly between tissues. RI
and RII differ in their molecular size (Taylor et al, 1990) and in the autophosphorylation
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site present on RII (ser 95). The phosphorylated protein has a lower affinity for the C-
subunit and hence dissociation will occur at a lower concentration of cAMP (Granot et
al, 1980). Once dissociated, this reaction can be reversed by the action ofphosphoprotein
phosphatases, thus raising the possibility that protein phosphatases may regulate protein
kinase activity selectively at the type II isoform.
In place of the phosphorylation site on RII the RI subunit has a pseudophosphorylation
site, capable ofbinding MgATP. In the presence ofATP, the rate of association of cAMP
saturated RI with the C-subunit is increased, as is dissociation of the cAMP (Chou et al,
1980). Under normal conditions, in healthy cells RI will be saturated with ATP
(Hofmann et al, 1975).
These differences may explain, at least in part the ability ofPK-A isoenzymes to respond
differently to given agonists, thus in certain cells where both isozymes are present,
selective activation of one isoform may be provoked by agonists acting via specific
receptors (Livsey et al, 1984). This is ofparticular interest to the signalling biochemistry
in mammary tissue where it has been shown that certain cAMP signalling pathways
operate as normal, whereas at least one, that communicating with acetyl CoA
Carboxylase is inoperative (Clegg, 1988., Clegg & Calvert, 1988 and Clegg & Ottey,
1990).
Further diversity is produced by molecular heterogeneity among the R-subunits, at least
two forms of each R-subunit type exist (RIa, Rip ,RIIa and RII P) encoded by separate
genes. Details of their tissue and cellular distribution are beginning to emerge; RIa and
Rlla are expressed in most cell types, whereas Rip and RIip are predominantly expressed
in the brain (for review see Taylor et al, 1990a). The C-subunits from both isoenzymes
are indistinguishable by a large number of criteria, i.e. similar chromatographic,
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chemical, physical, immunological, catalytic properties and are able to reassociate with
both type I and type II R-subunits (Uhler & McKnight, 1987). There are different
isoelectric forms (Sugden et al, 1976) but these are not specifically tied to one R-subunit
isoform. However using molecular genetic techniques, C-subunit was also found to
consist of a family ofclosely related gene products Ca, CP and Cy. The isoforms Ca and
CP share greater than 90% homology and are present in all tissues examined, where Ca
is usually the major isoform. Cy shares approximately 80% homology with Ca and Cp
and has different enzymological properties including an insensitivity to the protein kinase
inhibitor peptide (PKI) as a result of a single amino acid substitution at (Beebe et al,
1992). However this isoform is highly restricted in its distribution, only detected in the
human testis (Beebe et al, 1990 and Taylor et al, 1990b). The biological significance of
C-subunit isoforms has yet to be demonstrated; there is no apparent restriction in the
distribution of C-subunit isoforms between type I and type II holoenzyme forms.
However, the apparent conservation between species would argue that this heterogeneity
is not simply adventitious. In addition, various novel C-subunit molecules have been
cloned including a C-terminal splice variant from C.elegans (Gross et al, 1990). Aplasia
neurones have also been shown to contain a collection of structurally and functionally
diverse C- and R-subunits (Beushausen et al, 1992), which are able to target different
substrates (Panchal et al, 1994). A bovine variant has also been identified, CP2
(Wiemann et al, 1991) which lacks the usual myristoylation site and contains in its place
a putative amphiphilic a-helix, such a moiety is usually associated with membrane and
mitochondrial targeting.
C-subunit is also one of a growing number ofproteins found to be acylated (Mcllhinney,
1990). C-subunit is subject to co-translational modification in which a fatty myristoyl
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group is covalently attached to its N-terminal glycine (Carr et al, 1982). This is a
relatively stable modification, however there may be some scope for the co-existence of
both myristoylated and non-myristoylated forms of this protein within a single cell,
increasing heterogeneity ofPK-A still further.
The functional significance of this modification is not apparent, however in some cases
myristoylation has served to target and anchor proteins to a membrane site (Grand et al,
1989). There is also a growing body of evidence that C-subunit may undergo
translocation to a membrane site following dissociation from the R-subunits (Meinkoth
et al, 1990). Howevermutation ofthe N-terminal glycine, thus preventing myristoylation,
does not appear to effect either catalytic activity or the C-subunit's ability to form
holoenzyme, neither does it effect the enzyme's ability to regulate biological processes
occurring in distinct subcellular compartments (Clegg et al, 1989). Other possible
functions of this covalent modification may be related to the stability and turnover of the
protein and therefore the lifetime of the protein in vivo (Yonemoto et al, 1993).
1.6.4 A-Kinase anchoring proteins (AKAPs)
As described above PK-A is a multifunctional enzyme with a broad substrate specificity.
Therefore the question still remains as to how the kinase is able to phosphorylate the
correct target proteins rapidly and preferentially in response to activation by individual
hormones. The discovery that there are two major PK-A isoforms (type I and type II) has
raised the speculation that they may provide additional specificity to the cAMP system
by being preferentially located in different cellular compartments. The traditional view
that the enzyme is free to diffuse throughout the cytoplasm, would lead to an
indiscriminate burst ofphosphorylation following hormone activation and this is clearly
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not the case with only a few target proteins being phosphorylated. Thus a preferred
hypothesis has arisen in which PK-A is compartmentalised and that individual hormones
preferentially activate specific pools of kinase that are co-localised with substrate
proteins. Support for PK-A compartmentalisation is provided by three lines of evidence.
Firstly different hormones activate specific PK-A subtypes (Harper et al, 1985); secondly
cAMP accumulates in different cell compartments in response to different hormones
(Barsony et al, 1990); finally PK-A subunits are detected in different cellular
compartments (Litvin et al, 1984 and Livesey et al, 1982).
A growing body of evidence has shown that type II PK-A holoenzyme can be tethered
at specific subcellular locations through interaction of its R-subunits (RII) with A-kinase
anchoring proteins (AKAPS). Biochemical and immunological studies have shown that
PK-A localisation is directed through the R-subunit (Scott, 1991). Initially PK-A
anchoring proteins were identified as contaminants that co-purified with RII after affinity
chromatography on cAMP agarose. Further detailed studies were made possible by the
development of the overlay assay, essentially a modification of the western blotting
procedure, in which proteins fractionated from cell extracts, potentially containing
AKAPS, were immobilised on nitrocellulose (Lohman et al, 1984 and Carr et al, 1992a).
The majority of RH-anchoring activity is detected in particulate, cellular fraction,
implying attachment to membrane and cytoskeletal components (Scott, 1991).
Furthermore tissue-specific patterns ofRII anchoring proteins have also been found (see
Scott & Carr, 1992 for review).
Most recently the functional significance of the RIip isoform and PK-A localisation has
been elucidated in white and brown fat cells, where it is the principle R-subunit isoform.
Cummings et al (1996) described the features of gene knockout mice specifically bred
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to lack the gene encoding RIip. Loss of the RIip gene was compensated for by an
increase in RIa, PK-A activity in brown adipocytes was stepped-up, giving increased
energy expenditure, leanness and a marked resistance to diet-induced obesity. Although
the AKAP and compartmentalization of PK-A in brown adipocytes is unknown, the
isoform switch from type I to type II in RIip deficient brown fat cells is likely to cause
subcellular redistribution of PK-A, possibly contributing to the disregulation ofPK-A
activity.
Utilising recombinant DNA and protein chemistry techniques, a family ofRII deletion
mutants have been screened in order to map the AKAP-binding region on RII (Scott et
al, 1990 and Taylor et al, 1990). This was narrowed down to the N-terminal region of
RII, a region which has also been shown to be important for the dimerisation of RII
(Scott et al, 1990). In order to define more closely the AKAP-binding and dimerisation
domains, amino-terminal deletion mutants were constructed lacking the first five or ten
amino acids ofRlla. Both mutants were unable to bind AKAPs (as assessed by overlay)
and only the five amino deletion Rlla retained the ability to dimerise. Thus it appeared
that the AKAP-binding determinants were within the first five amino acid residues of the
Rlla protomer, whereas determinants of dimerisation were located closer to the C-
terminal. To identify their individual contribution to AKAP-binding, residues were
systematically replaced by alanines; in this way residues 3 and 5 (both isoleucines) were
shown to be ofcritical importance inRlla interaction with AKAPs (Hausken et al, 1994).
Complementary studies have examined the regions within AKAPS that interact with RII.
However a comparison of several primary AKAP sequences has showed no striking
homology between them, suggesting that the RII binding site is a conserved secondary
motif such as a amphipathic a-helix. Using computer aided structure analysis, an area
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predicted to be amphipathic helix was identified and shown to be shared by all AKAPS
examined (Scott & Carr, 1992., Carr et al, 1991., Carr et al, 1992a., Carr et al, 1992b.,
Coghlan et al, 1994 and McCartney et al, 1995). Disruption of this structure by the
introduction of a proline residue proved to inhibit AKAP/RII interaction (Carr et al, 1991
and Carr et al, 1992a). Furthermore, a synthetic peptide (anchoring inhibitor peptide)
encompassing the putative helical region blocked all RII-AKAP interaction (as measured
by overlay) and bound RII or the type II holoenzyme with nanomolar affinity (Carr et al,
1992a).
The anchoring inhibitor peptide has been used in certain critical experiments to determine
whether disruption of the anchoring could antagonise certain cAMP responsive events.
Using whole cell electrophysiology recording techniques it has been shown that
anchoring of PK-A by AKAPs is essential for the modulation of a-amino-3-hydroxy-5-
methyl-4-isoxazole-proprionic acid (AMPA) kainate responsive glutamate currents. This
was achieved by using a microelectrode as a delivery system to introduce the anchoring
inhibitor peptides into cultured hippocampal neurones (Rosenmund et al, 1994). The
anchoring inhibitor peptide blocked AMPA/kainate responsive currents; this effect was
mimicked by the PK-A inhibitor peptide (PKI), however the effect of both peptides was
not additive. Inhibition by the former was overcome by addition of C-subunit protein,
suggesting the anchoring inhibitor peptide interfered with PK-A dependent
phosphorylation but did not directly inhibit kinase activity. Control peptides unable to
block RII/AKAP interaction had no effect. These observations are supported by similar
work carried out using the L-type Ca2+ channels in skeletal muscle cells (Johnson et al,
1994). These observations provide evidence that PK-A anchoring is a physiologically
relevant regulatory mechanism, ensuring rapid and preferential phosphorylation of key
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substrates. Until recently the AKAPs were thought to function exclusively in the
localisation ofPK-A. However, this view has now been modified with the discovery that
certain AKAPs also function to localise the phosphatase 2B, calcineurin (CaN). The yeast
two hybrid system has been used (Durfee et al, 1993) to identify AKAP target proteins
in mouse. It was found that AKAP79 interacted with calcineurin, but not with the RII
alone. This suggested the existence of a ternary complex between CaN, the AKAP and
PK-A. Such a complex had been identified in bovine brain by two separate fractionation
methods (Coghlan et al, 1995a) Firstly, CaN was immunoprecipitated from purified
bovine brain extracts and was shown to co-precipitated with both AKAP75 (bovine
homologue ofAKAP79) and PK-A. Secondly, AKAP75 and the CaN holoenzyme were
co-purified (on cAMP-agarose) with R-subunit and specifically eluted using the PK-A
anchoring inhibitor peptide. Co-localisation ofkinases and phosphatases may account for
the exquisite modulation of certain phosphorylation events that are necessary for
maintaining cellular homeostasis.
1.6.5 Nuclear translocation of PK-A and gene transcription
Transcriptional regulation of eukaryotic genes by cAMP requires the presence of the
cAMP dependent protein kinase, ofwhich both R- and C-subunits have been postulated
to play a role in gene transcription (Constantinou et al, 1985., Cho-Chung, 1980 and
1993). The R-subunits which bind cAMP have also been shown to bind DNA (Jungmann
et al, 1986 and Wu & Wang, 1989) and share structural homology with the bacterial
catabolite activator protein (CAP) which can directly stimulate gene expression. However
there is some difference of opinion as to whether R-subunits enter the nucleus. The
cAMP analogue 8-C1 cAMP is reported to induce rapid nuclear translocation of RII(3
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(Ally et al, 1988). While more recent studies, involving microinjection of fluorescently
labelled subunits and holoenzyme have reported rapid and reversible translocation of the
C-subunit to the nucleus while type I holoenzyme and RI remained in the cytoplasm
(Meinkoth et al, 1990 and Adams et al, 1991). There is also growing evidence that the
free C-subunit may be all that is required for gene transcription (Riabowol et al, 1988 and
Grove et al, 1987). Therefore it remains uncertain as to whether R-subunits serve any
function other than to anchor and inhibit C-subunit.
Nuclear localisation of the C-subunit in stimulated cells has been suggested by
immunological studies using antibodies directed against the C-subunit (Nigg et al, 1990),
immunofluorescence studies (Byus & Fletcher, 1982) and studies using the thermostable
PK-A inhibitor (Whitehouse & Walsh, 1983). It has been further postulated that free C-
subunit possesses a potential nuclear localisation signal which is blocked by binding of
the R-subunits or the thermostable PK-A inhibitor peptide, PKI (Wen et al, 1995.,
Meinkoth et al, 1990 and Fantozzi et al, 1992). Once in the nucleus C-subunit can affect
the expression of a number of gene products. Cyclic AMP regulated gene expression
frequently involves a DNA element known as the cAMP regulated enhancer or cAMP
response element (CRE). Many transcription factors bind to this element including the
protein CREB (Montminy & Bilezikjian, 1987), which becomes activated as a result of
phosphorylation by PK-A (Gonzalez & Montminy, 1989). This modification stimulates
the interaction with one or more of the general transcription factors or allows the
recruitment of a co-activator such as CBP, CREB binding protein (Chrivia et al, 1993).
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1.7 Cyclic AMP dependent protein kinase and cellular proliferation and growth
Cyclic AMP has long been implicated in the regulation of growth in both normal and
malignant cells (Cho-Chung et al, 1991) including breast cancer cells (Houge et al, 1992
and Miller et al, 1985). This second messenger is also implicated in apoptopic cell death
in lymphoid cells and recently, activation ofPK-A was found to be associated with the
induction of programmed cell death during involution of the lactating mammary gland
(Marti et al, 1994).
1.7.1 Cross talk with the MAP kinase cascade
In mammalian tissues the mitogen activated protein kinase (MAP kinase) is rapidly
phosphorylated and activated in response to many extracellular stimuli including growth
factors, hormones and neurotransmitters. The various stimuli which can activate theMAP
kinase cascade employ distinct initial signal transduction pathways. Some such as EGF
and insulin induce receptor tyrosine kinase (Ahn et al, 1991 and Sturgill et al, 1988); or
non-receptor tyrosine kinases (Klauser & Samelson, 1992 and Gupta et al, 1992). Others
stimulate G-protein coupled receptors, generating the second messengers diacylglycerol,
inositol 1,4,5 trisphosphate, calcium or activating ion channels (Bading & Greenberg,
1991., Ely et al, 1990., Vouret-Crariari et al, 1993 and Winitz et al, 1993).
It is likely that the MAP kinase cascade serves specific functions in different cell types.
In PC 12 cells nerve growth factor (NGF) induces neuronal differentiation, via the MAP
kinase cascade (Cowley et al, 1994). However in other cell/tissue models MAP kinase
activation is associated with growth and proliferation. Activation ofMAP kinases has
been closely correlated with the control of cell cycle progression in fgfg cells (Mailer,
1991). For receptor tyrosine kinases a sequence of events leading to MAP kinase
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activation is emerging. Activated receptor tyrosine kinase increase GTP binding to c-Ras
through guanine nucleotide exchange factors and adapter proteins leading to its
activation. Activated c-Ras may then activate c-Raf kinase by direct binding (Wame et
al, 1993., Marshall et al 1994 and 1995), c-Raf can phosphorylate and activate MAP
kinase kinase (Dent et al, 1992), which in turn phosphorylates and activates MAP kinase
(Gomez & Cohen, 1991). Many transforming oncogenes encode mutant proteins whose
corresponding proto-oncogene products are components of this signal transduction
network and are activated in response to growth factor receptor stimulation (Nakielny et
al, 1992).
The effect of cAMP upon the MAP kinase cascade has been delineated in several cell
types including Rat-1 and NIH 3T3 fibroblasts, rat adipocytes and human arterial smooth
muscle cells (Burgering et al, 1993., Cook and McCormick, 1993., Graves et al, 1993.,
Sevetson et al, 1993 and Wu et al, 1993). In these cells cAMP inhibits the activation of
Raf-1, resulting in the inhibition ofboth growth factor stimulated cell proliferation and
MAP kinase activation. It has been further shown that Raf-1 is phosphorylated by PK-A
at a consensus sequence within the Raf-1 regulatory domain (Wu et al, 1993) reducing
the affinity ofRaf-1 for Ras.
While growth factors and cAMP have antagonistic effects on fibroblast growth, both
NGF and cAMP have been shown to induce neuronal differentiation ofPC 12 cells (Green
& Tischler, 1976., Schubert et al, 1978., Gunning et al, 1981 and Richter-Lansberg &
Jastorff, 1986). Moreover the treatment ofNGF plus cAMP has been shown to have a
synergistic effect on neurite formation (Gunning et al, 1981 and Richter-Lansberg &
Jastorff, 1986). The way in which cAMP induces differentiation is unclear, however such
findings have led to speculation that cAMP might actually stimulate the MAP kinase
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cascade in PC 12 cells. Some reports have disagreed with this hypothesis (Frodin et el,
1994 and Vaillancourt et al, 1994). However, more recent work has shown that PK-A
probably interacts by phosphorylation of Raf-1 (Erhardt et al, 1995 and Kikuchi et al,
1996). One of the major differences between the Ras/Raf/MEK/MAP kinase cascades in
PC 12 and rat fibroblast cells is the presence ofB-Raf in PC 12 cells, in which it appears
to be the majorMEK activator (Jaiswal et al, 1994 and Moodie et al, 1994). The PK-A
consensus sequence that is present on Raf-1 is not present on the B-Raf moiety
(Sithanandam et al, 1990). There is some evidence that B-Raf is resistant to inhibition by
PK-A and that this might in some way contribute to the cAMP stimulation of the MAP
kinase cascade in PC 12 cells (Erhardt et al, 1995).
1.7.2 RI as a positive regulator of cell growth
As already discussed PK-A exists as type I and type II isoenzymes which are
distinguished by their different R-subunits, RI and RII. The ratio of the two isoenzymes
has been shown to vary according to the phase of growth of the cell cycle. An enhanced
expression ofRI has been correlated with active cell growth and cell transformation, or
the early stages of differentiation, while a decrease in RI and/or increase in RII has been
correlated with growth inhibition and differentiation/maturation (Lohmann & Walter,
1984). Furthermore, differential expression ofRI and RII subunits and their mRNA has
also been correlated with neoplastic transformation and tumour growth. RI is the major
if not sole R-subunit of PK-A detected in a variety of human cancer cell lines (Cho-
Chung et al, 1989), including those derived from hormone-dependent and hormone
independent breast cancers. However, in primary breast tumours the picture is less clear;
significant increases in the RI/RII ratio (Handschin & Eppenberger, 1979), increases in
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RI (Weber et al, 1981) or no change at all in the RI/RII ratio (Handschin et al, 1983) have
all been reported. Changes in the pattern of PK-A isoenzyme expression have been
commonly observed accompanying in vitro cell transformation (for review see Cho-
Chung, 1993). Alteration in PK-A isoenzyme expression has also been found during
carcinogenesis. During dimethyl-benz(a) anthracene (DMBA)-induced mammary
carcinogenesis in rats, there was a transient increase in RI which coincided with the
action of the carcinogen in the mammary tissue (Cho-Chung et al, 1987). An increase in
RI also appears to be an early response to a variety of growth stimulatory agents, such
as TGF-a in normal rat fibroblasts (Tortora et al, 1989), and oestrogen in rat uterus and
DMBA-induced rat mammary carcinoma (Houge et al, 1992). Thus, RI appears to be a
positive effector ofcell growth responding to a variety of types ofgrowth (both ontogenic
and neoplastic) and stimulatory signals. One obvious difficulty with this concept derives
from the fact that R-subunits do not possess catalytic activity. There has been some
speculation that the R-subunits have a separate functional role which is unrelated to
kinase activity and this remains open to question.
The use ofRIa retroviral vectors provided the first direct evidence for a role ofRI in cell
proliferation (Tortora & Cho-Chung, 1990). Human mammary MCF-10A, rat thyroid
FRTL5 and Chinese hamster CHO cells were all infected with the RIa retroviral vector.
These cells showed morphological changes and were able to proliferate in a hormone
independent manner, exhibiting a cell cycle distribution similar to that of the parent
MCF-10A cells growing in the presence ofhormones and serum (Tortora et al, 1992).
The use of the synthetic cAMP analogues has been one favoured approach to test the
biological effects of PK-A. One such analogue, 8-C1 cAMP has been reported to have
unique growth-inhibiting effects under physiological concentrations (/iM), in a number
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of different cell lines, without causing cytotoxicity (Katsaros et al, 1987 and Tagliaferri
et al, 1988). It appears to inhibit growth while allowing cells to progress through their
normal cell cycle, albeit at a slower rate (Pepe et al, 1991). Thus, 8-C1 cAMP does not
prevent mitosis like cytotoxic drugs. Its mechanism of action has been ascribed to its
ability to selectively modulate the RI and RII isoforms, by down regulating the RI and
up regulating the RII isoform, thus restoring the normal balance of R-subunits (Rohlff
et al, 1993). The analogue does not affect the catalytic subunit ofPK-A (Roger et al, 1988
and Vintermyr et al, 1993). Furthermore, its effects in neoplastic mouse lung epithelial
cells have been shown to be independent of the PK-A activity (Lange-Carter et al, 1993).
Growth inhibition of a number of cell lines by 8-C1 cAMP, has also been shown to be
accompanied by suppression ofmyc and ras proto-oncogenes and TGF-a, morphological
changes, differentiation and reversal of transformation (Cho-Chung et al, 1989). This is
of immediate relevance to clinical oncology as 8-C1 cAMP has been included in
preclinical trials for the treatment ofhuman breast cancer (Cho-Chung, 1992a). However,
recent reports have suggested that the growth inhibitory effects of 8-C1 cAMP in CHO
cells and lymphoblasts were caused by biological active metabolites of 8-C1 cAMP rather
than the intact analogue (VanLookeren Campagne et al, 1991). This finding was
subsequently disputed with the report that non-hydrolysable forms of this analogue also
cause growth inhibition in HL-60 cells (Yokozaki et al, 1992).
The possibility that the type I R-subunit is a positive regulator of cell growth, essential
for cancer cell growth, has been explored with the use of antisense
oligodeoxynucleotides, which are complimentary to RI mRNA. It was found that
depletion of RIa using this strategy led to growth arrest in human cancer cells of
mammary or epithelial origin, including breast (MCF-7), colon (LS174T) and gastric
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(TMK-1) carcinoma, with no sign of cytotoxicity (Yokosaki et al, 1993). The effect of
RI antisense was further correlated to a decrease in RI and a concomitant increase in RII
levels. However the coordinated expression ofRI and RII was without effect upon C-
subunit levels.
The increase in RII might be responsible for the observed differentiation of cells treated
this way. Evidence for this is provided by the finding that exposure of cells to RII
antisence oligonucleotides results in a blockage in cAMP induced growth inhibition and
differentiation, at least in HL-60 cells (Tortora et al, 1990).
In conclusion, it has been proposed that the two isoforms of the PK-A regulatory subunit,
RI and RII, are positive and negative regulators, respectively of cell proliferation, a
unifying hypothesis to explain cAMP stimulation versus inhibition of cell growth. Thus,
cancer cells can acquire differentiation and stop growing upon the restoration of a normal
balance ofRI/RII via the use of antisence oligonucleotides.
By comparing the morphological and biochemical effects of 8C1 cAMP as compared with
those induced by okadaic acid (a ser/thr phosphatase inhibitor) which is known to induce
apoptopic cell death, it was shown that 8-C1 cAMP induces apoptopic rather than necrotic
cell death in a human mammary carcinoma cell line (MCF-7) (Boe et al, 1995). These
effects of 8-C1 cAMP were mimicked by the metabolite 8-C1 adenosine, while stable
cAMP analogues such as 8-CPT cAMP and N6-benzoyl cAMP, or foskolin failed to
induce cell death. Thus the effects of 8-C1 cAMP in inducing apoptopic cell death seem
to be independent ofPK-A activation, occurring through conversion to potent cytotoxic
metabolites.
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1.8 Aims of this study
The aim of the present study was to gain insight into the modulation ofPK-A activity
throughout the normal pregnancy/lactation/involution cycle of the rat mammary gland.
Primary objectives were (i) to assess whether expression ofPK-A generic C-subunit and
of the individual regulatory subunits (R-subunits: RI and RII) were developmentally
regulated in rat mammary tissue; (ii) to evaluate the possibility that catalytic activity of
C-subunit is acutely modulated in mammary tissue throughout the
pregnancy/lactation/involution cycle. Three distinct isoenzymes of C-subunit (a, P and
y, see section 1.6.2) have been described; since no functional significance has been
suggested for this diversity it was hoped to determine whether selective expression of the
isoforms occurred between pregnancy and lactation. Therefore the expression of Ca and
CP genes were probed in rat mammary tissue by northern-blotting of their mRNA
transcripts. This also enabled correlation of the steady-state level of these mRNAs and
of total PK-A activity with C-subunit protein mass, allowing the molecular level ofPK-A
regulation and consistency of C-subunit specific activity to be determined. C-subunit
protein mass was determined by an immunochemical method, customized to deal with
the problems inherent in measuring this protein at low concentrations in rat mammary
tissue.
Aberrant regulation of acetyl-CoA carboxylase has been reported in mammary tissue
from lactating animals (Clegg, 1988 and Clegg & Calvert, 1988). Since the regulation of
this enzyme is initiated via a cAMP-dependent mechanism, there have been some
suggestions that mammary PK-A has distinctive properties; some evidence has been
reported in support of this (Takhar & Munday, 1992). In order to identify any
distinguishing characteristics ofmammary tissue C-subunit, the present study also aimed
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to examine the immunochemical properties of the PK-A C-subunit throughout pregnancy
and lactation. Ofparticular interest was the maintenance of the specific catalytic activity
of the C-subunit which was determined in conjunction with total PK-A activity and C-
subunit protein mass, as described above.
The regulatory subunits ofPK-A have been the subject ofmuch investigation (see section
1.5.4) in which the enhanced expression of the RI isoform has been linked to neoplastic
growth, cell transformation, or the early stages of differentiation; most of the published
work relating specifically to the mammary gland has focused upon neoplastic cell
growth. R-subunit levels were determined using the photoaffinity label 8-azido-
[32P]cAMP to examine mammary tissue extracts for their content of R-subunit isoforms
and other cAMP binding proteins. The work described here hoped to examine the
relationship between expression ofR-subunit isoforms during normal ontogenic growth
and development of the mammary gland which occurs throughout pregnancy and
lactation.
One further objective was the measurement ofPK-A activity in mammary tissue during
pregnancy, lactation and involution in order to relate functional changes in mammary
PK-A to the developmental state of the tissue. Both "total", measured in the presence of
excess cAMP, and its "expressed" activity, representing dissociated free C-subunit
present within the tissue at the time of sampling to measure expressed activity of
mammary tissue, were measured.
With the discovery that cAMP may be a signal transducer for involutionary processes in
other tissues (Dowd and Miesfield, 1992); the study further aimed to determine the
pattern ofPK-A expression in rat mammary tissue during involution. PK-A activity, C-
subunit protein mass, C-subunit mRNA and expression of R-subunit isoforms were all
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examined in animals whose litters had been removed and comparisons were made with







Female Wistar rats were studied at various, defined stages of pregnancy and lactation.
Animals were given food and water ad libitum, and were fed on the C.R.N (E, expanded)
animal diet from S.D.S, Witham, Essex. All animals were maintained on a constant
lighting schedule (lights on between 08:00-20:00h), all experiments were started between
09:00 and 10:00h. For studies involving pregnant animals, only those carrying 8 or more
fetuses were used, while for lactating rats, litter size was adjusted to 10 pups after birth.
Litter removal
Pups were removed from day 10 lactating rats, day 1 being defined as the first day to
immediately follow the birth of the pups. Rats were then sacrificed 24h (LR24) and 48h
(LR48) following removal of the litter.
Prior to tissue sampling rats were anaesthetized with a non-recovery dose of sodium
pentobarbital (60mg/kg body weight), delivered intraperitoneally. Dissection commenced
once deep anaesthesia was attained. The mammary tissue was first freed from skin and
abdominal wall, without cutting through major blood vessels before being freeze-
clamped between aluminium tongs cooled in liquid nitrogen, excised and cryopulverized.
Thus the gland was sampled with the circulation intact. Pre-weighed aliquots of




Sheep were Finn-Dorset Horn cross-breds, between 2 and 5 years of age. Mammary
samples were taken from approximately 100 day pregnant ewes and ewes into their 15-
25th day of lactation. Animals were fed on hay ad libitum, plus a cereal mix (425g/day)
fed as two meals at approximately 07:00 and 16:00h. On the day of sampling animals
were deeply anaesthetized by intrajugular infusion of sodium pentobarbital (30mg/kg
body weight), delivered via a cannula which had been inserted the previous day.
Subsequently, animals were exsanguinated and tissue quickly excised and
cryopulverized. Tissue was stored at -70°C in pre-weighed aliquots prior to use.
2.1.3 Chemicals
All chemicals used were of analar grade or above, from the following suppliers:-












Calbiochem Novabiochem, Nottingham, Nottinghamshire.
Bistris propane
Fisons Scientific Equipment, Loughborough, Leicestershire.
(COOH)2 Mg (4H20)
HC1












Fluka Biochemika Ltd, Glossop, Derbyshire.
Bisbenzimide (H33258)
EGTA
Premier Brands UK Ltd, Stafford, Staffordshire.
Marvel (Skimmed milk powder)







2.1.4 Electrophoresis, Western blotting and immunodetection chemicals
Amersham International Pic, Amersham, Buckinghamshire.
ECL reagents 1 and 2 (RPN 2106)
HyBond-C extra
Biometra Ltd, Maidstone, Kent.
Bis-2 solution (2% ultra pure grade bis-acrylamide)
Acryl-40 solution (40% w/v ultra pure grade acrylamide)
Acryl/Bis 37.5:1 solution (38.98% w/v ultra pure grade acrylamide and 1.04% w/v bis-




Biorad, Hemel Hempstead, Hertfordshire.
Dye reagent concentrate (Bradford protein assay)
Hydroxyapetite (HAP)
Bohringer Mannheim UK (Diagnostics and Biochemicals) Ltd, Lewes, East Sussex.
Fatty acid free BSA





Sigma Chemical Company Ltd, Poole, Dorset.
Activated charcoal (untreated powder)
5'AMP (sodium salt, type II from yeast)
ATP (disodium salt)
Bovine Serum Albumin (Fraction V)






Prestained molecular weight markers
Soyabean Trypsin Inhibitor (Type II-S)
Specific PK-A inhibitor peptide (synthetic peptide corresponding to the active site of the
heat stable inhibitor protein of the cAMP dependent protein kinase, Cheng et al, 1986).
Whatman International Ltd, Maidstone, Kent.
DE-52 (DEAE cellulose)
Other
PK-A C-subunit peptides 322-332 and 1-12, synthesized as described in section 2.3.1
54
2.1.6. Radiolabeled chemicals
Amersham International Pic, Amersham, Buckinghamshire.
[y-32P] ATP (^4500 Ci/mmol)
ICN Pharmaceuticals Inc
8-azido adenosine 3',5'cyclic [32P] monophosphate (50 Ci/mmol)
Sodium 125I(17Ci/mg I)
2.1.7 Enzymes
BoehringerMannheimUK (Diagnostics and Biochemicals) Ltd, Lewes, East Sussex.
Endoproteinase Lys-C sequencing grade
Endoproteinase Glu-C sequencing grade
In-house
Recombinant PK-A C-subunit (unmyristoylated)
2.1.8 Drugs and hormones
Calbiochem Novabiochem (UK) Ltd, Beeston, Nottingham.
Forskolin
Sigma Chemical Company Ltd, Poole, Dorset.
Sodium pentobarbital
2.1.9 Antibodies
SAPU (Scottish Antibody Production Unit) Carluke, Lanarkshire.
Anti sheep/goat IgG serum (donkey)
AP-linked anti sheep IgG serum (donkey)




As-365, anti peptide 322-332/C-subunit serum (sheep), as described in section 2.3.
ab-365, anti C-subunit IgG, affinity purified from As-365, as described in section 2.3.5.
As-201, anti peptide 1-12/C-subunit serum (sheep)
2.2 Preparation and synthesis of materials
2.2.1 Purification of PK-A catalytic subunit
PK-A C-subunit was purified from sheep heart and mammary tissue (both pregnant and
lactating) by the method described by (Flockhart & Corbin, 1984). All operations were
carried out at 0-4°C. After excision tissue was quickly trimmed, diced and rinsed in
normal saline before being frozen at -70°C until required. Approximately 200g of tissue
was used per purification, and this was homogenised in 3 volumes of buffer (lOmM
potassium phosphate, ImM EDTA and O.lmM DTT pH 6.8 containing protease
inhibitors O.lmM PMSF, ImM benzamidine-HCl, 0.2/ig/ml soyabean trypsin inhibitor
and 25/zg/ml leupeptin) using a Waring blender at top speed, for lmin. The resulting
homogenate was then centrifuged at 10,000 rpm, for 30min. Supernatant was saved and
the pellet resuspended in the original volume of homogenisation buffer, repeating
homogenisation and centrifugation steps. The supernatants from both spins were
combined, filtered through glass wool and added to DEAE cellulose (55g) equilibrated
in homogenisation buffer. This mixture was then incubated at 4°C for 3h, stirring every
15min. The DEAE cellulose was batch-washed with 4 x 750ml homogenisation buffer,
and the resulting slurry poured into a column (6cm x 4.5cm, 130ml packed bed volume).
The column was washed overnight, using a total volume of 750ml (55mM potassium
phosphate, ImM EDTA and O.lmM DTT pFI 6.8) and was eluted with a cAMP
containing buffer (45mM potassium phosphate pH 6.8, O.lmM DTT and O.lmM cAMP
added immediately before use), at a flow rate of 2.72ml/min. Fractions (6.8ml) were
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collected at 2.5min intervals; 64 fractions being collected in total. UV absorbance
(280nm) was measured throughout the procedure, in order to monitor protein elution. A
small aliquot was taken from each fraction, diluted 1:100 in homogenisation buffer
containing 0.075% w/v BSA (fraction V) and assayed for PK-A activity (as described in
section 2.6.2). Those fractions representing the activity peak, (typically 20-55) were
pooled and loaded onto a HAP-column (1.5cm x 12cm) equilibrated in buffer (40mM
potassium phosphate, O.lmM DTT pH 6.8) at 2.5ml/min. The column was then washed
in this same buffer, and at the same flow rate for approximately 30min, or until the UV
absorbance monitor had returned back to base line indicating no further elution of
protein. Bound protein was eluted from the column in 2ml fractions by application of a
linear phosphate gradient (40-350mM potassium phosphate, O.lmM DTT pH 6.8) at a
flow rate of lml/min. The column was then eluted further with 350mM potassium
phosphate, O.lmM DTT pH 6.8 (60ml). Forty (2ml) fractions were collected in total, for
assay of PK-A activity aliquots of each fraction were first diluted 1:100 in BSA
containing buffer as described above. Active fractions were pooled (usually 20-30), and
diluted into 3 vols distilled water. In a final concentration procedure, the diluted pool was
pumped at a flow rate of 2ml/min onto a small HAP-column (1 x 1cm), equilibriated in
40mM potassium phosphate and O.lmM DTT pH6.8. The column was eluted manually
with buffer (350mM potassium phosphate, O.lmM DTT pH 6.8), from which 7x10 drop
fractions were collected, of which number 7 was ultimately discarded, its primary
purpose being to define the volume of the 10 drop fractions (approximately 0.5ml). A
sample of each remaining fraction was diluted 1:1000 and assayed for PK-A activity.
Protein was also measured as described in section 2.5.1. Less active fractions were
discarded, glycerol was added to retained fractions (final concentration of 50% v/v)
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which were then stored at -20°C. Glycerolised fractions were subjected to SDS-PAGE
analysis on 10% Laemmli gels (as described in section 2.5.4 and 2.5.5), sufficient protein
being loaded so as to give a "readable" result after staining with Coomassie blue
(approximately 2-3^g). A pure preparation produced a single band ofpredictedmolecular
weight (40kDa).
2.2.2 Autophosphorylation of PK-A C-subunit
32P-labelled C-subunit was prepared for use as an internal standard, enabling the recovery
ofC-subunit to be monitored throughout the various stages of the immuno-quantification
experiments (details in section 2.7). On the day of the autophosphorylation the following
solution was prepared 26.7mM MOPS/KOH pH 7.0, 21.3mM magnesium acetate,
5.3mM DTT. This solution was then used in the formulation of the following reaction
mixture, inside a screw top Eppendorf tube; 13mM MOPS, 10.7mM magnesium acetate,
2.7mM DTT, 10% v/v Triton X-100, 180/iCi [y-32P] ATP and 20/^g C-subunit, total
volume 1090fA. The reaction mixture was incubated at 30°C for 30min before being
quenched by the addition of 200/il phosphatase inhibitor mix (200mM NaF, 20mM
EDTA, 20mM EGTA, 5mM sodium pyrophosphate, 0.2mM sodium orthovanadate pH
7.0 with NaOH). The following were then added to the mixture; 5mg/ml cytochrome c
(50//1), lOOmM ATP (100/il) and 4.23ml bistris propane buffer (20mM bistris propane,
0.1mM DTT, 0.1% w/v NaN3, 10% v/v glycerol and 0.01% w/v BSA (fatty acid free),
pH 6.8 with HC1). The solution was mixed and loaded onto a CM-sepharose column
(lcm x 1cm) pre-equilibrated in the same bistris propane buffer. The column was washed
with 5 x 0.5ml buffer and eluted with 5 x 0.5ml bistris propane buffer (additionally
containing 300mM NaCl). Fractions (approximately 0.5ml) were collected and glycerol
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(0.5ml) added to the most radioactive fractions, which were then stored at -20°C. All
fractions and washes were subject to TCA precipitation analysis (as described in section
2.5.3). However fractions containing the putative phosphorylated C-subunit were also
subjected to SDS-PAGE analysis, followed by autoradiography (as described in section
2.5.4 and 2.5.10) in order to assess the degree of the autophosphorylation and association
of radioactivity with the C-subunit.
2.2.3 Iodination of Protein G
This reagent was prepared as a means of detecting IgG molecules bound indirectly to
nitrocellulose blots via their cognate antigens. The following reagents were dispensed
into Iodogen coated tubes and incubated at room temperature for 20min; 0.5M Na-
phosphate buffer pH 7.4 (10/H), 0.5mg/ml Protein G in 1M Na-phosphate buffer (10//1)
and 500/iCi 125I (10/H). To terminate the reaction 0.5M Na-phosphate buffer pH 7.5
(100/H) was added to the incubation followed by 2% w/v KI (200//1). Tube contents were
then transferred to a G10 Sephadex column (1cm x 1cm), pre-equilibrated in RIA buffer
(60mM NaH2P04,154mM NaCl, 0.5% w/v BSA (fatty acid free), 0.1% w/v NaN 3pH 7.4
with H3PO4). Radioactive fractions emerging close to the void volume of the column
were pooled and subjected to TCA precipitation and SDS-PAGE analysis in order to
check the extent of contamination of protein bound radioactivity with free 125I [iodide]
which elutes
later from a G10 Sephadex column. Before being used in the detection of IgG, the pooled
fractions were diluted into TBS buffer (0.9% w/v NaCl, 5mM Tris/HCl pH 7.6
containing 1% w/v fatty acid free BSA, 0.01% NaN3, and 0.02% w/v KI). The resulting
solution (62.5ng/ml, lOOOcpm/ng) was stored at 4°C prior to use.
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2.3 Raising of an anti PK-A C-subunit antibody
A peptide corresponding to the amino acid residues 322-332 of the catalytic subunit of
PK-A was synthesized and used to raise the polyclonal antiserum (As-365) in sheep,
initially as a conjugate with keyhole limpet haemocyanin (KLH). Such residues were
predicted and subsequently confirmed to reside on the surface of the intact C-subunit
(Knighton et al, 1991).
2.3.1 Peptide synthesis
The peptide PK-AC 322-332-cys (G-D-T-S-N-F-D-D-Y-E-E-C subsequently abbreviated
to 322-332) was synthesized by conventional F-MOC chemistry using a commercial
automated synthesizer, and further purified by gel filtration on a G-10 Sephadex column
(28 x 900) in 2.5% acetic acid, and preparative hplc on a reversed phase column (25 x
150mm). Final purity was checked by analytical reversed phase hplc and found to be
greater than 95%. Peptide identity was confirmed by mass spectroscopy.
2.3.2 Cross-linking peptide (322-332) to KLH
The heterobifunctional reagent MBS was employed to cross link the peptide 322-332 to
KLH. This contains a succinimido-ester functionality to react with -NH2 groups (pH
tolerance is broad with its optimum at pH 7.0), while also containing a maleimido
functionality to react with -SH groups (pH tolerance range is narrow, pH 6.5-7.5, inactive
at pH 8.0). In this way the MBS moiety was able to act as a "link" between KLH and the
peptide antigen 322-332 and its C-terminal cysteine residue. The KLH (5mg) was
dissolved in 50mM Na-phosphate buffer pH 8.0 (1ml), contained in a glass Reacti-vial
(Pierce); MBS was dissolved in DMSO at a final concentration of 5mg/ml. This solution
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(10/H) was then pipetted into the Reacti-vial while vigorously stirring the KLH solution.
Stirring continued for 30min at room temperature. The final concentration ofMBS was
160/iM representing a 100 fold excess over KLH. The reaction mixture was cooled on
ice and loaded onto a Sephacryl S200 HR column (13 x 210mm) equilibrated in 50mM-
Na phosphate buffer pH 8.0 and held at 4°C. The column was run using the same buffer
at approximately 0.75ml/min and 1ml fractions were collected. The absorbance of these
fractions was continuously monitored and the excluded absorbance peak (fractions 17-22,
4.5ml total volume) pooled. The pooled fractions were transferred to a 16mm tube.
Peptide 322-332 (5mg) was dissolved in 1.125ml 1M Na phosphate buffer pH 7.0 and
added quantitatively to the stirred "activated" solution ofKLH. Empirically determined,
this volume ofbuffer was sufficient to achieve a pH of 7.2; however the pH was checked
and any necessary adjustment made accordingly with 1M NaH2P04. The reaction was
allowed to continue for 3h at room temperature. Aliquots of 0.68ml were then snap
frozen in liquid nitrogen and stored at -20°C.
2.3.3 Immunisation strategy
Antibodies to the KLH-peptide conjugate were raised in Finn-Dorset cross bred sheep,
aged approximately 1 year. Immunogen was prepared by diluting a freshly thawed aliquot
of the peptide-KLH conjugate (containing approximately 0.6mg each of peptide and
KLH) into 1,25ml saline before emulsification in Freunds complete adjuvant (2.5ml). The
resulting emulsion was then administered to the animal as 4 x 0.5ml subcutaneous
injections at sites close to the major nodes of the lymphatic drainage of the limbs, and as
2 intramuscular sites in the hind limbs. Further inoculations were formulated in Freunds
incomplete adjuvant and given as described above a further 4 times at 10 day intervals.
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These were followed by three booster injections of unconjugated peptide (100//g, per
dose, divided between 6 sites of injection as described above) prepared as above and
administered monthly.
2.3.4 Antiserum preparation
The animal was bled via the jugular vein, seven days after the final injection. Whole
blood was allowed to clot by incubation at 37°C for lh and a further 6h at $ C. Serum
was then prepared by centrifugation at 18,000g, 4°C for lh; and complement inactivated
serum produced by a further incubation at 56°C for 30min. Antiserum was stored in
200/^1 aliquots and stored at -20°C.
2.3.5 Affinity purification of the anti PK-A C-subunit antiserum (As-365)
From a polyclonal antiserum such as As-365 it was possible to extract selectively those
IgG molecules which recognised the intact C-subunit ofPK-A. A purified preparation of
bovine C-subunit (lOO/^g/ml) was spotted onto 1cm x 1cm squares (20/il/square) of
nitrocellulose (0.45/i HyBond-C extra), supported on slightly undersized Whatman 3mm
blotting pads. Six squares were used per preparation; protein was allowed to adsorb for
1.5min before rinsing the squares in TBS (0.9% w/v NaCl, 5mM Tris/HCl pH 7.6,
containing 0.1% w/v NaN3 and 0.1mM PMSF). These were then blocked with 2% w/v
BSA (fatty acid free) in TBS, at room temperature for 1.5h. the antiserum was diluted
1:10 in this same blocking solution. After a brief rinse in fresh TBS the squares were
incubated with diluted antiserum (10ml) at room temperature for 2-3h. Squares were then
intensively washed with 3 changes of the BSA block solution over a 45min period,
followed by 2 x 15min washes in TBS alone. Squares were then incubated with 3ml 0.5M
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glycine/HCl pH 2.5 at room temperature for lh. Finally, nitrocellulose squares were
removed from the acidic buffer which was then neutralized with 2M Tris/HCl pH 8.1
(0.591ml per 3ml glycine/HCl buffer) to give a final pH of 7.4. An aliquot (0.19ml) of
this solution was saved for protein determination (as described in section 2.5.1); to the
remaining (3.4ml), soyabean trypsin inhibitor was added to a final concentration of
O.lmg/ml and BSA (fatty acid free) to 0.02%. This solution was then dialysed overnight
against 300ml TBS, aliquoted, snap frozen in liquid nitrogen and stored at -20°C until
required.
2.4 Characterisation and uses of As-365
2.4.1 ELISA (Enzyme Linked Immunosorbent Assay)
This technique was used as a means of testing putative sheep antisera. The assay was of
the direct type, that is the antigen, in this case KLH-322-332 conjugate (0.5mg/ml) or the
peptide 322-332 (0.2mg/ml), were first plated out (50/fr/well) into a 96 well ELISA plate
(Immulon-2 plates were used to efficiently adsorb peptide antigen). This was then
covered and incubated at room temperature, overnight. Any remaining non-specific
protein binding sites were then blocked by washing with a Tween-20 containing buffer
(PBS (7.2mM Na2HP04, ImM NaH2P04 and 144mM NaCl)/0.05% v/v Tween-20). The
putative antiserum was serially diluted in PBS/BSA 1% w/v solution, in the range of 1:5
through to 1:1000. Similar dilutions were also made for non-immune sheep serum. An
aliquot (200/H) of the diluted antiserum, or non-immune serum control was then added
to the immobilised peptide antigen in each well and incubated at room temperature for
2h. After intensive washing with PBS/0.05% Tween-20 the presence of any gamma¬
globulins was revealed by incubating the plates with a suitable second antibody, in this
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case, Alkaline Phosphatase linked anti-sheep IgG serum, raised in donkeys. This was
diluted 1:1000 in PBS/BSA 1% w/v and incubated (100/A/well) at room temperature for
2h; the wells were then thoroughly washed with PBS/0.05% Tween-20. A coloured
product, proportional to the amount of gamma globulin bound was then generated by
incubating each well, in the dark, at room temperature with 200/A of a lmg/ml solution
of the chromogenic substrate p-nitrophenol in phosphate buffer for 1,5h. Plates were then
read on a Microtitre plate reader (absorbance 450nm).
2.4.2 Peptide competition
Since As-365 was raised against a synthetic peptide it was expected that treatment of the
antiserum with its peptide antigen 322-332 would lead to a loss of immune reactions seen
in Western blotting experiments. Peptide "competition" experiments were therefore
performed using purified PK-A C-subunit and rat mammary tissue extracts in order to
identify specific immune reactions of the antiserum. The immune reaction of most
interest was that of the putative PK-A C-subunit, running at approximately 40kDa.
Peptide was dissolved in PBS/BSA 1% w/v to give a lmg/ml solution, 20//1 ofwhich was
incubated at 4°C, overnightwith an equal volume ofAs-365 or non-immune sheep serum.
The antiserum and non-immune serum was then used to probe Western blots ofpurified
C-subunit or rat mammary tissue extracts (the latter prepared as for assay of PK-A
activity, section 2.6.1). Western blots were first blocked with 4% w/v Marvel in TBS
(0.9% w/v NaCl, 5mM Tris/HCl pH 7.6), blots were physically divided into lanes using
a Miniblotter (Biorad) and probed with the peptide treated antiserum (diluted a further
1:500 in block solution). Control lanes were probed with diluted antiserum, or non¬
immune sheep serum which had been incubated, as described above, with the peptide
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solvent alone. The Miniblotter was then placed on a rocking table and incubated at room
temperature for 2-3h. After extensively washing blots with TBS, blots were finally
treated with a HRP-linked (horseradish peroxidase) anti sheep IgG antiserum, at a final
dilution of 1/5000 for lh at room temperature followed by ECL detection and
autoradiography (as described in sections 2.5.9 and 2.5.10).
2.4.3 Cleveland mapping
Using this technique PK-A C-subunit was cut into specific fragments using one of two
proteinase enzymes, following the general procedures described by (Cleveland et al,
1977). Two proteinases were employed; Endoproteinase Lys-C from Lysobacter
enzymogenes, which cleaves at the C-terminal side of lysine residues and Endoproteinase
Glu-C (V8), from Staphylococcus aureus which specifically cleaves at the C-terminal
side of glutamic acid residues. An aliquot ofpurified bovine heart C-subunit (20/u\) was
diluted with an equal volume of Laemmli disaggregation buffer (62.5mM Tris/HCl, pH
6.8, 2% w/v SDS, 10% v/v glycerol, 5% w/v 2-mercaptoethanol and 0.05mg/ml
bromophenol blue) and boiled for 2min. An aliquot of this mixture (10//1, equivalent to
5A£g ofprotein) was then loaded onto the stacking gel of a 12% SDS-PAGE gel (which
additionally contained ImM EDTA). Stock solutions (100/^g/ml) of the proteinase
enzymes were routinely stored in 50% glycerol at -20°C. On the day of the experiment
this solution was diluted 1:20 in a solution containing 62.5mM Tris/HCl, 0.1% w/v SDS,
ImM EDTA and 10% glycerol pH 6.8. An aliquot (20//1) of dilute enzyme was then
overlaid onto the C-subunit containing sample already within the sample well. The
proteins were run into the stacking gel, until the marker dye was just about to enter the
separating gel. The current was switched off and the gel allowed to stand for 30min.
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Electrophoresis was continued thereafter as described in section 2.5.4. Gels were then
blotted onto nitrocellulose, "ghost" gels were stained with Coomassie blue and dried in
order to visualise protein fragmentation. Blots were blocked in 4% w/v Marvel in TBS
and probed with As-365 (diluted 1:1000 in block solution) followed by anti-sheep IgG
(diluted 1:1000 in block solution) as described in section 2.5.7. Detection was made by
incubation of the blots with 125I-protein G, as described in section 2.5.8.
2.4.4 Immunoprecipitation
These experiments were designed to assess the ability of As-365, and derived affinity
purified preparations (ab-365), to recognise both the free C-subunit of PK-A, and that
associated with the R-subunits as holoenzyme. Lactating rat mammary cytosolic extracts
(day 12) were prepared as for the assay ofPK-A activity and described in section 2.6.1.
Cytosols were diluted 1:10 in homogenisation buffer containing 1Omg/ml BSA (fatty acid
free). Neat antiserum and non-immune sheep serum, or solutions of affinity purified ab-
365 and non-immune sheep gamma globulins (both at 30/^g IgG/ml), were all diluted
1:10 in this same BSA containing buffer. A panel of immuno-precipitations were then
performed in which fixed quantities of the dilute mammary tissue extract (50/fr) were
incubated with various quantities of the As-365/ab-365, in the presence of0.67/iM cAMP
(final volume 120//1).
A parallel set of incubations were also carried out in the absence of cAMP, in order to
examine the dependency of antibody/antigen recognition upon holoenzyme dissociation.
Samples were incubated on ice for 15min before addition of a 50:50 slurry of Protein G
Sepharose prepared in TBS containing 1% w/v BSA (fatty acid free), 0.02% w/v NaN3;;
60[A was added to incubations containing As-365 and 10/zl to incubations containing the
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affinity purified ab-365. Samples were then spun at 8,800g for 2min. The supernatant was
collected, transferred to fresh tubes and assayed for total PK-A activity as described in
section 2.6.2.
2.4.5 Immunoinhibition
Since As-365 was raised against a peptide corresponding to residues 322-332 of the PK-
A catalytic subunit, which are located at the surface of the protein, close to the binding
sites for substrate peptide and for adenine nucleotides, the possibility that the antiserum
would inhibit the catalytic activity of C-subunit was investigated.
Immunotitration inhibition analysis of purified C-subunit
Titration-like experiments were performed in which various quantities of As-365 were
incubated with purified PK-A C-subunit (100/^units). C-subunit preparations from several
sources were used, including bovine heart, pregnant and lactating sheep mammary tissue
and finally a recombinant source. The antiserum was first diluted 1:10 in PBS/ 1% w/v
BSA (fraction V). Purified preparations of C-subunit were also diluted in 1% w/v
BSA/PBS to give a solution containing approximately 4munits/ml.
A parallel series of control tubes was also set up, containing non-immune sheep serum
in place ofAs-365. All tubes were incubated at 37°C for 30min, after which time 10/fr
of the reaction mixture was assayed for total PK-A activity, as described in section 2.6.2.
From the calculation of total PK-A activity, titration curves were constructed from which
titre values of the antiserum for different preparations of C-subunit could be derived.
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Immunoinhibition analysis of rat mammary extracts
The first of these experiments were designed to assess the ability of As-365 to
immunoinhibit both activated/dissociated and inactive/associated PK-A activity in rat
mammary tissue extracts. Lactating rat mammary tissue extracts (day 12) were prepared,
as for the assay of PK-A activity (section 2.6.1), and diluted 1:10 in homogenisation
buffer containing lOmg/ml BSA (fraction V) and the following protease inhibitors:
O.lmM benzamidine, O.lmM PMSF and 1/zg/ml soya bean trypsin inhibitor. As-365 and
non-immune sheep serum were also diluted 1:10, in the same buffer. Aliquots (50/fr) of
diluted mammary extract (containing approximately 120yunits ofPK-A activity) were
pipetted into a series of Eppendorf tubes together with 4/uM cAMP or H20 (20yl); 50/fr
ofthe dilute antiserum or non-immune serum was then added to each tube. All tubes were
mixed and incubated at 37°C for 30min before being assayed in triplicate for total PK-A
activity as described in section 2.6.2.
In similar experiments, mammary extracts prepared from tissue sampled at different
stages ofpregnancy and lactation, were incubated with an excess quantity of As-365. In
this way the quantity of immunoinhibitable PK-A activity could be assessed throughout
rat mammary tissue development. Cytosolic, mammary tissue extracts, prepared as for
PK-A assay (section 2.6.1), were diluted 1:10 in homogenisation buffer containing
lOmg/ml BSA (fraction V) and protease inhibitors as described above. As-365 and non¬
immune sheep serum were also diluted 1:10, in the same buffer. Aliquots (50/il) of
diluted mammary extract (containing a maximum 120/mnits of PK-A activity) were
pipetted into a series of Eppendorf tubes together with 4/iM cAMP (20//1); 50/A of the
dilute antiserum (theoretically capable of immunoneutralising 250/czunits of C-subunit
activity), or non-immune serum was then added to each tube. All tubes were mixed and
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incubated at 30°C for 30min before being assayed in triplicate for total PK-A activity as
described in section 2.6.2.
2.4.6 Immunodetection ofPK-A C-subunit in Western blots
As-365 was used to detect and quantity C-subunit in purified preparations of this protein,
and in mammary tissue extracts, as discussed in sections 2.5.7 and 2.7.3.
2.5 Assays and analytical methods
2.5.1 Protein assay
The assay was commonly used to measure the protein content of tissue extracts and
solutions, as described by (Bradford, 1979). The assay is based upon the observation that
the maximum absorbance Amax, of an acidic solution ofCoomassie brilliant blue G, shifts
from 465nm to 595nm when binding to protein occurs. The dye interacts principally with
basic and aromatic amino acids. A standard curve was constructed by dilution, in water,
of a BSA standard (kept frozen in aliquots at -20°C), in the range of2-15/^g/ml. Samples
were also diluted to fall within this range.
2.5.2 DNA assay
The DNA content of tissue homogenates was measured via the enhancement of
fluorescence which occurs when the fluorochrome Bisbenzimide binds to DNA. RNA
does not interfere with this assay. Such determinations give a measure of cellularity and
so allowed results to be standardised on a per mg DNA basis.
The assay is based on that described by (Labarca & Paigen, 1980). Standards of salmon
sperm DNA were stored at -20°C as a stock solution in 2mM EDTA. Tissue homogenates
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were diluted into 0.5ml assay buffer (2M NaCl, 50mM Na-phosphate, pH 7.4). A
standard curve of salmon DNA (0-2/^g/ml) was also constructed in a final volume of
0.5ml assay buffer To these, a further 1ml of assay buffer was added followed by 1,5ml
bisbenzimide reagent (200/ig/ml in DNA assay buffer). Final assay volume was 3ml; all
solutions were then incubated at room temperature for lh. Fluorescence was read on a
Perkin-Elmer 3000 spectrofluorometer, with an excitation wavelengh set at 335nm and
emission set at 445nm and expressed in arbitrary units.
Most samples for DNA analysis were whole mammary homogenates, these were
generally diluted to a final "in assay" dilution of 1:3000 to 1:6000 with respect to wet
tissue weight. At lesser dilutions turbidity of the homogenate samples hindered the
attainment of stable readings.
2.5.3 TCA precipitation analysis
The object of this procedure was to precipitate proteins out of solution enabling the
partitioning of radioactivity between protein bound and unbound states to be determined.
An aliquot (50/^1) of the radioactive solution was counted (conventional y-counting for
125I and Cerenkov for32P); PBS/BSA 1% w/v (fraction V), (50/il) was then added as a
carrier protein. The mixture was then double diluted with an equal volume of ice cold
10% w/v TCA and incubated on ice for 15min. After spinning on a bench top centrifuge
for 2min (8,800g) the supernatant was removed and the pellet washed briefly by
resuspending in 1ml of the TCA solution and recentrifuging as above. The tube was then
blotted dry and counted for radioactivity. Results were normally expressed as per cent
TCA precipitable counts (cpm).
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2.5.4 Polyacrylamide gel electrophoresis (PAGE)
The sodium dodecyl sulphate (SDS) Tris-glycine discontinuous system was used as
described by (Laemmli & Favre, 1973). Slab gels, 14 x 16 x 0.15cm were used. Protein
solutions were solubilised by boiling for 2min in Laemmli sample buffer; 62.5mM
Tris/HCl pH 6.8, 2% w/v SDS, 10% v/v glycerol, 5% v/v 2-mercaptoethanol, 2mM
PMSF and 0.05mg/ml bromophenol blue marker. Gels were usually run in pairs at 200V
for 3h.
2.5.5 Coomassie blue dye staining
Staining of gels was applied to detect proteins following SDS-PAGE. When
electrophoresis was complete, gels were soaked for at least lh in a fixer solution ( 25%
isopropanol, 10% acetic acid) and then stained by soaking the gels for 10-20min in 0.1 %
Coomassie Brilliant blue R prepared in fixer. Protein bands were visualised by washing
the gel, over several hours in destainer (7% acetic acid, 1% glycerol), until the
background cleared.
2.5.6 Western blotting
Electrophoretic blotting ofproteins from SDS-PAGE gels onto nitrocellulose membranes
was as described by (Towbin et al, 1979). Transfer buffer contained 25mM Tris, 192mM
glycine and 20% v/v methanol. Gels were typically blotted at room temperature for 2.5h
at 350mA or overnight at 60mA.
2.5.7 Immunodetection of proteins on nitrocellulose
Blots were washed in TBS (0.9% w/v NaCl, 5mM Tris/HCl pH 7.6) for approximately
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lh at room temperature in order to remove contaminating methanol which is a major
constituent of transblot buffer. Blots were then incubated for a minimum of lh, at room
temperature, in a "block" solution consisting of4% w/v Marvel (skimmed milk powder)
in TBS. After a brief lOmin wash in fresh TBS the blots were then probed with the first
antibody; this was specific for the protein of interest e.g As-365 was immunospecific for
PK-A C-subunit. Neat antisera such as As-365 were generally diluted 1:1000 in block
solution; affinity purified antibodies such as ab-365, of lower IgG concentration were
diluted to a lesser extent e.g 1 TOO. Blots were incubated at room temperature with the
first antibody for 2-3h followed by an extensive washing period of lh, with a minimum
of 5 changes of TBS during this period. A second antibody was used in order to amplify
the detection of the first; this was diluted in block solution as for the primary antibody
and incubated with the blot at room temperature for lh. The blot was then vigorously
washed in TBS before being subjected to detection procedures such as ECL or further
incubation with I25I-protein G.
2.5.8 125I-Protein G detection
125I-protein G was used as the detection system in experimental blots which had been
probed with a sheep antibody (As-365, ab-365 or As-201) followed by anti sheep IgG
antiserum, raised in donkeys. Prior to use the 125I-protein G was diluted in TBS solution
containing 1% w/v BSA (fatty acid free), 0.01% w/v NaN3, 0.02% w/v KI; (final
concentration of 62.5ng/ml, approximately 1000 cpm/ng). Blots were incubated in this
solution for 2-3h, washed for lh (with a minimum of 5 changes of TBS, 0.01% w/v
NaN3, 0.02% w/v KI), dried in air and exposed to X-ray film.
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2.5.9 ECL detection
ECL (Enhanced Chemiluminescence) is a light emitting, non-radioactive method of
detection of specific immobilized antigens, conjugated indirectly with a HRP-labelled
(Horse Radish Peroxidase) antibody. Blots were blocked in 4% w/vMarvel/TBS and then
treated with the specific first antibody as described in section 2.5.7. Blots were then
incubated with a HRP-linked IgG diluted 1:1000 in blocking solution for lh at room
temperature. Incubation with the HRP-linked IgG, was followed by vigorous washing in
TBS, excess liquid was drained off and the blot was then incubated for lmin with a 1:1
mixture ofECL reagents 1 and 2 (Amersham RPN 2106). Excess mixture was drained
off the blot which was placed between sheets of Saran Wrap. In order to avoid the
problem of light scattering throughout the blot, it was important at this stage to remove
all excess ECL mixture by applying sufficient pressure to the wrapped blot with a paper
towel. The blot was then exposed to Fuji X-ray film for approximately lmin (although
both shorter and longer periods were often required depending upon the strength of signal
obtained) in a Kodak X-Omatic cassette, with card for extra compression.
2.5.10 Autoradiography
Autoradiography was used to detect proteins (a) labelled either directly or indirectly with
the radioactive isotopes 32P or125 I; or (b) linked indirectly to a source of
chemiluminescence, such as during ECL detection (2.5.9). The radioactive blot or dried
radioactive gel was exposed to Fuji X-ray film in a Kodak X-Omatic cassette at -70°C.
For ECL detection, blots were exposed to film at room temperature. The film was then
developed for 2min with Kodak GBX developer and fixed for 5min using Kodak GBX
fixer. The resulting autoradiographs were then analysed by densitometry in order to
73
quantify individual protein bands. Alternatively, the autoradiograph was used as a
reference, to locate radioactive protein bands on gels which were then excised and
counted for radioactivity.
2.6 Assay of PK-A activity
2.6.1 Mammary extract preparation
Extracts for the assay of PK-A activity were prepared by homogenization of frozen,
pulverized tissue, at 4°C in 4 volumes of ice cold buffer (lOmM MES/NaOH, 0.2mM
EDTA, O.lmM DTT and 0.5mM IBMX, pEl 6.8 containing the following protease
inhibitors: O.lmM benzamidine-HCl, O.lmM PMSF and l//g/ml soyabean trypsin
inhibitor) by using a Polytron homogenizer operating on setting 4 giving 22,000 rev/min
for 2 x 10s. A sample of the resulting homogenate was withdrawn for DNA estimation
(as described in section 2.5.2). Homogenisation buffer containing 11.1 mg/ml BSA
(fraction V) was added to aliquots of the resulting homogenate, diluting the samples a
further 10-fold and giving a final BSA concentration of lOmg/ml. Gross particulate
material was removed by centrifugation for 15min at 8,800g in a bench top Eppendorf.
Aliquots (200/fi) of the resulting supernatant were then snap frozen and stored at -70°C
for amaximum period of 1 month prior to assay. Immediately before assay, extracts were
thawed and diluted a further 20-fold in homogenization buffer, containing lOmg/ml BSA
(fraction V). Validation experiments showed that for mammary tissue extracts, a dilution
of 1:1000 (with respect to wet tissue weight), resulted in a range of activities over which
the assay was linear with respect to amount of sample added (results not shown).
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2.6.2 Activity measurement
The assay is based upon the incorporation of a 32P from [y-2 P] ATP into a peptide
substrate (Kemptide), as described by (Roskoski, 1983). Tissue extracts were incubated
with radiolabeled ATP, in triplicate under three distinct conditions: in the absence of
cAMP and the presence of the specific PK-A inhibitor peptide, the absence ofboth cAMP
and inhibitor and finally in the presence of cAMP and absence of inhibitor. Such
measurements allowed the calculation ofphosphorylation not attributable to PK-A. Total
activity was taken as that measured in the presence of a maximally stimulating
concentration of cAMP (0.6/iM, Clegg & Ottey, 1990). Basal activity was that measured
in the absence of additional cAMP. An activity ratio was derived from these two values
as follows:-
Activity Ratio = Basal Activity
Total Activity
PK-A activity was expressed in units as follows:-
Unit definition: l/xmol phosphate transfered/min
In principle the measurement of PK-A activity ratio offers the possibility of a more
precise determination of the intracellular cAMP status of tissue than can be made by the
direct measurement of tissue cAMP (Corbin, 1983 and Clegg & Ottey, 1990). This is
especially true for mammary tissue derived from lactating animals, where this nucleotide
is to be found at relatively high levels in milk (approximately 2-5/TM, Sapag-Hagar &
Greenbaum 1974). Furthermore, since all known physiological responses to cAMP occur
through the PK-A system it is useful to know the levels of dissociation and therefore the
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consequential activation of this enzyme.
On the day ofassay, a radioactive ATP/Kemptide mixture was made up at 4°C containing




7.5ul lOmCi/ml [y-32P] ATP*
Final Volume 1.5ml with distilled water
*(volume adjusted as isotope decayed to give a mixture containing 5/iCi/ml)
An aliquot (40yzl) of this mixture was pipetted into Eppendorf tubes, held on ice, which
contained either 10/fi PK-A inhibitor peptide (0.6mg/ml), distilled water or cAMP
(4/zM). Samples were thawed, and if necessary, diluted further (within the range 0.1-
5munits/ml) in homogenisation buffer plus lOmg/ml BSA (fraction V). Tubes were then
pre-warmed for 3min by transfer, in a timed sequence to a dry block held at 30°C. The
reaction was started by the addition, again in a timed sequence, of 10/fi ofdiluted sample.
Tubes were thenmixed and incubated for 15min. Under these conditions phosphorylation
ofKemptide was linear with respect to time for at least 20min (results not shown), a fixed
duration of 15min was therefore routinely used throughout these studies. The reaction
was stopped by spotting 30/Ti of the reaction mix onto labelled squares (2cm x 2cm) of
Whatman P81 cation exchange cellulose paper. These were then dropped into a stirred
beaker containing 300ml of 75mM phosphoric acid. Papers were washed until the end of
all incubations and then for a further 5min before being transferred to a fresh beaker of
phosphoric acid for the second 5min wash. The 5min washes were repeated twice more
before removing the papers and blotting them dry with paper towelling. Papers were
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placed in scintillation vials and scintillant (5ml, Emulsifier-Safe) added, before samples
were counted for 4min on a Packard 1600 TR Liquid Scintillation Analyser, from which
a cpm value was obtained. Two sets of blanks were additionally run, consisting of
ATP/Kemptide mix (20/^1) spotted onto papers and added at the washing stage, both
before and after the experimental series. These allowed the assessment of background
contamination, indicating whether or not the washing procedure was sufficient. Finally
in order to determine the specific radioactivity of the ATP/Kemptide mix, a further
aliquot (40//1) of this mixture, equivalent to the input to each assay tube was spotted onto
filter papers and placed directly into vials for counting.
2.7 Immuno-quantification of C-subunit
2.7.1 Immuno-quantification of C-subunit in rat mammary tissue extracts
In these experiments mammary tissue extracts were prepared from animals sacrificed at
different stages of pregnancy and lactation together with tissue from lactating animals
whose litters had been removed. Attempts to immunoquantify C-subunit in mammary
extracts prepared for assay ofPK-A activity proved unsatisfactory; problems arose from
the low concentration of tissue proteins, large quantities ofBSA and high levels of non¬
immune reactions. Therefore less dilute cytosols were prepared and a strategy of cytosol
"clean-up" and affinity purification of As-365 implemented.
2.7.2 Preparation ofmammary tissue extracts
All operations were carried out at 0-4°C. One part by weight of cryopulverised tissue was
homogenised with a Polytron for 2 x 10s at setting 4 (2,200 rev/min) in 4 volumes of
homogenisationbuffer (lOmMMES/NaOHpH 6.8,1.2mMEDTA, ImM EGTA, O.lmM
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DTT, 0.5mM IBMX with the following protease inhibitors: 0.1mM benzamidine/HCl,
O.lmM PMSF, lyug/ml soyabean trypsin inhibitor and phosphatase inhibitors: lOmM
NaF, 0.25mM sodium pyrophosphate, lOmM sodium orthovanadate) which was
supplemented with AjjM cAMP immediately before use. Gross particulate material was
removed by centrifugation at 8,800g, 4°C for 15min. The following reagents were then
added to 0.5ml of the supernatant; 32P labelled C-subunit (10/fr, 0.043/zg), 50mg/ml
cytochrome c (20^1) and PBS/BSA 15% w/v (fatty acid free) (35//1). The 32P labelled C-
subunit (prepared as described in section 2.2.2), was present as an internal standard,
reporting C-subunit recovery throughout subsequent stages of the immuno-quantification
process (see below). The above mixture was first filtered through 5/um and 0.45/mi
Acrodiscs before loading onto a 1ml CM Sepharose column, equilibrated in lOmM
MES/NaOH pH 6.8, 0.2mM EDTA, O.lmM DTT and 0.5mM IBMX. The column was
washed in buffer (5 x 0.5ml), which were bulk collected and subjected to TCA
precipitation analysis. Elution was carried out with 5 x 0.5ml 8M urea, 2% SDS, 15%
glycerol, in 125mM Tris/HCl pH 6.8. Fractions were monitored for radioactivity; the
most radioactive fraction (usually the second) was retained and replicate aliquots (200/il)
of this solution disaggregated by adding 2-mercaptoethanol (2.5/fr) and by boiling for
2min.
2.7.3 Immuno-quantification procedure
Samples of 180^1 were then loaded and run on duplicate SDS-PAGE (8% gels, 14 x
16cm) in the Laemmli buffer system (as described in section 2.5.4). At least one lane on
each gel was reserved for loading with disaggregated 32P-labelled C-subunit (0.043/ig)
and prestained Mr standards (Sigma). On completion of electrophoresis, separated
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proteins were electroblotted onto nitrocellulose sheets (section 2.5.6). After suitable
washing and blocking, the electroblots were probed with affinity purified ab-365
(0.2/ig/ml) or non-immune sheep IgG of the same concentration (as described in section
2.5.7). Treatment with second antibody (antisheep IgG, raised in donkeys and diluted
1:1000) was followed by exposure of blots to 125I labelled Protein G (62.5 ng/ml,
approximately 1000 cpm/ng) and exposed to X-ray film (see sections 2.5.7, 2.5.8 and
2.5.10). The position on the nitrocellulose of radioactive bands was determined by
reference to the autoradiograph and excised. Control "bands" of the same dimensions and
from the same lanes as those of the experimental series were also excised and counted for
32P and for1251. Detection of32 P was made by Cerenkov counting (in the absence of
scintillant), on a Packard 1600 TR Liquid Scintillation analyser. 125I was detected by
conventional y-counting on a Packard, Cobra Autogamma machine. A third gel was also
loaded with 4 x aliquots (0.043/ig) of the disaggregated 32P labelled C-subunit, equivalent
to that added to mammary tissue samples as internal standard. However, this gel was not
electroblotted but fixed and dried; C-subunit bands were located by autoradiography and
counted by Cerenkov in order to obtain the number of cpm associated with the labelled
C-subunit (see below).
2.7.4 Calculation of C-subunit protein mass
The 32P labelled C-subunit was employed as a reporter of C-subunit recovery (internal
standard) and enabled an estimation of the endogenous C-subunit protein mass to be
made for experimental samples. Labelled C-subunit was detected in both experimental
samples and controls by Cerenkov counting. By measuring those counts associated with
a known quantity of labelled C-subunit, an estimate of that remaining in each
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experimental sample could be made. Since all experimental samples received the same
quantity of internal standard, any differences between them in this recovery value could
be related to different conditions experienced by C-subunit in the homogenates, or during
experimental procedures. Thus, a correction value could be applied to y-counts for the
same samples, which represented total C-subunit mass (both endogenous and internal
standard). A final estimate ofC-subunit protein mass could be made for each sample by
reference to the y-counts associated with a known quantity of 32P C-subunit, which had
been run separately on the original SDS-PAGE gel (see above). C-subunit mass
representing the internal standard was deducted from this value and following further
corrections for dilutions, an estimate of tissue C-subunit was made. Such data was used,
in conjunction with total PK-A activity data to estimate the specific catalytic activity of
C-subunit in rat mammary tissue.
2.8 Northern blotting
2.8.1 RNA preparation from rat mammary tissue
RNA was prepared from rat mammary tissue by the method previously described by
(Travers & Barber, 1993). Mammary tissue stored at -80°C (0.5g) was pulverised under
liquid nitrogen to produce a fine powder before being allowed to thaw into 3.5ml GIT
(4M guanidine isothiocyanate, 50mM Tris, 20mM EDTA, 2 % v/v sarkosyl, 1% v/v 2-
mercaptoethanol). The resulting slurry was then passed through a series of fine needles
(18 and 21 gage) in order to shear the DNA present. The homogenate was weighed and
solid CsCl added to it (lg CsCl: 2.5g homogenate), mixing well. Homogenate was then
layered onto a 1.2ml cushion of 5.7M CsCl and 0.1M EDTA, contained in a 5ml
Beckman polyallomer tube, using a sterile Pasteur pipette. Tubes were balanced and
filled to capacity with GIT prior to spinning at 800rpm, 20°C for 18h in a Beckman T7
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(SW55 rotor). The supernatant was then removed with a sterile pasteur pipette, down to
the level of the CsCl cushion and discarded. The CsCl cushion was also discarded and
the sides of the tube wiped dry before quantitatively resuspending the pellet in 1ml water
(deionised HPLC grade). To this a 1:1 v/v mixture of chloroform/butanol was added
(lml), mixed thoroughly with the sample and spun at 2750rpm, room temperature for
lOmin. The top aqueous phase was then added to a sterile Corex tube. The organic phase
was re-extracted, by adding an equal volume of water (deionised) and spinning as
described above. The aqueous phase from this extraction was then removed and
combined with that of the first.
RNA was precipitated by addition of 0.1 volumes 3M sodium acetate pH 6.0 and 2.5
volumes absolute alcohol. This was then mixed thoroughly and incubated overnight at
-20°C before being spun at 11,000rpm, °4 C for 30min. Discarding the supernatant,
samples were freeze dried to remove all traces of solvent and redissolved in water
(deionised, 400/fr per 0.5g original weight mammary tissue). The RNA concentration of
the solution was then determined by measuring the absorbance ratio of l/fr (diluted into
lml deionised water) read at 260nm (and 280nm); water (deionised) was used as a blank.
A standard curve was constructed by dilution, in water (deionised), of an RNA standard
ofknown concentration; thus the absorbance of the sample could be converted into fj-gfrA.
The absorbance ratio of the sample 260nm/280nm was used to determine the purity of
the RNA sample i.e. a ratio of 1.6-1.8 equalled a sample free from DNA and protein.
2.8.2 Northern blotting
Northern blots were performed using RNA prepared from rat mammary tissue and by the
method previously described by (Travers & Barber, 1993). RNA samples were prepared
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by heating the equivalent of 2/ig RNA (in approximately 2.5A) at 65°C for 5min, after
addition of 1.5A LDB (0.03mM MOPS, 1.3mM EDTA, 10.6mM sodium acetate, 66%
v/v formamide and 20% v/v formaldehyde). Samples were then cooled on ice, tracking
dye added (5/^1) and pulse spun directly before being loaded onto a MOPS gel. Samples
were then separated on a MOPS gel (1.2% agarose, 5% v/v formaldehyde and 0.005%
v/v ethidium bromide) run at 70V for 2h. Gels were photographed (under UV) in order
to visualise the RNA before being given two 15min washes with 10 x SSC buffer (0.3M
sodium citrate buffer pH 7.0, containing 3M NaCl). Gels were then placed "wells down"
on a piece ofWhatman 3mm paper, which had been soaked in water, before addition of
the nylon membrane (ICN Biotrans cut to size). A further two sheets ofWhatman paper
were placed over the membrane; care was taken at all stages to ensure maximum contact
between membrane and gel. To these a large wadge of paper towels was added (6cm in
height) and a glass plate, on top ofwhich a 1kg weight was placed. The whole was then
placed above a reservoir containing 10 x SSC, with which the lower layer ofWhatman
paper made contact to form a salt bridge. The gel was then left to blot overnight
(approximately 16h). The blot was fixed by drying at 37°C for 30min and stored at 4°C
until ready to probe.
2.8.3 Detection of Ca and CP mRNA
The cDNA probe for the a-isoform of the rat PK-A C-subunit and the riboprobe for the
rat P-isoform and rat a-casein cDNA were as described by (Massa et al, 1991).
Autoradiographic signals from the Northern blots were integrated by scanning
densitometry. Correction factors were applied to the densitometric data from a single blot
to adjust for differences in the loading of 28s rRNA in each electrophoretic track, as
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described by (Travers and Barber, 1993). After assay of tissue DNA content (described
in section 2.5.2), the resulting corrected levels ofC-subunit mRNAs were then calculated
on a per mg DNA basis.
2.9 Photoaffinity labelling
Photoaffmity labelling has been extensively used to study binding proteins for the cyclic
nucleotides cAMP and cGMP. The most widely used photoaffinity analogue of cAMP
is
8-N3[32P] cAMP, which was used here to detect cAMP binding proteins in a variety of
mammary tissue extracts as described by (Walter & Greengard, 1983).
2.9.1 Mammary extract preparation
Extracts were prepared by homogenising frozen, pulverized tissue in 10 volumes of ice
cold buffer (lOmM MES/NaOH, 0.2mM EDTA, O.lmM DTT and 0.5mM IBMX, pH 6.8
containing the following protease inhibitors: O.lmM benzamidine-HCl, O.lmM PMSF
and l/ig/ml soyabean trypsin inhibitor) using a Polytron homogenizer, setting 4, giving
approximately 22,000 rev/min for 2 x 10s. Cytosolic extracts were made by spinning the
resulting homogenate at 40,000 rpm, 4°C for lh. The resulting supernatant was then
removed, and snap frozen in aliquots (200/^1), before being stored at -70°C for a
maximum 1 month period.
Particulate extracts were made by resuspending the pellet fractions using a semi-micro,
hand operated, Potter-type, all glass homogeniser, in 1ml of homogenisation buffer, and
respinning as above. The supernatant was then discarded and the pellet resuspended in
homogenisation buffer, such that the final protein concentration was within the range of
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2.0-5.0mg/ml.
2.9.2 Photoaffinity labelling of tissue extracts
Samples in a grouped experiment were equalized with respect to their protein
concentrations, by dilution in homogenisation buffer supplemented with protease
inhibitors. Samples were generally used at a protein concentration between 0.5-2.0mg/ml.
8-Azido [32P] cAMP was diluted in homogenisation buffer, to a working concentration
of3//M (approximately 150/iCi/ml) immediately before use. The reaction was carried out
in a 96 well polystyrene microtitre plate, into which the standardised protein sample
(50//1), diluted 8-azido [32P] cAMP (15/fi) and 0.37M MES/0.053M MgCl2 solution
(15/il), were pipetted and incubated at room temperature in darkness for lh. The plate
was then irradiated for 60s using a 15watt long wavelengh UV lamp, at approximately
20cm from the samples. The reaction was stopped by the addition of 3 x Laemmli sample
buffer (40/fi) to each well. Samples were transferred to screw-top Eppendorf tubes,
disaggregated by boiling for 3min, loaded onto 12% acrylamide gels and subjected to
SDS-PAGE. (Samples from experiments ofpaired design were run on the same gel). Dye
fronts were removed and discarded prior to fixation in order to diminish the burden of
unbound radioactivity. Gels were fixed overnight, or for aminimum 8h period in gel fixer
solution (10% v/v glacial acetic acid, 10% v/v glycerol and 40% v/v methanol) and dried,
under vacuum at 60°C for lh, before being subject to autoradiography. Radiolabelled
proteins were quantified by densitometric analysis of autoradiographs. Alternatively the
position on the nitrocellulose of radioactive bands was determined by reference to the
autoradiograph and excised. Control bands of the same dimensions and from the same
lanes as those of the experimental series were also excised and added to scintillation vials
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together with scintillant (5ml, Emulsifier-Safe), samples were then counted for 4min on
a Packard 1600 TR Liquid Scintillation Analyser, from which a cpm value was obtained.
2.9.3 Photoaffinity cAMP competition
In order to show that the labelled protein bands were authentic cAMP binding proteins,
competition experiments were performed using radio-inert cAMP. Protein samples were
diluted in homogenisation buffer with and without non-radioactive cAMP (136/frVI) and
taken through the photoaffinity labelling procedure described above. Bands seen in the
experimental lanes but not in the presence ofnon-radioactive cAMP were deemed to be
cAMP binding proteins. Further competition experiments, using cGMP and 5'AMP in
place of cAMP, were also performed under these same conditions in order to define the
properties of these proteins still further.
2.10 DEAE-cellulose resolution of PK-A holoenzyme isoenzymes from rat
mammary tissue
2.10.1 Mammary extract preparation
One part, by weight, of rat mammary tissue from day 10-12 lactating animals was
homogenized in 4 volumes of buffer (lOmM MES/NaOH, 0.2mM EDTA and O.lmM
DTT pH 6.8 plus protease inhibitors: O.lmM benzamidine-HCl, O.lmM PMSF and
lyug/ml soyabean trypsin inhibitor). Aliquots (1ml) were then centrifuged at, 8,800g for
15min at 4°C. Supernatant was collected and spun for a further 15min. The supernatant
from this centrifugation was aliquoted (1ml), snap frozen and held at -70°C for a
maximum period of 1 month.
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2.10.2 Preparation ofDEAE-cellulose
The DEAE cellulose (50g) was suspended in 250ml lOOmM MES (pH approximately
4.5); under these conditions, bicarbonate adsorbed onto the cellulose is converted into
carbonic acid. The slurry was then transferred to a stoppered 1 litre Buchner flask and a
vacuum applied. Gentle swirling promoted the non-catastrophic "boiling off of C02,
until no more gas emerged. The slurry was then transferred to a plastic beaker and the pH
adjusted to 6.8 with NaOH. After allowing for settling, the supernatant was aspirated off
and replaced with 250ml of lOmM MES/NaOH, 0.2mM EDTA, and 0.1 mM DTT pH
6.8. The slurry was swirled and allowed to settle several times over a 15min period after
which the pH was again adjusted to 6.8. The supernatant was replaced with fresh MES
buffer and the process repeated before resuspending the equilibrated cellulose as a 1:1
slurry (settled bed:supernatant buffer volume). NaN3 was added to a final concentration
of 0.2% and the slurry transferred to a plastic screw-top bottle for storage at 4°C. Omnifit
columns (15mm x 150mm) were poured in advance of isoform separation, and stored at
4°C prior to use.
2.10.3 Isoform resolution
The isoenzymes I and II ofPK-A were resolved from rat mammary tissue as described
by (Livsey & Martin, 1988). On the day of the experiment, cytosolic extracts (see 2.10.1)
were thawed and filtered through 5/um and 0.45/mi Acrodiscs. A small aliquot of filtered
extract was saved for assay of PK-A activity, (as described in section 2.6.2). The
remainder was loaded onto a DEAE-cellulose column (15mm x 100mm, 22.5ml packed
bed volume) equilibrated in MES homogenisation buffer described above, at a flow rate
of 3ml/min. This flow rate was maintained for about lh in order to wash the column
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before elution ofbound protein with a salt gradient. A small aliquot (0.5ml) of this bulk-
wash was retained for assay ofPK-A activity. Resolution ofPK-A isoforms was achieved
by the application of a NaCl salt gradient (0-400mM in MES buffer). Fractions were
collected at lmin intervals (3ml) and assayed for PK-A activity under 2 conditions: plus
cAMP/ minus PK-A inhibitor peptide and minus cAMP/ plus inhibitor.
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Chapter 3
Immunochemical properties of PK-A catalytic
subunit in mammary tissue
Introduction
The following describes the characterisation of an anti C-subunit antiserum and its use
in examining the biochemical properties of PK-A catalytic subunit derived from
mammary tissue. As-365 was raised in sheep against a peptide corresponding to
residues 322-332, a region predicted and subsequently shown to reside on the surface
of murine C-subunit. This region is conserved in both a and P isoforms of the C-
subunit and is present in all species examined (Knighton et al, 1991). The antiserum
was primarily raised for immuno-quantification of C-subunit. Long term objectives
existed; to examine the expression of PK-A catalytic subunit throughout the normal
pregnancy/lactation/involution cycle of rat mammary tissue. Therefore, it was required
that the antiserum be able to recognise the intact C-subunit protein in rat mammary
tissue extracts, as well as the purified protein and the peptide antigen, 322-332. Hence
a succession of experiments were carried out, designed to investigate the properties of
this antiserum, and to assess its suitability for C-subunit immuno-quantification
purposes.
Since residues 322-332 reside close to the substrate peptide-binding and adenine
nucleotide-binding sites on the intact C-subunit, the possibility that the antiserum could
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immunoinhibit C-subunit catalytic activity was also investigated. Inhibition of C-subunit
activity, by As-365 was initially studied using purified preparations of the PK-A C-
subunit. Additional experiments defined the ability of the antiserum to immunoinhibit
PK-A activity present within rat mammary tissue extracts.
3.1 Recognition of the peptide antigen (ELISA)
The immunisation strategy, described in section 2.3.3, was used to raise the anti-
peptide antiserum, As-365 from a single sheep (365). A number of bleeds were
generated from which putative antisera were produced, as described in section 2.3.4.
ELISA assays, of the "direct" type were performed upon putative sheep antiserum, as
described in section 2.4.1. In order to assess the success of the immunisation strategy
in provoking an immune response, antisera generated from initial bleeds were tested
using the keyhole limpet haemocyanin-peptide conjugate (KLH-322-332) as antigen.
ELISA assays indicated the presence of antibodies to this large conjugate (results not
shown), however it was not clear whether the antisera possessed antibodies that would
also recognise the "target" peptide sequence 322-332. Therefore, subsequent assays
employed the unconjugated peptide 322-332 or KLH alone. Antisera generated from
initial bleeds were strongly reactive towards the KLH but poorly reactive to the
peptide 322-332 (results not shown). Lollowing boosting of the animal with the free
peptide, antisera were generated which reacted strongly in ELISA assays towards the
peptide 322-332. Lurthermore for dilutions between 1/100 and 1/10,000, a linear
relationship was observed between the antiserum concentration and measured
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Figure 3.1 Linearity of As-365 dilution and antigen recognition
The above Figure is representative of several ELISA assays which were carried out,
as described in section 2.4.1, using peptide 322-332 as antigen. A number of As-365
dilutions were used, to determine the assays linearity, with respect to concentration
of serum and consequently IgG concentration.
four major bleeds were taken from a single animal (sheep 365). Antisera generated
from bleeds three and four were used in this and subsequent results chapters. ELISA
assays indicated very similar IgG titres with respect to both peptide 322-332 and C-
subunit moieties (results not shown), therefore the antisera are commonly referred to
as As-365 throughout.
3.2 Recognition of PK-A C-subunit in Western blots
Having shown that As-365 could recognise the C-subunit peptide 322-332 (section 3.1),
it was expected that the antiserum would also recognise the intact C-subunit protein.
In order to investigate this further, Western blots were prepared using a purified C-
subunit preparation (derived from sheep heart). Further studies examined the ability of
the antiserum to recognise proteolytic fragments derived from C-subunit. For the
purpose of comparison, a second anti C-subunit antiserum, As-201, was also used
throughout this section. Fike As-365, As-201 was raised in sheep against a peptide
antigen. However the peptide used to raise As-201 corresponded to residues 1-12, of
the N-terminal sequence of the intact Ca-subunit; plus an additional tyrosine moiety
(GNAAAAKKGSEQY). It was also desirable that the antiserum be able to recognise
C-subunit in a variety of cell and tissue extracts, and in particular rat mammary
extracts. Therefore a number of Western blots were prepared, and As-365 used to
detect C-subunit within soluble rat mammary tissue extracts for which PK-A activity
data already existed.
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3.2.1 Quantitative recognition of the intact C-subunit in Western blots by As-365
Purified C-subunit, prepared from sheep heart (as described in section 2.2.1), was
disaggregated and between 0.1 and 1,6^g C-subunit protein loaded onto polyacrylamide
gels before being subjected to SDS-PAGE and Western blotting, as described in
sections 2.5.4 and 2.5.6. Electroblots were then blocked and probed with the diluted
As-365, as described in section 2.5.7. Detection was made using 125I-protein G and
autoradiography, as described in section 2.5.8. Quantification of C-subunit was made
by densitometric analysis of autoradiographs, or alternatively, by excision of protein
bands and conventional y-counting, as described in section 2.5.10.
The antiserum quantitatively recognised the intact C-subunit in Western blots (Figure
3.2); in that it gave a Western blot signal related in intensity to mass of C-subunit
protein in the electrophoresed sample. This was independent of the quantification
system involved, both quantitative densitometric analysis and y-counting of radioactive
protein bands revealed an immunological signal which was proportional to the quantity
of C-subunit protein present.
In order to examine whether recognition of the C-subunit protein by As-365 could be
selectively competed out by the peptide antigen (322-332), antiserum was first treated
with the peptide (as described in section 2.4.2). Also used in this experiment was a
second anti C-subunit antiserum, As-201. A purified preparation of C-subunit, derived
from sheep heart (10 x 0.1/ig) was loaded onto 8% polyacrylamide gels and subjected
to SDS-page and Western blotting (as described in sections 2.5.4. and 2.5.6). As-365
and As-201, were first incubated with their respective peptide antigens, or peptide
solvent (as described in section 2.4.2.). Electroblots were mechanically divided into
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Figure 3.2 As-365 recognition of the intact C-subunit
The above data represents a single experiment. Various quantities of a purified
preparation of C-subunit (sheep heart) were loaded onto a 8% polyacrylamide gel,
subjected to SDS-PAGE and Western blotted onto nitrocellulose before being probed
with As-365 (as described in sections 2.5.4 and 2.5.6). Detection was made using
125I-protein G (as described in sections 2.5.7 and 2.5.8). Quantification of C-subunit
protein was exacted by both densitometric analysis of the resulting autoradiographs,





Figure 3.3 Competitive action of peptide 322-332 in Western blots of purified C-
subunit
The above data represents a single experiment. Purified C-subunit (10 x OA/xg from
sheep heart) was loaded onto a 8% polyacrylamide gel and subjected to SDS-PAGE
and Western blotting as described in sections 2.5.4. and 2.5.6. As-365 and As-201,
were first incubated with their respective peptide antigens, or peptide solvent as
described in section 2.4.2 and indicated on the Figure by " + " and " —" signs
respectively. Electroblots were mechanically divided into lanes; duplicate lanes were
then probed with the above antisera (final dilution 1/1000 with respect to neat
antisera). Control lanes were probed with untreated non-immune sheep serum (NIS),
also diluted 1/1000. Detection was made using 125I-protein G as described in sections
2.5.7, 2.5.8 and 2.5.10.
lanes, enabling a single blot to be probed with treated/control antisera and non-immune
sheep serum (NIS). Both antisera and NIS were diluted 1/1000 with respect to the neat
serum. Detection was made using 125I-protein G and autoradiography of dried
electroblots, as described in sections 2.5.7, 2.5.8 and 2.5.10. As expected, following
treatment of the two antisera with their respective peptide antigens, recognition of the
intact C-subunit was substantially diminished (Figure 3.3). However treatment of As-
365 or As-201 with peptides 1-12 and 322-332 respectively had no effect upon C-
subunit recognition (results not shown). Hence the peptides 322-332 and 1-12 could act
as selective competitors in antisera recognition of C-subunit. It was also of interest that
the intensity of signal produced via As-365, under identical conditions and dilutions,
was much more intense than that generated via As-201.
3.2.2 Recognition of C-subunit fragments
Since As-365 appeared to contain populations of IgG molecules which recognised the
intact C-subunit and the C-subunit peptide 322-332, it was expected that the antiserum
would also recognise degraded fragments of C-subunit protein, as long as they
contained the 322-332 motif. The ability of the As-365 to recognise such fragments,
was investigated by the generation of proteolytic fragments and by adaptation of those
methods first described by (Cleveland et al, 1977). Purified C-subunit (bovine heart)
was first digested by one of two proteinases, Endo-glu-C (V8) or Endo-lys-C, followed
by SDS-PAGE and Western blotting as described in sections 2.4.3. Proteolytic
degradation was then detected by probing the electroblots with either As-365 or another
















Figure 3.4 As-365 recognition of C-subunit proteolytic fragments
Purified C-subunit, derived from bovine heart (5/xg per track) was loaded on to the
stacking gel of a 15% polyacrylamide gel and digested using the analytical proteases
Endo-lys-C or Endo-glu-C, as described in section 2.4.3. The resulting digest was
then subject to SDS-PAGE and Western blotting, as described in section 2.5.4 and
2.5.6. Electroblots were then probed with either As-365 or a second anti C-subunit
antibody, As-201, both diluted 1/1000. Detection was made using I25I protein G and
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Figure 3.5 Peptide competition of 322-332 in As-365 recognition of C-subunit
proteolytic fragments
Purified C-subunit, derived from bovine heart (2/tg track) was digested with Endo-
Glu-C and subjected to SDS-PAGE followed by Western blotting, as described in
section 2.4.3. Control lanes on the gel contained the intact C-subunit preparation
alone. Electroblots were mechanically divided into lanes using a Miniblotter. As-365
was incubated overnight with the peptide 322-332 before being used to probe the blot,
as described in section 2.4.2. Control lanes were probed with the untreated As-365
or with non-immune sheep serum (NIS).
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the electroblots, as described in section 2.5.7. Detection was made using 125I protein
G and autoradiography, as described in section 2.5.8.
Of the two endoproteinases employed in these experiments, the Endo-glu-C enzyme
proved the most effective in digesting the C-subunit protein. Endo-lys-C generated a
single protein fragment, which migrated close to the intact C-subunit and was detected
by both As-365 and As-201 (Figure 3.4), and coomassie blue dye staining (results not
shown). Endo-glu-C produced a succession of protein fragments, and those fragments
recognised by the two antisera were quite dissimilar in pattern from each other (Figure
3.4). Peptide competition experiments were performed in order to check the specificity
of these immune reactions (as described in section 2.4.2). Recognition of As-365 for
both the intact C-subunit and proteolytic fragments was almost completely competed
out by pretreatment of the antiserum with its respective peptide antigen (Figure 3.5).
3.2.3 Recognition of C-subunit in rat mammary extracts
The ability of the antiserum to recognise the C-subunit in mammary tissue extracts was
investigated. A series of Western blots were prepared, using soluble rat mammary
extracts, identical to those prepared for assay of PK-A activity, as described in section
2.6.1. Extracts derived from both pregnant and lactating rats were subsequently
disaggregated, and quantities representing approximately 4mg tissue loaded onto gels,
subjected to SDS-PAGE and Western blotted, as described in section 2.5.4 and 2.5.6.
Electroblots were then probed with As-365, at a dilution of 1:1000 as described in
section 2.5.7. Detection was made using a HRP-linked second antibody followed by
ECL as described in section 2.5.9.
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Figure 3.6 Specific recognition of C-subunit in pregnant rat mammary tissue
extracts
Rat mammary tissue extracts were prepared as for assay of PK-A activity (section
2.6.1). Samples equivalent to 4mg of mammary tissue were then loaded onto 8% gels
and subjected to SDS-PAGE followed by Western blotting. Electroblots were
transferred to a Miniblotter and alternate lanes probed with either As-365 or non¬
immune sheep serum (NIS), as shown in (a). In (b) As-365 was first treated with
peptide in a competition experiment (as indicated by " 4-" and " —" signs respectively
and described in section 2.4.2), before being used to probe a similar electroblot.
Detection was made using ECL, as described in section 2.5.9. P8, P12 and P16 refer
to the number of elapsed days of pregnancy and lactation respectively.
In mammary tissue extracts derived from pregnant rats, As-365 recognised a protein
of the same apparent molecular weight as authentic sheep heart C-subunit run in the
same gels (40kDa). Many other protein bands were detected by ECL, however only the
40kDa protein was found to be specific, not being detected on Western blots treated
with non-immune serum. Detection of this protein was also diminished following
treatment of As-365 with peptide 322-332 in competition experiments (Figure 3.6),
described in section 2.4.2. However, in mammary tissue extracts derived from lactating
animals, non-immune reaction occurring at the same position as the authentic C-subunit
made definition of C-subunit somewhat difficult (results not shown). Since these non¬
immune reactions at approximately 40kDa occurred only in tissue extracts derived from
lactating animals it seemed probable that they arose from unspecific binding of
antibodies to rodent a-casein molecules (Mr approximately 40kDa, Jones et al, 1985),
as these proteins are only expressed during lactation. Conversely to C-subunit, a-casein
molecules are highly acidic in nature, thus affording the opportunity to separate
selectively these two proteins by a simple ion exchange mechanism (details of this
methodology and its results are given in more detail in sections 2.7 and 4.4).
3.3 Immunoinhibition analysis using As-365
Since the As-365 was raised against a peptide sequence of the PK-A C-subunit, closely
associated with both substrate peptide and ATP binding, it was expected that the
antiserum should inhibit catalytic activity. In order to investigate this further,
immunotitration-inhibition experiments were performed using purified C-subunit,
prepared from various sources (preparation described in section 2.2.1).
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Immunoinhibition studies were also carried out on a panel of rat mammary extracts,
sampled throughout pregnancy and lactation.
3.3.1 Immunotitration inhibition analysis of purified C-subunit
Titration-like experiments were performed, as described in section 2.4.5, using As-365
against purified C-subunit obtained from several sources including: pregnant and
lactating sheep mammary tissue and a recombinant source (murine Ca, Slice & Taylor,
1989). As-365 was incubated for 30min at 37°C together with a solution of C-subunit,
containing approximately 4munits/ml PK-A activity, in a series of incubations as shown
in Table 3.1 overleaf. PK-A activity remaining was then measured, as described in
section 2.6.2. Curves were constructed from which titre values of the antiserum for the
different preparations of C-subunit could be derived (Figure 3.7).
As predicted the antiserum was an effective inhibitor of C-subunit catalytic activity,
independent of the enzymes source (Figure 3.7). No major differences were revealed
in the titre values of As-365 between preparations of C-subunit derived from mammary
tissue of pregnant (54//units//zl As-365) and lactating sheep (58/iunits/^l As-365) or of
a recombinant, non-myristoylated C-subunit (77/mnits/^l As-365). Such experiments
therefore suggested that there were no major changes to the intrinsic specific catalytic
activity of the C-subunit, as induced by differentiation in the mammary gland, or by
manipulation of its acylation status using recombinant expression techniques.
It is also of interest that 100% inhibition of C-subunit catalytic activity was never
achieved. A residual 15% of input activity consistently remained. It was not possible
at this stage to determine whether this activity was due to the nature of the antiserum
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As-365 Oil) NIS (/i\) C-subunit
solution Oil)
1% BSA/PBS
0 50 25 50
0 10 25 90
0.5 9.5 25 90
1.0 9.0 25 90
3.0 7.0 25 90
5.0 5.0 25 90
7.0 3.0 25 90
10.0 0 25 90
50.0 0 25 50
Table 3.1 Immunotitration inhibition analysis of purified C-subunit
Various quantities of As-365 (0-10/il) were incubated together with a fixed quantity
of purified C-subunit (100/iunits) derived from various sources including lactating and
pregnant sheep mammary tissue and finally a recombinant source. The final serum
concentration was 10/zl; the final incubation volume was 125/xl. All incubations were
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Figure 3.7 Immunotitration inhibition of the purified C-subunit
Titration experiments were performed in which purified C-subunit (lOOpiunits) was
incubated at 37°C, with a range of As-365 concentrations as shown in Table 3.1 and
further described in section 2.4.5. Total activity was then measured, in the absence
of cAMP as described in section 2.6.2. C-subunit prepared from different sources
were used, including pregnant and lactating sheep mammary tissue and from a
recombinant source (murine Ca, Slice & Taylor, 1989).
or to the resistance of certain C-subunit molecules to immunoinhibition. However, it
was possible to attribute this residual kinase activity to PK-A, due to the design of the
assay which incorporates the use of a specific, PK-A inhibitor peptide (as described in
section 2.6.2). This phenomenon also appeared to be independent of the tissue, or
other, source from which the C-subunit preparation was derived.
3.3.2 Immunoinhibition of PK-A in rat mammary extracts
The following experiments examine the ability of the antiserum to inhibit PK-A
catalytic activity in crude rat mammary extracts. Rat mammary tissue was sampled
from rats in their twelfth day of lactation (LI2) and extracts were prepared from the
tissue, as for the measurement of PK-A activity, described in section 2.6.1.
Initial experiments aimed to determine whether cAMP, and therefore dissociation of
the holoenzyme complex, was first necessary before immunoinhibition by the
antiserum. Extracts were incubated with As-365 at 37°C, both in the presence and
absence of cAMP (0.6//M), as described in section 2.4.5. Non-immune sheep serum
(NIS) was substituted for As-365, in controls which were designed to distinguish the
effects of the antiserum from possible non-immunological effects induced by cAMP.
As-365 was found to be an effective inhibitor of rat mammary PK-A activity, even
when cAMP was absent during the initial incubation of antiserum and tissue extract
(Figure 3.8); although this was possibly a reflection of immunoinhibition occurring
during assay of total PK-A activity, when cAMP was present in the assay mixture.
There was also a great deal of non-immune inhibition present in control samples in
which cAMP was present. As illustrated in Figure 3.8, the additional non-immune
inhibition arrising from the presence of cAMP (61) was greater than the increase in
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Figure 3.8 As-365 immunoinhibition of rat mammary tissue extracts
Immunoinhibition experiments were performed as described in section 2.4.5. L12 rat
mammary tissue extracts (approximately 160/zunits), were incubated with As-365 or
NIS, at 37°C for 30min, in both the presence and absence of 0.6/xM cAMP. 51
represents non-immune, deactivation of PK-A following cAMP induced dissociation
in mammary tissue. 52 represents further immunoinhibition occuring as a result of
PK-A dissociation. The above histogram is representative of three similar
experiments.
immunoinhibition (82). Therefore it was not possible to conclude from these
experiments whether dissociation of the holoenzyme complex was necessary before
antiserum recognition of the C-subunit.
3.3.3 Immunoinhibition analysis of rat mammary PK-A activity throughout
pregnancy and lactation
Rat mammary extracts were prepared from tissue sampled at different stages (4 day
increments) of pregnancy and lactation, as described in sections 2.1.1 and 2.6.1.
Extracts were then incubated with excess As-365 (5/H sufficient to inhibit
approximately 250/mnits of PK-A activity) in the presence of 0.6/iM cAMP, for 30min
at 30°C, as described in section 2.4.5. Residual PK-A activity was then measured as
described in section 2.6.2. In total, three developmental series of rat mammary tissue
extracts were analysed in this way. In these studies, the total amount of tissue imput
was constant, but PK-A activity input was variable, dependent upon the developmental
stage of the tissue extract being examined; higher levels of activity were present in
those tissue extracts derived from lactating animals than those from pregnant.
Nevertheless, As-365 was found to be an effective inhibitor of PK-A activity, under the
concentration used and in all extracts examined, regardless of the stage of pregnancy
or lactation of the tissue of origin. As previously found, not all PK-A activity was
inhibited, but a residual of approximately 15% remained in all samples examined
(Figure 3.9). Hence the proportion of non-immunoinhibitable activity appeared to
remain constant throughout pregnancy and lactation, apparently unaffected by the
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Figure 3.9 Immunoinhibition analysis of rat mammary tissue extracts
Extracts of rat mammary tissue were prepared as described in section 2.6.1 and
incubated in the presence of 0.6^M cAMP with As-365 for 30min at 30°C. BSA was
present to a final concentration of 1% to minimise spontaneous activity loss. Each
incubation contained the equivalent of O.lmg mammary tissue and 5/j.l As-365,
capable of immunoinhibiting approximately 250/xunits ofC-subunit activity. Total PK-
A activity was then measured in the presence of cAMP (as described in section 2.6.2).
P4, L4 etc refer to elapsed days of pregnancy or lactation respectively. The results
shown above are from a single experiment, representative of three carried out.
It is also of interest that under the lower incubation temperatures used here, non¬
immune inhibition of PK-A activity, first described in section 3.3.2 above, was
significantly reduced. This finding prompted a more detailed investigation (described
in section 3.4) into the nature of this apparently endogenous inhibition of rat mammary
PK-A activity.
3.3.4 Immunoprecipitation of PK-A activity in rat mammary extracts by As-365
and ab-365
Immunoprecipitation experiments were performed in order to determine whether As-
365 and affinity purified antiserum (ab-365), required holoenzyme dissociation prior
to recognition of the C-subunit. Various quantities of either As-365 or ab-365 were
incubated together with rat mammary tissue extracts (L12) both in the presence and
absence of 0.6/^M cAMP, as described in section 2.4.4. Thus a series of incubations
were set up as shown in the Table 3.2, overleaf.
At lower concentrations of As-365 and under all concentrations of Ab-365 used,
immunoprecipitation was found to be cAMP dependent (Figure 3.10). Only at higher
concentrations of antiserum did any significant loss of PK-A activity occur in the
absence of cAMP. It is also of interest that even under saturating concentrations of
antibody, 100% immuno-precipitation was never achieved; a residual of approximately
15% of total PK-A activity consistently remained in these incubations.
3.4 Detection of a C-subunit deactivating factor in rat mammary tissue
Tissue extracts in general may contain inhibitors and/or activators of protein kinase
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#tl L12 cytosol
(1:500 wrt to wet
tissue wt.)
Hi As-365 (1:10) or
Ab-365 (3#tg/ml IgG)
n\ NIS (1:10) or Non¬
immune IgG (3#«g/ml)
jil cAMP (4jiM) or
h2o
50 - 50 20
50 50 - 20
50 40 10 20
50 30 20 20
50 10 40 20
50 5 45 20
Table 3.2 Immuno-precipitation of PK-A activity in rat mammary tissue extracts
by As-365 and ab-365
Various quantities of As-365 (0-5^1), or the affinity purified ab-365 were incubated
with soluble rat mammary tissue extract (L12, day 12 of lactation) in the presence of
0.6^M cAMP at 0°C for 5min. Protein G was added to all incubations which were
held at 0°C for a further 15min followed by brief centrifugation (8,800g for 2min).
The remaining PK-A activity was measured in supernatant as described in section
2.6.2.
0 1 2 3 4 5
ab-365 (mD
Figure 3.10 Cyclic AMP dependence of As-365 and ab-365 immunoprecipitation
of PK-A activity in rat mammary tissue extracts
Immunoprecipitation experiments were performed as shown in Table 3.2 and further
described in section 2.4.4. L12 rat mammary extracts were incubated with various
quantities of affinity purified ab-365 (a) or As-365 (b), either in the presence or
absence of 0.6/rM cAMP. Immunocomplexes were precipitated using Protein G
Sepharose, followed by brief centrifugation (8,800g/2min). The above Figure shows
data from two individual experiments.
activity. The existence of a PK-A deactivating factor/s in rat mammary tissue was
suggested from those studies outlined in sections 3.3.2 and 3.3.3. The following
experiments were performed to test for their presence in a number of rat mammary
tissue extracts, prepared as for assay of PK-A activity and described in section 2.6.1.
By variation of the incubation conditions it was possible to characterise the nature of
this activity loss; thus a number of experiments were carried out to investigate the
effects of temperature, PK-A dissociation and a time scale for PK-A deactivation.
To determine the extent of spontaneous activity loss, through incubation alone, rat
mammary tissue extract (L20, approximately 70/mnits) and a purified preparation of
PK-A C-subunit (lactating sheep mammary tissue, approximately lmunit) were
incubated at 30 or 37°C for 30min, as shown in Table 3.3. Samples which had been
diluted, but not subjected to the incubation procedure served as controls. All samples
were assayed for total PK-A activity as described in section 2.6.2. Initial findings
showed that incubation alone had no effect on total PK-A activity levels, measured for
both the C-subunit preparation and rat mammary tissue extracts, and this remained true
for both incubation temperatures used (Table 3.3).
To investigate whether PK-A dissociation was a mandatory condition of its deactivation
in rat mammary tissue, tissue extracts from both pregnant and lactating animals (P20
and L20) were incubated at 37°C for 30min in the presence and absence of cAMP
(0.67/iM), as shown in Table 3.4. The presence of cAMP had a pronounced effect
upon total PK-A activity levels, as measured in lactating and pregnant rat mammary
samples (Table 3.4). However it was not possible to prove conclusively from such




C-subunit (/tl) Tissue extract L20
0*1)
BSA lOmg/ml 0*1) Total munits
remaining
No pre-incubation 50 - 50 1.15
No pre-incubation - 50 50 0.07
30 50 - 50 1.23
37 50 - 50 1.12
30 - 50 50 0.08
37 - 50 50 0.08
Table 3.3 Effect of incubation temperature upon PK-A C-subunit and PK-A
activity within rat mammary tissue extracts
Purified C-subunit (lactating sheep mammary, approximately 1.0 munit) and lactating
rat mammary tissue extract (L20, prepared as described in section 2.6.1 and diluted
1:10 in lOmg/ml BSA) were incubated at 30 and 37°C for 30min before being
assayed for total PK-A activity as described in section 2.6.2. The results shown above








BSA lOmg/ml 0x1) Total imnits
remaining
h2o 50 - 50 39
h2o - 50 50 35
cAMP 50 - 50 0.0
cAMP - 50 50 18
Table 3.4 Effect of cAMP upon PK-A activities within rat mammary tissue
extracts
Lactating and pregnant rat mammary tissue extracts were prepared as described in
section 2.6.1 and diluted 1:10 in lOmg/ml BSA. These were then incubated at 37°C
for 30min, as shown above, in both the presence and absence of cAMP (0.67/tM).
Residual PK-A activity was then measured as described in section 2.6.2. The results
shown above are from a single experiment.
Incubation
temperature (°C)
C-subunit Oil) Tissue extract L20
Oil)
BSA lOmg/ml 0x1) Total munits
remaining
No pre-incubation - 50 50 0.08
No pre-incubation 50 - 50 1.52
0 50 50 50 1.56
30 50 50 50 1.24
37 50 50 50 0.64
Table 3.5 The ability of mammary extract to promote the deactivation of
exogenous C-subunit
Purified C-subunit (approximately 1.5munits) was incubated with a lactating rat
mammary tissue extract (L20, prepared as described in section 2.6.1 and diluted 1:10
in lOmg/ml BSA) for 30min at 0, 30 and 37°C before being assayed for residual
catalytic activity as described in section 2.6.2. The results shown above are from a
single experiment, representative of three performed.
dissociation alone.
Further experiments were carried out in which purified C-subunit (lactating sheep
mammary tissue) was incubated with rat mammary tissue extracts (L20), in the absence
of cAMP. Kinase activity was then measured (section 2.6.2) and compared to the sum
of the individually measured activities i.e. C-subunit alone and mammary extract alone.
Initial results showed that in the absence of cAMP the free C-subunit was subject to
deactivation by factor/s present within rat mammary tissue extracts (results not shown).
The experiment was repeated at various temperatures (0,30 and 37°C), as shown in
Table 3.5. Results indicated that the susceptibility of free C-subunit to deactivation in
mammary tissue extracts was temperature sensitive, being moderate at 0-30°C but
extreme at 37°C (Table 3.5).
In a similar experiment lactating sheep mammary C-subunit was incubated at 37°C for
30min with rat mammary tissue extract (LI6) in the absence of cAMP. Samples were
then dissagregated and subjected to SDS-PAGE and Western blotting, as described in
sections 2.5.4 and 2.5.6. C-subunit was detected using As-365, 125I-protein G and
autoradiography, as described in sections 2.5.8. Autoradiographs showed no
indications of C-subunit proteolytic degradation, however when radioactive C-subunit
bands were located, excised and counted, a small but significant fall in total number of
counts (cpm) was recorded (results not shown). In a single experiment, rat mammary
extracts (LI6) were incubated in the presence of cAMP (0.67/iM) and +/- MgATP
(0.2mM), at 37°C for 30min before being assayed for total PK-A activity. Results
showed that MgATP provided partial protection to PK-A activity within rat mammary
tissue (results not shown).
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Figure 3.11 Time course of C-subunit deactivation of catalytic activity
Purified C-subunit was incubated with lactating rat mammary tissue extracts, prepared
as described in section 2.6.1, for 0, 2, 4, 16 and 30 min respectively before being
assayed for residual catalytic activity as described in section 2.6.2. The results are
from a single experiment.
Finally a time course for the PK-A deactivation was measured. Purified C-subunit
(lactating sheep mammary tissue) was incubated at 37°C with rat mammary tissue
extract (L20) as described above, for 0,2,4,8,16 and 30 mins before being assayed for
total PK-A activity as described in section 2.6.2. Results showed a time-dependent loss
of PK-A activity under the conditions used (Figure 3.11).
3.5 Discussion
The results discussed in this chapter demonstrate the immunological properties and
therefore the biochemical uses of the polyclonal antiserum, As-365. However, further
to this, studies have also revealed some interesting immunochemical properties of C-
subunit within rat mammary tissue. Using the technique of ELISA, it was shown that
the antiserum recognised the C-subunit peptide antigen, corresponding to residues 322-
332. Western blotting studies, using C-subunit purified from sheep heart, demonstrated
the ability of the antiserum to recognise the intact protein. As-365 was also shown to
give a Western blot signal related in intensity to the mass of C-subunit protein in the
electrophoresed sample. Furthermore recognition of the intact C-subunit could be
competed out by pre-treatment of the antiserum with the C-subunit peptide (322-332)
suggesting that identical, or overlapping populations of IgG molecules were responsible
for recognition of both.
The antiserum was also shown to detect multiple proteolytic fragments from bovine
heart C-subunit, generated by the endoproteinase, Endo-glu-C. Digestion of the
purified C-subunit with another endoproteinase, Endo-lys-C was more limited,
generating only a single fragment which was detected by both As-365 and a second anti
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C-subunit antiserum, As-201. No homology was identified between the pattern of
protein fragments recognised by As-365, as compared with those recognised by As-
201. This was not suprising since the two antisera were originally raised against peptide
antigens which corresponded to amino acid sequences located at opposite ends of the
intact C-subunit molecule; such that each antiserum could only recognise those
fragments which contained residues 322-332/1-12 respectively. Recognition of both
intact C-subunit and proteolytic fragments by As-365 was competed out by pre-
treatment of the antiserum with the peptide 322-332.
As-365 detected a protein in pregnant rat mammary tissue extracts which had a similar
mobility on SDS gels as authentic sheep heart C-subunit run in the experiments (40kDa
ref). Estimates of the molecular weight of PK-A C-subunit have varied between 39-
42kDa, depending upon tissue, species and experimental technique used. The present
result is comparable to that of myristoylated bovine heart C-subunit, estimated at
40kDa, also by SDS-PAGE (Shoji et al, 1983 and Carlson et al, 1979). However,
attempts to estimate the relative C-subunit mass in mammary tissue extracts derived
from lactating animals was hampered by the presence of non-immune signals occurring
at the same position as the authentic C-subunit. Such reactions probably occurred as a
result of non-specific binding of antibodies to rodent a-casein molecules. High levels
of BSA in the mammary extract samples, prepared for assay of PK-A activity, also
contributed significantly to the high levels of background detected.
Preparing samples of greater tissue concentration, in the absence of BSA, and further
passing the samples through individual CM-Sepharose columns, prior to SDS-PAGE,
completely eliminated the appearance of non-immune signals at the 40kDa position for
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all samples analysed. Immunoquantification studies also employed affinity purified As-
365 (ab-365); a process designed to isolate those IgG molecules with the greatest
affinity for C-subunit from those with lower to zero affinity for C-subunit. The use of
a 32P labelled C-subunit as internal standard, enabled corrections to be made for
differential loading of gels and geometrical variation of CM-sepharose columns etc.,
thus enabling an estimation of C-subunit protein mass, including that from lactating
animals to be made. C-subunit protein mass could now be examined throughout
pregnancy and lactation, and compared to other measurements of PK-A expression,
such as total activity. Such comparisons would be necessary in identifying
developmental fluctuations in the specific catalytic activity of C-subunit and post
transcriptional/translational regulation of C-subunit protein mass (see Chapter 4).
In addition to recognising the C-subunit in Western blots, As-365 was also shown to
be an effective inhibitor of its catalytic activity, inhibiting both the purified protein and
that PK-A activity intrinsic to rat mammary tissue extracts. As previously discussed,
As-365 was raised against a peptide corresponding to residues 322-332 of the primary
structure of PK-A catalytic subunit. From the determination of the 3D structure of C-
subunit (Knighton et al, 1991), it is now known that approximately 70 residues,
including amino acids 322-332, extend over a large portion of the surface of the small
lobe of the C-subunit. Despite being outside the catalytic core, this area seems to
participate in peptide/nucleotide recognition. Thus, As-365 is able to inhibit catalytic
activity by binding to, and obstructing this important region of the C-subunit.
Studies, in which a fixed quantity of PK-A activity was titrated out by increasing levels
antiserum, (immunotitration-inhibition analysis), revealed no major differences in the
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titre of As-365, between purified C-subunit preparations from mammary tissue of
pregnant and lactating sheep or of a recombinant non-myristoylated C-subunit. Such
results provided evidence for a general lack of change in the intrinsic specific activity
of C-subunit; as induced in mammary tissue by differentiation or by the manipulation
of its acylation status using recombinant expression techniques. Similar conclusions
were drawn from studies performed on a panel of rat mammary tissue extracts, taken
from animals at various stages of pregnancy and lactation. No major differences were
revealed in the inhibitory capacity of As-365 between pregnancy and lactation.
However not all PK-A activity was neutralised by As-365 during these immuno-
inhibition experiments. A residual 15% of input activity consistently remained
following incubation of excess As-365 with purified preparations of C-subunit and rat
mammary tissue extracts. This residual activity was wholly attributable to PK-A, due
to the design of the assay which incorporates the use of the PK-A specific inhibitor
peptide (as described in section 2.6.2). One explanation for this residual PK-A activity
may lie in the polyclonal nature of As-365; if some IgG molecules were less effective
at occluding substrate and adenine nucleotide-binding sites than others, then not all C-
subunit molecules would be inhibited by IgG binding. Alternatively such findings may
be indicative of a sub-population of C-subunit molecules which are resistant to immuno-
inhibition by As-365.
The findings of immuno-precipitation experiments, appear to favour the latter of these
two hypotheses. As for the immuno-inhibition studies described above,
immunoprecipitation experiments revealed that even under saturating concentrations of
antiserum, 100% immuno-precipitation of PK-A activity was never achieved. This was
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true whether purified preparations of C-subunit were used or rat mammary tissue
extracts. Unlike the immuno-inhibition experiments, described in section 3.3.1 and
3.3.2, the effectiveness of immuno-precipitation was not dependent upon the ability of
the antiserum to inhibit C-subunit catalytic activity, only IgG binding was necessary to
promote precipitation by protein G Sepharose. Therefore it must be concluded that
residual PK-A activity was as a result of C-subunit not being recognised by the
antiserum, supporting the idea an atypical population of C-subunit molecules exist
within mammary tissue. Such molecules may have all or part of the epitope 322-332
occluded either by some small molecule, not removed by the purification process, or
by some post translational/proteolytic modification.
Several independent lines of evidence have suggested that PK-A is atypical in its
biochemical properties in mammary tissue (Clegg, 1988., Clegg & Ottey, 1990.,
Bussman et al, 1984. and Takhar & Munday, 1992). From the studies outlined above
there is no indication of any significant alterations in the intrinsic catalytic capacity of
the C-subunit, as brought about by differentiation and development of the mammary
tissue throughout pregnancy and lactation. However possible hetergeneity was
demonstrated with the identification of a subpopulation of C-subunit molecules,
apparently not recognised by the As-365.
Immuno-precipitation techniques, also confirmed that recognition of the C-subunit by
As-365 was dependent upon the dissociation of the holoenzyme complex. Only at
higher concentrations of antiserum did any significant loss of PK-A activity occur in
the absence of cAMP; probably as a result of a mass action-type effect in which the
high concentration of IgG "pulls" the reversible PK-A subunit interaction in the
105
direction of dissociation, even in the absence of cAMP. However when
immunotitration-precipitation like experiments were performed using the affinity
purified Ab-365, which contained a lower IgG concentration, immuno-precipitation was
found to be wholly cAMP/dissociation dependent.
From immunoinhibition experiments described in section 3.3.2, it became apparent that
PK-A activity associated with rat mammary tissue extracts, was susceptible during
incubation procedures, to inhibition by a factor/s other than As-365. Further
experiments, described in section 3.4, clarified this position, showing that the activity
losses were not due to incubation alone. Purified C-subunit could be deactivated by its
co-incubation with rat mammary tissue extracts, while endogenous mammary activity
losses occurred following incubation of the extracts with cAMP. Thus deactivation of
PK-A C-subunit was dependent upon its dissociation from the regulatory subunits. The
present finding that free C-subunit becomes deactivated following its combination with
mammary tissue extracts does not contradict the work of (Clegg & Ottey, 1990) who
made similar measurements but observed an increase in combined activity; since these
measurements were effectively made at time zero, when the mammary
inhibitor/deactivator had little chance to make an impact.
Activity losses were also shown to be temperature dependent, activity loss was greatest
at 37°C, where it showed a slow linear progression with respect to time, deactivation
became moderate at 30°C. It appeared then that rat mammary tissue contained a
deactivator of PK-A activity; the thermo-susceptibility of PK-A activity and the time
dependency of the deactivation seemed to connect with the involvement of a protein.
In contrast no evidence of proteolytic degradation was found when extracts were
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incubated under conditions that would lead to PK-A deactivation before being analysed
by SDS-PAGE and Western blotting procedures. As-365 failed to detect any proteins
other than the intact C-subunit, despite being previously shown to detect proteolytic
fragments generated by the endoproteinase, Endo-Glu-C.
PK-A deactivation has been described in other tissues, some of the characteristics of
the rat mammary PK-A deactivation are shared by the heat-stable inhibitor of PK-A,
first described by Walsh and colleagues in rabbit skeletal muscle (Walsh et al, 1971).
For example, both PK-A inhibitors interacted with free C-subunit but not the
undissociated holoenzyme. However the kinetics characteristics of mammary PK-A
deactivation were not shared by the Walsh inhibitor which has been shown to be a
competitive inhibitor and therefore appears to be instantaneous in its recognition of free
C-subunit either in purified systems or in crude extracts (Ashby & Walsh, 1973 and
Whitehouse & Walsh, 1983). The time dependency of mammary PK-A deactivation
seemed to rule out inhibition. Deactivation of mammary PK-A was inhibited by the
presence of MgATP, which provided moderate but significant protection to the PK-A
activity.
PK-A deactivation has been reported in other tissues, such as the identification of a
proteinase, responsible for specific, restricted and limited proteolysis of the C-subunit
in brush border membranes isolated from rat small intestine (Alhanaty & Shaltiel,
1979). This proteolytic activity specifically clipped the free C-subunit with the
appearance of a 30kDa degradation product which was devoid of catalytic activity, no
intermediatory degradation products were detected. The attack of C-subunit by the
membranal proteinase was blocked by the presence of MgATP and did not affect the
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undissociated (inactive) form of the holoenzyme. The proteinase appeared to be specific
to C-subunit with other endogenous and exogenous proteins being unaffected; neither
could the proteolytic degradation be simulated by other proteinases such as trypsin. The
brush border extracts also inactivated pure exogenous C-subunit without addition of
cAMP whatsoever. The fact that no such proteolytic products were detected in rat
mammary tissue extracts may be due to hydrolysis of the epitope recognised by the
antiserum, As-365; concordant with this observation is the finding that MgATP
afforded C-subunit some protection from deactivation by the mammary inhibitor, with
the ATP binding site lying close to the epitope and residues 322-332. MgATP has also
been shown to prevent proteolysis by stabilizing the holoenzyme complex (Hofmann
et al, 1975) which it binds with an affinity 100 times greater than C-subunit. Similar
proteinases have also been described for rat renal brush border (Schmitz et al, 1973;
and Hopfer et al, 1973).
The specific inactivation of C-subunit, by a proteinase or deactivator, together with the
prevention of its action by substrate and R-subunits, raise the possibility it may have
a distinct physiological (possibly regulatory) assignment. In principle it might be the
first step initiating its biodegradation or constitute a safety device to prevent
phosphorylation of proteins where and when such phosphorylation may have undesired
consequences. Down regulation of total PK-A activity has been decribed previously




PK-A expression in the developing rat mammary
gland
Introduction
The main objective of this study was to assess whether the expression of PK-A, both
in terms of its activity and generic C- and R-subunits (R-subunits: RI and RII) were
under developmental regulation in the rat mammary gland, throughout pregnancy and
lactation. The structural and functional development which occurs during pregnancy
and lactation is discussed more fully in the Introductory chapter, however to summarise
here; upon pregnancy a dramatic phase of development occurs, under the influence of
lactogenic hormones, ductal cells begin to proliferate and alveolar structures bud out
from the ducts, filling the fat pad and its periphery. By late pregnancy, alveolar cells
cease to proliferate and begin to synthesize and secrete milk components, differentiation
of these cells is complete by lactation, immediately following parturition.
An early objective of the study was to measure mammary tissue PK-A activity
throughout pregnancy and lactation and to relate functional changes in PK-A activity
to that of the developmental or proliferational state of the tissue. In order to establish
the level at which total PK-A activity is regulated, both C-subunit protein mass and C-
subunit mRNA expression were measured.
C- and R-subunits are classically believed to be dynamically regulated in order to
maintain the one to one ratio present in the holoenzyme complex. Studies were
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therefore undertaken to measure the relative abundance of R-subunit protein mass
within this same mammary tissue, by a photoaffinity labelling technique using 8-azido-
[32P]cAMP. Such an approach incidentally allowed the distinction to be made between
the relative levels of the two major isoenzymes of PK-A, type I and type II, which are
defined by their characteristic R-subunit isoforms, RI and RII. In conjunction with this,
mammary PK-A isoenzymes were also separated and partially quantified using ion
exchange chromatography on DEAE cellulose.
4.1 Developmental rat series
Whole mammary tissue was sampled from female Wister rats at various, defined stages
of pregnancy and lactation (as described in section 2.1.1). Tissue was sampled at 4 day
increments i.e. P4 to P20, referring to the number of elapsed days of pregnancy, and
L4 to L20, referring to the number of elapsed days of lactation. Thus a series of tissue
samples was collected representing rat mammary gland development throughout
pregnancy and lactation. In total seven such rat series were collected; these were then
used to study the effects of rat mammary development upon the expression of PK-A
activity, C-subunit protein mass, Ca and CP mRNA abundance and the relative
abundance of R-subunit isoforms (RI and RII).
4.2 Pregnant and lactating sheep mammary tissue
Whole mammary tissue was sampled from 4 x 100 day pregnant ewes and 6 x ewes in
their 15 to 25th day of lactation, as described in section 2.1.2. Tissue was used to study
the expression of PK-A activity and the relative abundance of R-subunit isoforms (RI
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and RII) between pregnancy and lactation. Examination of ruminant tissue provided a
contrast to those, more detailed studies carried out upon rat mammary tissue and
assisted identification of important, non-species specific developmental trends in PK-A
expression.
4.3 PK-A activity measurement
Soluble tissue extracts were made (as described in section 2.6.1) and assayed for both
"total" PK-A activity i.e. that measured in the presence of excess cAMP and
"expressed activity" i.e. that measured in the absence of added cAMP, as described in
section 2.6.2. By measuring total PK-A activity, an index of the total amount of C-
subunit protein present in the tissue, and also therefore, the cells capacity for cAMP-
dependent protein phosphorylation, could be determined. This parameter does not
however reflect immediate intracellular conditions, in vivo. These are more accurately
reflected by expressed PK-A activity. Expressed activity provided a measure of the
dissociated C-subunit, free from regulatory subunits, present in the tissue at the
moment of sampling. Procedures were adopted to prevent association/dissociation of
the C- and R-subunits of PK-A, (as described in section 2.6.1) and thus maintain the
R2 + 2C ^ R2C2 equilibrium.
4.3.1 PK-A activity throughout pregnancy and lactation in the rat mammary gland
Based on fresh tissue weight, total activity was seen to approximately double during the
course of pregnancy and again during lactation. During pregnancy most of the increase
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Figure 4.1 Total PK-A activity in rat mammary tissue throughout pregnancy and
lactation
Mammary tissue was sampled from rats at defined stages of pregnancy and lactation.
Extracts were prepared and assayed for "total" PK-A activity (as described in section
2.6). Results are means (+ S.E.M.) of determination on 6 series of pregnant/lactating
animals. Results are expressed on both wet tissue weight (a) and tissue DNA basis
(b).
through parturition until L4 of lactation. From L4 onwards total activity increased in
a more or less linear function with time until L20, the last post partum day on which
measurements were made (Figure 4.1a).
Rat mammary tissue DNA (DNA/g tissue) increased progressively throughout
pregnancy, rising sharply at parturition and early lactation, to remain nearly constant
by mid-lactation (Figure 4.2). Levels of tissue protein also increased, following a
similar progression to DNA, throughout both pregnancy and lactation (Figure 4.2).
Therefore when total PK-A activity was expressed on a tissue DNA basis, the trends
described above were reversed to give the developmental pattern shown in Figure 4. lb.
Total activity was found to be greatest during pregnancy, falling dramatically at
parturition before rising steadily throughout lactation; although prepartum values were
never reached (Figure 4. lb).
The level of expressed PK-A activity (per mg of DNA), fell quickly with the onset of
pregnancy to peak again in late pregnancy (Figure 4.3a), remaining at a low but
constant level throughout lactation. Expressed activity did not remain in fixed
proportion to total activity throughout the course of pregnancy and lactation, thereby
giving rise to characteristic fluctuations in the PK-A activity ratio (expressed
activity/unit of total activity), accompanying the growth and differentiation of the tissue
as shown in (Figure 4.3b). It was expected that the activity ratio of PK-A would reflect
the intracellular concentration of cAMP throughout pregnancy and lactation. The
activity ratio was generally higher during lactation than pregnancy, reaching a peak at
L4 (Figure 4.3b). Published figures for the concentration of cAMP in rat mammary
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Figure 4.2 Composition of rat mammary tissue throughout pregnancy and
lactation
Mammary tissue was sampled from rats at defined stages of pregnancy and lactation.
Extracts were prepared and assayed for protein and DNA content (as described in
sections 2.5.1 and 2.5.2). Results are means (± S.E.M.) of determinations on 6 series
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Days pregnant/lactating
Figure 4.3 Expressed PK-A activity and activity ratio of rat mammary tissue
throughout pregnancy and lactation
Mammary tissue was sampled from rats at defined stages of pregnancy and lactation.
Extracts were prepared and assayed for expressed PK-A activity (as described in
section 2.6). Results are means (± S.E.M.) of determination on 6 series of
pregnant/lactating animals. The activity ratio equals expressed/total PK-A activity.
Tissue cAMP content is that data originally described by Sapag-Hagar & Greenbaum
(1974).
P20, with values being greatest during pregnancy and falling with the onset of lactation
(Figure 4.3c). Therefore despite expectations, the activity ratio of PK-A did not reflect
the apparent cAMP status of rat mammary tissue.
4.3.2 PK-A activity during pregnancy and lactation in the sheep mammary gland
To determine whether PK-A activity was under developmental regulation in the
ruminant mammary gland, total and expressed PK-A activities were measured in
pregnant and lactating sheep mammary tissue extracts. Whole mammary tissue was
sampled from pregnant and lactating ewes (as described in section 2.1.2). Soluble
extracts were made (as described in section 2.6.1) and assayed for total and expressed
PK-A activity (as described in section 2.6.2).
When expressed on a wet tissue weight basis, total PK-A activities were found to be
higher in tissue extracts derived from lactating animals (64.09 + 5.8 munits/g tissue),
compared with those from pregnant animals (52.31 +3.6 munits/g tissue), (Table 4.1).
An increase in total PK-A activity between pregnancy and lactation was tested for using
the Student's t test and found to be significant for P<0.1. Levels of DNA, per wet
weight of sheep mammary tissue, remained relatively constant, figures were not
significantly different between pregnancy and lactation (Table 4.1). Therefore, when
total PK-A activity was expressed on the basis of tissue DNA, it was found to be higher
in tissue extracts derived from lactating animals than in those from pregnant animals
(18.6 ± 1.7 and 15.6 ± 1.7 munits/mg DNA respectively). Expressed PK-A activities
showed a similar trend, mean values were higher for lactating tissue than pregnant
(Table 4.1). An increase in expressed PK-A activity between pregnancy and lactation
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Tissue DNA mg/g Protein mg/g Total PK-A Total PK-A Expressed PK- Activity ratio
source
tissue tissue activity activity A activity
munits/mg munits/mg DNA munits/g tissue
tissue
Pregnant sheep 3.5 ±0.5 34.9 ±5.4 52.3 ±3.6* 15.6 ±1.7 10.5 ±0.9** 0.2 ±0.03
Lactating sheep 3.5 ±0.2 48.9 ±1.9 64.1 ±5.8 18.6 ±1.7 16.2 ±1.1 0.262 ±0.04
Table 4.1 PK-A activity during pregnancy and lactation in the sheep mammary
gland
Mammary tissue was sampled from pregnant and lactating sheep as described in
section 2.1.2. Extracts were prepared and assayed for total and expressed activity as
described in section 2.6. Protein and DNA contents were also measured as described
in sections 2.5.1 and 2.5.2. Results are means (± S.E.M) for not less than 4 animals.
Statistically significant increases between pregnancy and lactation were assessed by
Student's t test (of randomized, 2 group design): *P<0.1 and **P<0.005.
was tested for using the Student's t test and found to be significant for P<0.0.05. The
PK-A activity ratio also appeared to be elevated in lactating sheep mammary tissue,
with respect to that from pregnant animals; however this failed to reach statistical
significance in a Student's t test for P<0.1.
4.4 C-subunit protein mass in the rat mammary gland throughout pregnancy and
lactation
Given the characteristic pattern of total PK-A activity, previously described in rat
mammary tissue extracts, over pregnancy and lactation (section 4.3.1), it was hoped
to establish whether or not this activity was related to levels of C-subunit protein
present within the tissue, or upon the presence of some uncharacterised intracellular
modulator of kinase activity, differentially expressed throughout pregnancy and
lactation.
Using the anti C-subunit antiserum (As-365), and the immunoquantification procedure
outlined in section 2.7, C-subunit protein was measured in mammary tissue extracts
prepared from a pregnant and lactating rat series (section 4.1). Results were compared
with PK-A activity data, which already existed for these same tissue samples, to yield
the developmental profile shown in Figure 4.4. The immunoquantification profile of
C-subunit mirrored that of total PK-A activity, allowing the conclusion that the specific
activity, intrinsic to C-subunit, remained constant throughout rat mammary
development. The level of total PK-A activity in mammary tissue was apparently
dependent upon the corresponding level of C-subunit protein within the tissue. The
mean specific activity was ± S.E.M37.8 ± 2.4 units/mg of C-subunit protein for rat
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(a)
P4 P8 P12 P16 P20 L4 L8 L12 L16 L20
(b)
Days Pregnant/Lactating
Figure 4.4 Quantification of C-subunit protein mass in rat mammary tissue
throughout pregnancy and lactation
The above Figure (a) shows the combined data from two separate experiments using
the same tissue samples, and is representative of determinations carried out on two
series of pregnant and lactating animals. PK-A activity was measured in rat mammary
tissue extracts prepared and assayed as described in sections 2.6.1 and 2.6.2. C-
subunit mass was measured in similar mammary tissue extracts as described in section
2.7. The autoradiograph (b) shows samples from a single immuno-quantification
experiment.
Tissue Specific catalytic activity
source (units/mg protein)
Pregnant 7.9 ± 2.5
sheep
Lactating 5.3 ± 1.9
sheep
Sheep Heart 4.9 ± 1.0
Table 4.2 Specific activity of PK-A C-subunit
The PK-A C-subunit was purified from various sheep tissues as described in section
2.2.1. Preparations were assayed for protein, as described in section 2.5.1. Catalytic
activity was assayed as described in section 2.6.2. The above figures are means
(+S.E.M) for not less than three preparations.
mammary tissue. This value was higher than those previously reported for other rat
tissues, and those estimates of specific activity made from purified C-subunit
preparations derived from pregnant and lactating sheep mammary tissue (Table 4.2).
4.5 Ca and CP mRNA expression throughout pregnancy and lactation in the rat
mammary gland
Given the characteristic pattern of PK-A total activity demonstrated throughout rat
mammary development, and its apparent close correlation to C-subunit protein mass
(sections 4.3.1 and 4.4), experiments were initiated to examine Ca and CP mRNA
expression throughout pregnancy and lactation, and therefore determine if C-subunit
protein mass was under transcriptional regulation. Studies were performed using six
series of pregnant and lactating rat tissue samples, for which PK-A activity and C-
subunit data already existed.
RNA was prepared from rat mammary tissue as described in section 2.8.1; Northern
blotting was carried out as described in section 2.8.2. C-subunit mRNAs were detected
in Northern-blot experiments with isoenzyme specific probes as shown in Figure 4.5
and further described in section 2.8.3. The abundance of mRNA for both isoforms
(expressed per mg of tissue DNA) reflected the total PK-A activity throughout
pregnancy and lactation (compare the lower panel of Figure 4.5 with Figure 4.1b).
Although there was a decrease in the level of mRNA for both Ca and CP at the
transition from pregnancy to lactation, there was no indication of any change in the
ratio of Ca to CP mRNA during the mammary developmental programme. Although
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Figure 4.5 Northern blot analysis of mRNA encoding C-subunit isoform a and
/3 in mammary tissue throughout pregnancy and lactation
Samples estimated to contain equal amounts of RNA were loaded into each
electrophoretic lane; the intensity of the fluorescent signal from 28 S rRNA in each
lane of the ethidium bromide-stained gel (shown above) was used to apply the
appropriate correction factors for minor variations in RNA loadings. Autoradiographs
of blots hybridized with probes specific for Ca, C/3 and rat a-casein are shown above
for a single representative series of lactating and pregnant mammary tissue samples.
Densitometric analysis of the 3 such data sets gave the numerical values plotted
(means ± S.E.M) in the lower part of the Figure.
mRNA, it is clear from the intensity of the autoradiographic signals elicited when
cDNA probes of roughly equivalent specific radioactivity were used, that the mRNA
for Ca is considerably more abundant than that for Cp. The pattern of expression of
a-casein throughout pregnancy and lactation (Figure 4.5) was in close agreement with
the results of others (Hobbs et al, 1982).
4.6 Cyclic AMP-binding proteins of the mammary gland
As previously discussed, both total and expressed PK-A activities appear to be
developmentally regulated throughout pregnancy and lactation (section 4.3).
Furthermore, levels of total PK-A activity were shown to be in direct proportion to the
level of C-subunit protein, which itself proved to be under transcriptional regulation
(sections 4.4 and 4.5). To examine the possibility that R-subunit expression was also
developmentally regulated, the cAMP analogue, 8-azido-[32P]cAMP was used to detect,
mammary cAMP-binding proteins as described in section 2.9. Photoaffinity labelling
additionally allowed the distinction to be made between the levels of the two major PK-
A isoenzymes, type I and type II, which are defined by their characteristic R-subunit
isoforms RI and RII.
4.6.1 Cytosolic cAMP-binding proteins in the rat mammary tissue
Soluble, cytosolic extracts were prepared from each developmental series (as described
in section 2.9.1) consisting of pregnant and lactating rat mammary tissue samples as
described in section 4.1. In each experiment extracts were equalised for protein before
being labelled with the cAMP analogue 8-azido[32P]cAMP, as described in section
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Figure 4.6 Cytosolic cAMP-binding proteins in rat mammary tissue
Cyclic AMP-binding proteins were identified by photoaffinity labelling as described
in section 2.9. The autoradiograph shows from left to right: standard signals obtained
from Human tumour biopsy samples (known to contain either predominantly RII or
RI respectively); signals from PI2 and L12 rat mammary extracts taken from the
same autoradiograph and P12 and L12 samples taken from a separate experiment in
which photoaffinity labelling was carried out both in the presence and absence of radio
inert cAMP (as indicated by " + " and respectively).
2.9.2. Samples from each series were run together in a single gel allowing comparison
of the developmental expression of R-subunits and their isoforms. In total, four series
of rat tissue samples were examined in this way. In order to identify high affinity,
specific cAMP-binding proteins, cAMP competition experiments were also performed,
as described in section 2.9.3.
The photo-activated ligand, 8-azido-[32P]cAMP labelled two major proteins from the
cytosolic fractions ofmammary tissue from both pregnant and lactating animals. These
migrated on SDS-PAGE at the same position as for RI and RII standards (Mr 45000-
51000 respectively), which had been subjected to the same experimental procedure
(Figure 4.6). A minor band of Mr 37-38000 was also detected in all cytosolic mammary
samples examined. This protein most probably corresponded to one of a family of
fragments derived from R-subunits by the proteolytic cleavage of the susceptible hinge
region, and previously described by (Weldon & Taylor, 1985). Labelling of all three
bands was successfully competed out by excess cAMP (Figure 4.6) and was absent
when no u.v. irradiation was applied to the samples (results not shown).
The lower molecular weight R-subunit (RI) was apparently the major cAMP-binding
protein within rat mammary tissue and this remained the case throughout both
pregnancy and lactation. However the relative amounts of RI and RII varied throughout
this period. There was a progressive increase in the levels of RII throughout pregnancy
and lactation, which largely fostered the increase in the RILRI ratio also observed. In
early pregnancy RII accounted for just 12% of the total R-subunit, by late lactation it
accounted for more than 38% (Figure 4.7). The RILRI ratio was able to increase
progressively throughout pregnancy and lactation despite an increase in the level of RI
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Days Pregnant/Lactating
Figure 4.7 Cytosolic R-subunit composition in the rat mammary gland
The relative abundance of the RI and RII isoforms was determined in cytosolic rat
mammary extracts as described in section 2.9. The autoradiograph shows the changing
levels of the two major R-subunit isoforms throughout pregnancy and lactation in a
single labelling experiment; the graph shows RI levels from the same experiment and
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Figure 4.8 Comparison of R- and C-subunit levels in the rat mammary gland
throughout pregnancy and lactation
Total C-subunit and R-subunits were compared throughout pregnancy and lactation for
a single representative series of rats. At each stage, assay of C-subunit catalytic
activity and photoaffinity labelling of R-subunits were performed on the same tissue
extract, as described in Materials and methods, sections 2.6 and 2.9 respectively.
which peaked during mid-pregnancy; sustained at this time by increasing levels of RII.
However, following parturition and into early lactation, levels of RI declined back to
those seen during early pregnancy which further contributed to the increasing RII:RI
ratio (Figure 4.7).
Total R-subunit levels (RI + RII), were also compared to C-subunit protein mass
determined for the same set of tissue samples (section 4.4). The exact molecular ratio
of the two PK-A subunits (normally expected to equal 1.0) could not be evaluated,
since absolute levels R-subunit protein mass were not measured here. However, the
ratio of R- to C-subunit was shown to remain relatively constant throughout much of
pregnancy and lactation; although a transient over-expression of mammary R-subunit
between late pregnancy and early lactation was suggested by the data presented (Figure
4.8).
4.6.2 Cytosolic cAMP-binding proteins in the sheep and goat mammary tissue
To determine whether R-subunit expression was under developmental regulation in the
ruminant mammary gland, photoaffinity labelling experiments were performed on
pregnant and lactating, sheep and goat mammary tissue extracts, prepared and labelled,
as described for rat mammary tissue, in sections 2.9.1 and 2.9.2.
The photo-activated ligand, 8-azido[32P]cAMP, labelled two major cAMP-binding
proteins in cytosolic extracts derived from lactating and pregnant, sheep and goat
mammary tissue (Figure 4.9). These migrated on SDS-PAGE close to the positions for
rat mammary RI and RII; apparent molecular weights for the goat and pregnant sheep
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Figure 4.9 Cytosolic cAMP-binding proteins in sheep and goat mammary tissue
The above autoradiographs represent cAMP-binding proteins identified in cytosolic,
mammary tissue extracts, derived from (left to right) pregnant and lactating sheep and
goat respectively. Such reactions were competed out using excess cAMP as described
in section 2.9.3 ( " + " and " —" indicate the presence and absence respectively of
excess cAMP during photoaffinity labelling of the mammary tissue extracts).
Tissue Cytosolic RI Particulate RI Cytosolic RII Particulate RII Cytosolic Particulate
(cpm) densitometric (cpm) densitometric RII:RI ratio RII:RI ratio
dUUlVv
band volume band volume
(arbitrary) (arbitrary)
Pregnant sheep 600 ±26 50.6 ±8.1 478 ±46 89.4 ±7.1 0.800 ±0.02 1.8 ±0.14
Lactating sheep 399 ±40 88.5 ±12.3 899 ±70 202.5 ±14.2 2.250 ±0.2 2.4 ±23
Table 4.3 Relative abundance of cytosolic and particulate R-subunit isoforms
throughout pregnancy and lactation in the sheep mammary gland
Mammary tissue was sampled from pregnant and lactating sheep as described in
section 2.1.2. Cytosolic and particulate mammary tissue extracts were made and
labelled with 8-azido-[32P]cAMP as described in sections 2.9.1 and 2.9.2. The above
figures are taken from two separate labelling experiments (for cytosolic and particulate
samples respectively) and are means (+ S.E.M) for not less than 4 animals.
Tissue source RI (cpm) RU (cpm) RII:RI ratio
Pregnant goat 161 ± 34 154 ± 10 1.03 ± 0.16




Table 4.4 Relative abundance of cytosolic R-subunit isoforms throughout
pregnancy and lactation in the goat mammary gland
The above figures are taken from a single experiment in which mammary tissue was
sampled from three pregnant and two lactating goats, as described in section 2.1.2.
Extracts were made and labelled with 8-azido-[32P]cAMP as described in sections
2.9.1 and 2.9.2.
derived from lactating sheep mammary tissue exhibited higher molecular weights (Mr
48000 and 54000 for RI and RII respectively, this is best illustrated in Figure 4.12a).
A minor band of Mr 39000 was also detected in all cytosolic sheep and goat mammary
samples examined. Labelling of all three bands was successfully competed out by
excess cAMP (Figure 4.9). The relative amount of RI and RII did not remain constant
between pregnancy and lactation. The RI isoform was in slight excess over RII in
samples from pregnant animals. However, in samples derived from lactating animals
RII levels far exceeded those of the RI isoform. Thus the RILRI ratio rose from 0.8 to
>2.0 between pregnancy and lactation for sheep mammary tissue and increased from
1.0 to 1.85 for goat mammary tissue (Tables 4.3 and 4.4). Interestingly, it was possible
to sample goat mammary tissue from animals which were simultaneously lactating and
pregnant; when photoaffinity experiments were performed on such tissue, a level of RI
and RII expression was found, intermediate between that in pregnant only or lactating
only animals (Table 4.4).
4.6.3 Particulate cAMP-binding proteins in the rat mammary tissue
The cytosolic R-subunit isoforms, RI and RII, have been shown to be subject to
dynamic regulation throughout pregnancy and lactation in rat mammary tissue (section
4.6.1). In order to examine the possibility that the particulate forms of these proteins
were also under developmental regulation, photoaffinity labelling experiments were
performed on mammary samples derived from two rat series. Cytosolic and particulate
extracts were prepared simultaneously from each series of mammary tissue samples,
by the methods described in section 2.9.1. Samples were equalised for protein before
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Days Lactating/ Pregnant
Figure 4.10 Particulate R-subunit composition of rat mammary tissue
The relative abundance of the RI and RII isoforms was determined in particulate rat
mammary extracts as described in section 2.9. The autoradiograph shows the changing
levels of the two major R-subunit isoforms throughout pregnancy and lactation in a
single labelling experiment; the graph shows RI levels from the same experiment and
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Figure 4.11 Specificity of cAMP-binding proteins in cytosolic and particulate rat
mammary tissue
The above Figure shows data from a single competition experiment in which
photoaffinity labelling was performed (as described in section 2.9.3.) in the presence
and absence of cGMP and AMP, in addition to radioinert cAMP. All samples were
equalised with respect to protein concentration prior to labelling. The above
autoradiograph shows cytosolic and particulate fractions from (a) lactating rat
mammary tissue (b) pregnant rat mammary tissue respectively.
being photoaffinity labelled, as described in section 2.9.2.
As for the cytosolic fraction, the photoaffinity ligand labelled two major proteins in the
particulate fractions from rat mammary tissue (Figure 4.10). These ran at the same
positions as those cytosolic bands, previously denoted RII and RI (section 4.6.1). The
minor Mr 37-38000 cAMP-binding protein, previously described in cytosolic fractions,
was not always seen in the particulate samples. Both particulate cAMP-binding proteins
(RI and RII), could be successfully competed out by cAMP, as described in section
2.9.3, and shown in Figure 4.11. The total amount of cAMP-binding protein (i.e. RI
+ RII calculated on a per mg protein basis) was found to be greater in cytosolic
mammary extracts, with respect to those of the particulate compartment (results not
shown). The level of RI relative to RII did not remain constant between pregnancy and
lactation (Figure 4.10). RI remained in excess of RII throughout most of pregnancy.
However, following parturition, RI levels rapidly decreased, falling below those of RII;
at the same time total levels ofRII increased, reaching a peak at L12. This combination
of events led to the increase in the RII:RI ratio observed throughout lactation (Figure
4.10).
4.6.4 Specificity of mammary tissue cAMP-binding proteins
In order to further characterise cAMP-binding proteins described in rat mammary
tissue, additional competition experiments were performed in addition to those utilising
cAMP. As already described, excess cAMP prevented any significant radio-labelling
of those cytosolic and particulate proteins, denoted RI and RII, as well a Mr 37-38000
protein band, found in cytosolic mammary tissue extracts. Similar competition
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experiments were performed using the related compounds, cGMP and AMP (136/iM).
AMP apparently increased labelling of the RI and RII bands, at least for cytosolic rat
mammary tissue extracts; bands were too faint to determine the effect of AMP on
labelling of particlate tissue extracts. Conversely, cGMP reduced the level of radio-
labelling of the putative RI band, in all cytosolic samples examined by approximately
40-50% (Figure 4.11); once again bands for particulate fractions were too faint to
ascertain whether cGMP had a similar effect on the labelling of these samples. A
similar effect of cGMP has been documented before by (Handschin et al, 1983).
4.6.5 Particulate cAMP-binding proteins in the sheep mammary tissue
Common developmental trends between the cytosolic fractions of sheep and rat
mammary tissue have been shown (section 4.6.1 and 4.6.2). Therefore cAMP-binding
proteins were examined in the particulate fraction ofmammary tissue extracts prepared
from pregnant and lactating sheep. Both particulate and cytosolic extracts were
prepared from the same tissue samples as described in section 2.9.1. All samples were
equalised with respect to their protein concentration before being labelled with the
photoaffinity ligand 8-azido [32P]cAMP as described in section 2.9.2. Competition
experiments using radio-inert cAMP were also carried out, as described in section
2.9.3.
The photoaffinity ligand detected two major cAMP-binding proteins in the particulate
fraction of sheep mammary tissue. These ran at the same positions on SDS-PAGE as
for Lactating sheep, cytosolic mammary proteins, previously denoted RI and RII (Mr
48000 and 54000 respectively, Figure 4.12). However unlike cytosolic extracts the
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(a) (b) (c)
Cytosolic Particulate Pregnant sheep
Figure 4.12 Comparison of sheep cAMP-binding proteins between pregnancy and
lactation in both particulate and cytosolic compartments
Autoradiographs show: (a) Cyclic AMP-binding proteins labelled by 8-azido-
[32P]cAMP in cytosolic extracts of pregnant and lactating sheep mammary tissue, (b)
Shows particulate cAMP-binding proteins labelled in extracts derived from the same
pregnant and lactating sheep tissue (" +" and " —" refers to the presence and absence
respectively, of radioinert cAMP during photoaffinity labelling, section 2.9.3). (c)
Shows cAMP-binding proteins from pregnant sheep, cytosolic and particulate
mammary tissue extracts which were equalised for protein, labelled and run side by
side in the same gel.
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apparent Mr of RI and RII remained constant between pregnancy and lactation (Figure
4.12). Binding of the ligand to both proteins was successfully competed out by excess
cAMP (Figure 4.12(b)). The Mr 39000 protein observed in cytosolic mammary extracts
was not present in particulate extracts examined here (Figure 4.12).
The relative amounts ofRI and RII also varied between pregnancy and lactation. RI and
RII were present in approximately equal quantities in samples derived from pregnant
animals; levels of both isoforms decreased with lactation, falling below pregnant levels
(results not shown). However R-subunit loss was greatest with respect to the RI
isoform, thus an increase in the RII:RI ratio was observed in samples from lactating
animals. As for the rat mammary gland, total levels of R-subunits were lower for the
particulate fractions than in the corresponding cytosolic compartment (data not shown).
4.7 DEAE cellulose separation of type I and type II PK-A isoenzymes from rat
mammary
PK-A is known to exist as two major isoenzymes, classically denoted type I and type
II, which refers to the order in which they are eluted from a DEAE cellulose column
in a salt gradient. These distinctive PK-A isoenzymes are further defined by their
characteristic R-subunit isoforms, RI and RII (as previously described in section 4.6).
It was therefore possible to assess the relative abundance of mammary tissue PK-A
isoenzymes, following their resolution on DEAE cellulose, and subsequent assay of
column fractions for total PK-A activity (i.e. that measured at a saturating
concentration of cAMP, as described in section 2.6.2).
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Type II
Figure 4.14 Resolution of PK-A isoenzymes from lactating rat mammary tissue
by ion-exchange chromatography on DEAE cellulose
A 0.5ml portion of a 8,800g supernatant fraction (total PK-A activity 50/xunits)
prepared from lactating rat mammary tissue (as described in section 2.10.1) was
loaded onto a column (15mm x 100mm, 22.5ml packed bed volume) of DEAE
cellulose equilibrated with lOmM MES/NaOH, 0.2mM EDTA, 0. ImM DTT pH 6.8.
After washing with this same buffer (100ml) until no further protein was eluted
(monitored at 280nm) the column was developed with a linear gradient of NaCl (0-
400mM) in the same buffer, at 3ml/min. Fraction volume was 3ml and these were
assayed for total PK-A activity as described in section 2.6.2. Type-I and Type-II refer
to the two major isoenzymes of PK-A.
Figure 4.15 Separation of PK-A hoioenzyme from lactating rat mammary tissue
by ion-exchange chromatography on DEAE cellulose
The above Figure represents a single experiment in which both "total" and
"expressed" PK-A activities were measured for isoenzyme fractions resolved from
lactating rat mammary tissue extracts. Precedures were as described in the legend to
Figure 4.14.
4.7.1 DEAE cellulose separation of lactating rat mammary PK-A isoenzymes
Experiments were performed on soluble mammary extracts, originating from between
day 10 (L10) and L12 lactating rats, prepared as described in section 2.10.1.
Isoenzymes were resolved by ion-exchange chromatography, in which samples were
loaded onto a DEAE cellulose column and subsequently eluted by the application of a
salt gradient, as described in section 2.10.3. Fractions were collected and assayed for
total PK-A activity, in both the absence and presence of the PK-A inhibitor peptide, in
order to distinguish PK-A activity from that of other mammary kemptide kinases which
may also have been resolved by this technique. That activity not inhibited by the
peptide, and therefore not associated with PK-A, was deducted before plotting the
resolution profiles shown in Figures 4.14, 4.15 and 4.16. In a single experiment,
expressed PK-A activity was also measured in order to validate the separation of
holoenzyme from the free C-subunit (Figure 4.15). The recovery of activity from
DEAE-cellulose columns was approximately 62% of that loaded. Such separations
revealed that type II isoenzyme was the predominant form of PK-A in lactating rat
mammary tissue; the type I isoenzyme accounted for only 30% of the total PK-A
activity recovered from the column (Figure 4.14).
Peak positions and levels of both isoenzyme type I and type II agreed with the
published findings of (Clegg & Ottey, 1990). However, results were of stark contrast
to previous findings, generated through photoaffinity labelling of R-subunits (section
























Figure 4.16 Separation of pregnant rat mammary PK-A isoenzymes by ion-
exchange chromatography on DEAE cellulose
The above Figure represents a single experiment in which PK-A isoenzymes were
resolved for a pregnant rat mammary tissue extract, prepared and subject to the same
precedures as described in the legend to Figure 4.14.
4.7.2 DEAE separation of pregnant rat mammary PK-A isoenzymes
Experiments were performed on soluble mammary extracts, originating from between
day 12 (PI2) and P16 pregnant rats. Isoenzymes type I and II were resolved on a
DEAE cellulose column (as described in section 2.10.3). As described for lactating rat
mammary tissue, the type II enzyme was apparently the predominant isoenzyme (Figure
4.16), accounting for >90% of the total PK-A activity recovered. Once more, results
were not in complete agreement with those findings made by photoaffmity labelling
(section 4.6.1). The level of RII expression has previously been shown to be at its
lowest during pregnancy, yet the results shown here clearly stated the opposite.
4.8 Discussion
With the onset of pregnancy there is a marked change in the cellular composition of
mammary tissue (see Knight & Peaker, 1982b for review). As mammary development
progresses adipocytes, which comprise a major proportion of the tissue weight before,
and during early pregnancy, become progressively replaced by proliferating, secretory
epithelial cells. The DNA content of rat mammary tissue (mg DNA/g tissue) changed
markedly over pregnancy and lactation as a result of epithelial proliferation. The extent
and pattern of changes reported here are largely in agreement with those changes
previously reported by others (Tucker & Reece, 1963ab and Munford, 1963).
Therefore, PK-A activity was described in terms of tissue DNA, as opposed to tissue
wet weight; in this form the data was best able to describe that activity associated with
proliferating (as during pregnancy) and differentiating (as during lactation) epithelial
cells.
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Total PK-A activity was shown to decline sharply following parturition, closely
paralled by C-subunit protein mass allowing the conclusion that the overall specific
activity of C-subunit was constant throughout rat mammary development. This
conclusion was consistent with those findings discussed earlier (chapter 3, section
3.3.3) where the amount of an anti-C-subunit antiserum (As-365) required to maximally
inhibit the PK-A activity in pregnant and lactating rat mammary extracts was found to
be directly proportional to the total activity present. Immunotitration inhibition studies
had also revealed no major differences in the titre of As-365 between mammary tissue
C-subunit preparations purified from pregnant and lactating sheep (section 3.3.1).
The absolute level of mammary tissue C-subunit protein found in this study,
approximately 2/ug/g of tissue in lactating animals, does not differ significantly from
that reported by others (Clegg & Connor, 1991). However when the specific activity
of C-subunit in rat mammary tissue was determined (approximately 38 +2.4 units/mg
C-subunit protein) and compared to measurements made for purified C-subunit
preparations, including those from lactating and pregnant sheep mammary tissue, it was
found that the C-subunit present in mammary extracts possessed a specific activity
several-fold greater than the best values measured for the purified protein. Findings
may be indicative of major losses of activity as a result of C-subunit purification or an
enhancement of C-subunit activity within mammary tissue extracts. Enhancement of C-
subunit activity has been described previously in lactating rat mammary tissue extracts
(Clegg & Ottey, 1990).
Evidence for the deactivation of C-subunit in rat mammary tissue extracts has been put
forward in the previous chapter (section 3.4). Deactivation of C-subunit in other tissues
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has been previously described (Alhanaty & Shaltiel, 1979., Schmitz et al, 1973. and
Hopfer et al, 1973) where losses were largely attributed to the activity of specific
proteases. Certainly it is well established that C-subunit is extremely labile and
susceptible to rapid deactivation in tissue extracts unless special care is taken, hence the
rigorous conditions applied to the preparation of tissue extracts and measurement of
PK-A activity (section 2.6).
Several independent lines of evidence have suggested that PK-A is atypical in its
biochemical properties in mammary tissue. In particular there has been suggestion that
the acute regulatory functions of PK-A are modified in mammary tissue from lactating
animals (Bussmann et al, 1984., Clegg, 1988., Clegg & Ottey, 1990). Inhibitory effects
on the activity of acetyl-CoA carboxylase, and the associated changes in the
phosphorylation level of serine-79 have been shown to be absent. In other tissues
inactivation of acetyl-CoA carboxylase was initiated by a cAMP-dependent process,
although the actual phosphorylation event has been attributed to the AMP-activated
kinase (Hardie, 1992). One explanation for these altered responses has been that PK-A
itself has distinctive properties in mammary tissue. Some evidence for this has been
reported by (Takhar & Munday,1992) who observed changes to C-subunit substrate
specificity. Findings reported here indicate that these properties do not derive from
changes to the intrinsic specific activity of C-subunit, with respect to the substrate,
Kemptide, between pregnancy and lactation. However, it is possible that mammary
tissue may contain a novel C-subunit, not recognised by Northern Ca and C6 probes
or by the C-subunit antibody (As-365/ab-365). In this respect it is of interest that 15%
of C-subunit appears to be insensitive to immunotitration and immunoprecipitation by
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As-365. Such C-subunit may exhibit abberrant sensitivity to inhibitors and deactivators,
and/or intrinsic differences in C-subunit acylation or autophosphorylation. In relation
to putative tonic influences of PK-A on mammary growth and development, it is likely
that expressed activity is the most physiologically relevant of the catalytic parameters
determined, being indicative of cAMP dependent protein phosphorylation events. It is
therefore of interest that this remains relatively constant throughout mid-pregnancy but
approximately doubles during late-pregnancy, immediately preceding the steep increase
in the rate of DNA synthesis which persists throughout early/mid lactation. This
enhancement in expressed PK-A activity does not persist correspondingly, but instead
declines back to base line.
It was expected that the PK-A activity ratio should be a reflection of the cAMP
concentration within the tissue. However, the present results, taken together with those
published by others (Sapag-Hagar & Greenbaum, 1974), appear to show that this is not
the case in developing rat mammary tissue. The apparent peak in the cAMP profile
coincides with that in expressed PK-A activity and not that of activity ratio. The
disparity between previously published data and that of the present study may be
attributable to the gross technical problems inherent in deriving the intracellular cAMP
content of mammary tissue; where high levels of the cyclic nucleotide in milk make
accurate estimates of intracellular cAMP extremely difficult.
Alternatively intracellular sequestration of cAMP (other than by PK-A R-subunits) or
changes in the specific activity of C-subunit might also have a role to play. The present
study found no evidence of any intrinsic differences in the specific activity of C-subunit
between pregnancy and lactation, in either rat mammary tissue extracts or purified
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sheep preparations. However, there is some evidence in the current literature, for the
existence of "mute" C-subunit molecules (Steinberg, 1991), or C-subunit with altered
specific activities in small, distinct sub-cellular populations (Clegg & Connor, 1991).
Further regulation of PK-A activity can be achieved by negative feedback; cAMP
influences PK-A expression by initiating the down regulation of C-subunit (Hemmings,
1986 and Schwoch, 1987) presumably by a protease with a particular efficiency against
free C-subunit (Alhanaty and Shaltiel, 1979). It can also be achieved by increasing the
level of R-subunit relative to C-subunit; in the present study there is some evidence to
suggest this occurs around parturition (see 4.6.1). The principle was recently confirmed
by the identification of RIa (Boshart et al, 1991 and Jones et al, 1991) as the
extinguisher of cAMP-induced gene responses, TSE (tissue specific extinguisher).
The expression of Ca- and CP-subunit mRNA, in the rat mammary gland, appears to
be coordinately regulated throughout pregnancy and lactation, in that their ratio to one
another does not change. This pattern of expression in which the Ca subunit
predominates over that of the CP subunit, is characteristic of the liver and kidney, but
unlike that of the brain, where the two mRNAs are roughly equal (Showers & Maurer,
1986). Absolute levels of both Ca and CP are repressed during lactation. Furthermore,
since Ca and CP mRNA and total C-subunit protein levels parallel each other, this
suggests that transcriptional factors are the major determinants of Ca and CP activity.
The mechanism for this repression during lactation is at present unknown; however,
it is in sharp contrast with the control of the expression of milk protein genes, which
are thought to be positively regulated at the transition from pregnancy to lactation by
decreasing progesterone and increasing serum prolactin concentrations. Whether the
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factors involved in the induction of milk protein gene expression from mid-pregnancy
to mid-lactation are also responsible for the repression of the C-subunit expression is
not yet known.
R-subunits were identified in rat mammary tissue extracts as those proteins which
bound both 8-azido[32P]cAMP and cAMP interchangeably. Related molecules such as
AMP did not inhibit binding of 8-azido[32P]cAMP to designated cAMP-binding
proteins, however cGMP was shown to produce a 40-50% reduction in binding to the
putative RI band, a similar effect of cGMP has been described previously for the
purified protein (Handschin et al, 1983). These proteins ran at similar positions on
SDS-PAGE as tissue standards known to over express either RI or RII respectively.
The apparent molecular weights of RI and RII were calculated as 45 and 51kDa
respectively. These values were slightly lower than the published molecular weights for
RI and RII in other tissues and species; RI was determined by SDS-PAGE and given
as 49kDa from porcine, bovine and rabbit skeletal muscle, and RII as 56-58kDa from
bovine heart (Nimmo et al, 1977 and Hofmann et al, 1975). It has been shown that the
apparent molecular weight of RII determined by SDS-PAGE can differ significantly
between species and tissues (Robinson-Steiner et al, 1984). In addition, the extent of
migration can differ for some forms of RII, depending on the presence of phosphate in
the autophosphorylation site (Rubin & Rosen, 1975., Rosen et al, 1975 and Robinson-
Steiner et al, 1984). RI does not undergo autophosphorylation and shows similar but
slightly less pronounced discrepancies in molecular weight when determined by
different methods (Nimmo et al, 1977 and Doskeland, 1978).
In addition to the two R-subunits a minor cAMP-binding protein of approximately 37-
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38kDa was also detected in cytosolic mammary extracts. This may have been one of
a family of protein fragments derived from the R-subunits by proteolysis at the
susceptible hinge region as previously described by others (Weldon & Taylor, 1985).
Total and relative levels of RI and RII isoforms did not remain constant throughout rat
mammary development. Furthermore, both cytosolic and particulate forms of these
proteins were apparently subject to developmental regulation. When measured in
cytosolic mammary extracts, RI was found to be the most abundant R-subunit isoform
throughout rat mammary development; as a fraction of total R-subunit RI levels peaked
at day 12 of pregnancy, coinciding with the peak in cellular proliferation, declining
throughout lactation where cell numbers remain approximately constant. Thus the
present study showed a level of RI expression, throughout normal rat mammary
development, which reflected the changes in the rate of cellular proliferation in the
tissue. Such findings were consistent with the hypothesis that type-I is a general growth
promoter. Type I and type II PK-A isoenzymes have been shown to be under separate
hormonal control, at least in sex steroid-dependent tissues where increased expression
of RI has been correlated positively with hormone induced growth (Doskeland et al,
1975, and Russel, 1978). Cho-Chung and co-workers have repeatedly demonstrated a
predominance of the RI isoform in tumour cells derived from mammary tissue and have
shown strong correlation between RI and cellular proliferation (Cho-Chung, 1992).
Selective inhibition of the RI isoform using cAMP analogues or antisense
oligonucleotides leads to cell growth inhibition in a wide variety of cell lines and
tumours including those derived from mammary tissues (Yokozaki et al, 1993. and
Ciardiello et al, 1993).
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An alternative explanation for the early predominance of the RI isoform in rat
mammary development might be that the RI gene generally responds more rapidly than
that of RII in response to demand for increased R-subunit synthesis; as shown when
tissues expand in response to anabolic hormones (Russel, 1978, and Doskeland et al,
1975) re-feeding (Ekanger et al, 1988) and regeneration (Ekanger et al, 1989).
In contrast levels of the RII isoform were seen to steadily increase throughout both
pregnancy and lactation, thus the RII:RI ratio also increased over this same period to
peak in late lactation. Preferential expression of type II PK-A has been shown to be
induced by treatment of tumour cells with cAMP analogues or differentiating agents
and is typical of terminally differentiated tissues (Cho-Chung et al, 1991).
Unlike the R-subunits, the 37-38kDa protein showed no discernible developmental
pattern of expression; its abundance remained proportional to total R-subunit
concentration throughout both pregnancy and lactation. Neither was there any evidence
to suggest that the fragment was derived specifically from either R-subunit isoform (RI
or RII).
The levels of R-subunits reported in the present results are also in agreement, at least
for lactating tissue extracts, with those observations made by others (Clegg & Connor,
1991, using an antibody based technique previously described by Ekanger &
Doskeland, 1988). Estimation of RI and RII levels were given as 97 ± 11 and 54 ±
5 pmol protein/g wet weight tissue respectively. However, data from an earlier report
in which relative levels of PK-A isoenzymes, type I and type II were estimated using
DEAE cellulose ion exchange chromatography, showed the type II isoenzyme to be the
predominant form in cytosolic mammary tissue extracts derived from lactating rats
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(Clegg & Ottey, 1990, using methods previously described by Livsey & Martin, 1988).
This observation was duplicated in the present study, using a similar methodology
which revealed that type II was the predominant isoenzyme in extracts derived from
both pregnant and lactating rat mammary tissue. Photoaffmity labelling had consistently
shown a predominance of the RI isoform throughout both pregnancy and lactation.
Despite increasing levels of the RII isoform into lactation figures did not transcend
those of RI for cytosolic rat mammary tissue extracts i.e. the RII:RI ratio did not
exceed 1.0. Since PK-A isoenzymes are defined by their characteristic R-subunits, such
high levels of RI would normally be expected to confer a predominance of the type I
holoenzyme upon mammary tissue. There was therefore, a clear disparity between
those findings made by ion-exchange resolution of isoenzymes and those made by
photoaffinity labelling of R-subunits. One explanation may be that a reservoir of free
RI existed within the tissue, such a reservoir had been described by others (Ogreid et
al, 1987) in carcinomas derived from rat mammary tissue; while in the regenerating rat
liver, expression of total R-subunit has been shown to transiently exceed that of the C-
subunit before a period ofmost intense cellular proliferation (Ekanger et al, 1989). In
the present study the ratio of R- to C-subunit remained relatively constant throughout
much of pregnancy and lactation; although a transient over-expression of mammary R-
subunit between late pregnancy and early lactation was suggested by the data presented.
The exact molecular ratio of the two PK-A subunits (normally 1.0) could not be
evaluated, since absolute levels R-subunit protein mass were not measured.
The disparity might also be explained by differences in the two technologies. DEAE
cellulose ion-exchange can only be used to detect R-subunits associated with the
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holoenzyme complex, since quantification of isoenzymes is achieved by measuring the
activity of the associated C-subunit. Therefore, there is some scope for underestimation
of R-subunits by this method. Any activity loss or aberration of the specific activity of
associated C-subunit, for example by co-purification with inhibitory factors, might lead
to underestimation of isoform abundance. Likewise, preferential activation of the type
I isoenzyme within tissue extracts would reduce that RI detected. Differential activation
of PK-A isoenzymes has been described in human breast cancer cells (Livsey et al,
1984). Several reports have also been published warning against the possible incorrect
identification of PK-A isoenzymes when using DEAE-cellulose analysis alone. For
example the elution behaviour of several type-II isoenzymes has been found to differ
(Corbin et al, 1977 and Beebe et al, 1984), while murine adipose tissue type-I has been
shown to elute at a higher salt concentration thus contaminating type-II isoenzyme
(Malkinson et al, 1983). Similar reports have also been made for rat thyroid (Toru-
Delbaufte et al, 1982). Other workers have found that a second fractionation on DEAE-
cellulose is sometimes required to completely resolve the two isoenzymes, especially
when the type-I to type-II ratio was high (Robinson-Steiner et al, 1984).
R-subunit levels were also measured for the particulate fraction of rat mammary tissue
where they were found to be in lower abundance with respect to that of the cytosolic
compartment. However the relative levels of RII (as a fraction of total R-subunit) were
greater than those seen in cytosolic tissue extracts throughout both pregnancy and
lactation. Levels of this isoform increased throughout rat mammary development, to
become the most abundant R-subunit isoform by day 16 of pregnancy. Therefore,
preferential localisation of the RII isoform to the particulate compartment ofmammary
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tissue seemed to be implicated by the data. The mechanism of type II PK-A localisation
probably involves protein-protein interaction between RII and specific Rll-anchoring
proteins. The majority of A-kinase anchoring proteins or AKAPs have been detected
in the insoluble, particulate fractions, implying attachment to membranes and the
cytoskeleton (see Scott & Carr, 1992, for review). Biochemical and
immunocytochemical studies have shown that PK-A localisation is directed through the
R-subunit (Scott, 1991) and may be a key regulatory event in determining the
intracellular sites of hormone action. Certain tissues including brain contain up to 75 %
of either RII isoform (Rlla and RIIP) in particulate form, associated with plasma
membrane, cytoskeletal component, secretory granules, or the nuclear membrane via
AKAPs.
In most cells RI and type I PK-A appear to be unanchored, cytoplasmic proteins
although some exceptions to this general rule have been reported. For example the bulk
of the RI in human erythrocytes is tightly bound to the plasma membrane (Rubin et al,
1972) and in c.elegans the RJ-like subunit is associated with the detergent-insoluble
fraction of homogenates (Lu et al, 1990). A recent study carried out with normal
human T-lymphocytes, demonstrated reversible targeting of PK-A type I to the
cytoplasmic surface of the plasma membrane (Skalhegg et al, 1994) however, it is not
yet known whether targeting was via R- or C-subunits.
Analysis of ruminant mammary tissue provided a contrast to those, more detailed
studies discussed above and assisted in the identification of important, non-species
specific developmental trends in PK-A expression. The increase in tissue DNA (mg/g
tissue) which accompanied cellular proliferation in the rat mammary gland was not
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apparent in that of the sheep, where values were not significantly different between
pregnant and lactating animals. Neither was there a sudden fall in total PK-A activity
(per mg tissue DNA) with the onset of lactation, as previously described for rat
mammary tissue. Instead a small but significant increase in total PK-A activity was
observed between pregnancy and lactation. Expressed PK-A activity showed a similar
pattern of expression to total activity between pregnancy and lactation.
PK-A activity ratio was in closer agreement to rat mammary tissue data; values were
greater in tissue extracts derived from lactating with respect to pregnant animals. Such
an outcome may be indicative of the greater significance of this parameter in sheep
mammary development and function, with respect to total PK-A activity. No data is as
yet available on C-subunit protein concentrations between pregnancy and lactation;
however there was no indication of developmental changes to the specific catalytic
activity of C-subunit, from determinations made upon C-subunit protein purified from
pregnant and lactating sheep mammary tissue. At present no data is available to
determine whether sheep mammary C-subunit is under transcriptional regulation.
Analysis of R-subunit isoforms within the cytosolic fraction of sheep mammary tissue
revealed a pattern of expression not dissimilar to that already described for the rat
mammary gland. However the relative abundance of the RII isoform was much greater
than that exhibited in the rat. The RI isoform which showed a predominance in samples
derived from pregnant sheep, was replaced by RII as the most abundant R-subunit
isoform, in samples derived from lactating animals. In the mid-pregnant rat the RII:RI
ratio was approximately 0.3 and this figure rose to 0.7 by mid-lactation; in contrast this
ratio rose from 0.8 to >2.0 between pregnancy and lactation in sheep mammary tissue
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measured. Therefore the doubling in the level of RII with respect to RI appeared to be
a common developmental signal in both the rat and sheep mammary gland.
Also peculiar to sheep mammary extracts was a mobility shift of the RI and RII bands
between pregnancy and lactation. The putative RI and RII protein bands, derived from
lactating animals, exhibited apparent molecular weights 2-3kDa greater than those
derived from lactating animals. Such mobility shifts may have arisen as a result of
phosphorylation events. It is generally acknowledged that the RII isoform contains a
PK-A recognition sequence which becomes readily autophosphorylated (Durgerian and
Taylor, 1989); this site is replaced by a pseudophosphorylation site binding MgATP
in the RI isoform. However, RI may be subject to phosphorylation by other kinases;
the cGMP-dependent protein kinase has been shown to phosphorylate RI, with slow
kinetics (Geahlen and Krebs, 1980).
The expression of the R-subunit isoforms in the particulate fractions of sheep mammary
tissue showed a similar trend to those already discussed for the cytosolic fractions.
However there was no shift in the apparent molecular weight of the R-subunit isoforms
between pregnancy and lactation. R-subunits derived from pregnant and lactating sheep
mammary tissue exhibited apparent molecular weights (as deduced from SDS-PAGE)
previously shown to be characteristic of Lactating sheep mammary, cytosolic R-
subunits. Total R-subunit levels were lower (on a protein basis) in these extracts than
in those of the cytosolic fraction. The relative level of the RII isoform was also in much
greater abundance throughout both pregnancy and lactation, probably as a consequence
of the presence of AKAPs and their association with type II isoenzyme (Scott, 1991).
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Chapter 5
Expression of PK-A in the rat mammary gland
following litter removal
Introduction
After weaning the lactating mammary gland undergoes a reductive remodelling process
termed involution, during which the tissue gradually returns to a less differentiated
state, to resemble that observed prior to pregnancy. The biological changes which
occur during mammary involution are discussed more fully in the Introductory chapter
(section 1.6). However to summarise here: involution is accompanied by the apoptopic
death of the majority of secretory epithelial, and myoepithelial cells, and by extensive
fat infiltration.
Persistent expression of the differentiated function by mammary epithelial cells during
lactation requires the continued stimulation of sensory nerve endings, by the suckling
young. This ultimately stimulates prolactin production by neuronal feedback to the
hypothalamus (Grosvenor & Mena, 1974). Interruption of this feedback mechanism
leads to the abrupt cessation of milk synthesis and initiates involution of the mammary
gland (Lascelles & Lee, 1987). Thus involution may be triggered and studied
experimentally by removal of the litter from the nursing rat. Incidentally, this also leads
to milk stasis, the accumulation of milk within the mammary tissue, which itself
triggers involutional progression of the mammary epithelium (Flint et al, 1981).
The process of de-differentiation and involution entails the concerted modification of
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the expression of large numbers of genes, such pleiotropic transcriptional regulation
is a well documented function of PK-A (Montminy et al, 1990). Furthermore cAMP
and PK-A have both been implicated in the initiation of involution and apoptopic cell
death, in a number of cell and tissue models including mammary gland involution
(Dowd & Miesfeld, 1992 and Marti et al, 1994). The present study therefore undertook
to characterise the behaviour of PK-A, both in terms of its activity and generic C- and
R-subunits (both RI and RII), in the mammary gland following litter removal.
5.1 Litter removal
Mammary tissue was sampled from lactating rats (LR24 and LR48), whose litters had
been removed for 24 and 48h respectively, as described in section 2.1.1. Tissue was
also harvested from day 12 lactating rats (L12), which were used as controls. In total,
three sets of tissue samples were collected, 5 x LR24, 5 x LR48 and 5 x L12. These
were then used to study the effects of litter removal upon the expression of PK-A
activity, C-subunit protein mass, Ca mRNA abundance and the relative abundance of
R-subunits (both RI and RII).
5.2 PK-A activity in the rat mammary gland following litter removal
Soluble extracts were prepared, as described in section 2.6.1, from the sets of rat
mammary tissue described above (section 5.1). Samples were then assayed for both
total PK-A activity i.e. that measured in the presence of excess cAMP, and expressed
activity; that measured in the absence of added cAMP, as described in section 2.6.2.
By measuring total PK-A activity, an index of the total amount of C-subunit protein
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Figure 5.1 PK-A activity (total, expressed and activity ratio) in rat mammary
tissue following litter removal
Mammary tissue was sampled from rats as follows: L12, at day 12 of lactation;
LR24, 24h following removal of litter at day 10 of lactation; LR48, 48h following
litter removal. Extracts were prepared and assayed for PK-A activity (as described in
section 2.6). Total activity was that measured in the presence of 0.67/xM cAMP,
while expressed activity was that measured in the same extracts without added cAMP.
Results are means (± S.E.M) of determinations on not less than 5 animals.
present in the tissue, and therefore the cell's capacity for cAMP-dependent protein
phosphorylation, could be determined. Based on wet tissue weight, total PK-A activity
declined sharply following the first 24h of litter removal; activity declined from 102.0
+ 7.4 (for L12 control rats) to 36.0 + 3.2 munits/g tissue (for LR24 rats). However
total activity recovered somewhat following 48h litter removal (LR48) to 52.1 + 4.3
munits/g tissue, (Figure 5.1). This recovery was analysed using the Student's t test and
found to be statistically significant for P <0.005.
The DNA and protein content of the tissue declined only slightly following litter
removal (Table 5.1), therefore total PK-A activity also fell when calculated on the basis
of tissue DNA. Total activity more than halved, falling from 35.6 + 1.9 (L12 control)
to 15.7 + 1.1 munits/mg DNA (LR24). As for values calculated on the basis of wet
tissue weight, total PK-A activity recovered slightly following 48h litter removal,
reaching 17.0 ±1.4 munits/ mg DNA.
By measuring expressed PK-A activity a measure of the free C-subunit, present within
the tissue at the time of sampling was obtained. Procedures were adopted to prevent the
association/dissociation of the C- and R-subunits (as described in section 2.6.1).
Following 24h litter removal expressed activity underwent a similar, but somewhat
exaggerated response to that of total PK-A activity. Based on wet tissue weight, figures
fell from 14.5 + 2.4 (for L12 controls) to 5.7 + 1.2 munits/g tissue (LR24), giving
rise to a transient decrease in activity ratio, although this was outside the error limits
of the experiment (Figure 5.1). However, expressed activity recovered slightly over the
next 24h of non-suckling to 7.3 + 1.3 munits/g tissue (LR48), to give rise to an








LR24 73.0 ± 6.6 2.81 ± 0.27
LR48 79.3 ± 4.2 3.06 + 0.15
L12 80.7 ± 4.5 3.82 ± 0.03
Table 5.1 Composition of rat mammary tissue following litter removal
DNA and protein were determined for those mammary tissue samples described in
section 5.1 (L12, LR24 and LR48). Extracts were prepared and assayed for protein
and DNA content (as described in section 2.5.1 and 2.5.2 respectively). Values are
(means ± S.E.M.) for groups of not less than 5 animals.
trend when data was expressed on a per mg DNA basis (results not shown).
5.3 Effects of litter removal upon C-subunit protein mass
Litter removal has been shown to expedite the down regulation of PK-A activity
measured in rat mammary tissue extracts. Adopting the immunoquantification
procedure described in section 2.7, tissue derived from LR24 and LR48 rats (for which
PK-A activity data already existed) was analysed for C-subunit protein mass. Thus,
allowing the effect of litter removal (if any), upon the specific catalytic activity of the
C-subunit protein to be investigated. Soluble tissue extracts were made (as described
in section 2.7.2) and C-subunit protein mass quantified (as described in section 2.7.3).
Mammary extracts derived from nursing rats in their twelfth day of lactation (L12)
were used as controls.
Following 24h litter removal, C-subunit protein mass declined from 2.51 ± 0.20 (for
L12 controls) to 1.5 + 0.27 ^g/g tissue (LR24), as shown in Figure 5.2. Levels
recovered slightly to 1.68 + 0.18 /ig/g tissue following a further 24h of non-suckling
(LR48); however this failed to reach significance when tested using the Students t-test.
Although C-subunit protein mass appeared to follow the general pattern of decline and
recovery observed for total PK-A activity (section 5.2), the decline in C-subunit protein
mass was less exaggerated, with the result that total PK-A activity fell more quickly
than could be explained by loss of C-subunit mass alone. Thus litter removal appeared
to be accompanied by a decline in the specific activity of C-subunit (Figure 5.2).
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Figure 5.2 C-subunit protein mass, specific catalytic activity and PK-A total
activity: effect of litter removal
C-subunit protein mass was quantified in rat mammary tissue samples for which PK-A
activity data already existed (L12, LR24 and LR48 are as described in section 5.1).
The quantification procedure was that described in section 2.7. PK-A activity data is
that described in Figure 5.1. Results are (+ S.E.M) for not less than 4 animals.
5.4 Ca mRNA levels in the rat mammary gland following litter removal
Initiation of involution by litter removal was found to be accompanied by a rapid
decline in total PK-A activity, as described in section 5.2. Furthermore corresponding
levels of C-subunit protein were also seen to fall, but not in fixed proportion to total
PK-A activity. Thus the fall in total PK-A activity could not be wholly explained in
terms of declining C-subunit protein mass. In order to determine the degree of
transcriptional regulation of C-subunit protein mass, levels of Ca mRNA were
measured by Northern blotting techniques, as described in section 2.8. Studies were
performed on groups of 5 animals for which PK-A activity data already existed, as
described in section 5.1.
The abundance of Ca mRNA (expressed mRNA/g of tissue wet weight) did not reflect
PK-A protein mass, measured in both LR24 and LR48 mammary samples (Figure 5.3).
In contrast to total PK-A activity and C-subunit protein mass, which were seen to fall
following the first 24h of litter removal, levels of Ca mRNA showed a small increase,
although this fell outside the error limits of the experiment (Figure 5.3). Forty eight
hours after litter removal, levels of Ca mRNA decreased to those levels observed for
control mid-lactating rats (LI2); once again this was in contrast to total PK-A activity
which recovered slightly between 24 and 48h litter removal, but did not attain those
levels observed in L12 controls. Thus C-subunit protein mass and total PK-A activity
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Figure 5.3 Abundance of Cor mRNA following litter removal: Comparison with
C-subunit protein levels
Quantification of C-subunit protein mass was as described in section 2.7.
Quantification of Ca mRNA was as described in section 2.8. Results are means (±
S.E.M) for 5 animals. C-subunit protein mass is that data previously shown in Figure
5.2.
5.5 Cyclic AMP-binding proteins
The initiation of involution by litter removal was accompanied by a decline in both total
and expressed PK-A activities. C-subunit protein levels also fell but not in proportion
to total PK-A activity; neither did C-subunit protein levels appear to be
transcriptionally regulated. It therefore followed, that unless R-subunit levels were
similarly down-regulated following litter removal, the C-: R-subunit ratio, classically
regarded as equalling 1.0 in terminally differentiated tissues (see Beebe & Corbin, 1986
for review), would not be maintained.
The relative abundance of cAMP-binding proteins in tissue extracts derived from
LR24, LR48 and L12 rats were examined using the cAMP analogue, 8-azido
[32P]cAMP. Photoaffinity labelling also allowed the distinction to be made between the
levels of the two major isoforms of PK-A, type I and type II, which are defined by their
characteristic R-subunits. In order that a more dynamic picture of the subcellular
localisation of PK-A isoenzymes could be obtained, both cytosolic and particulate
mammary extracts were examined in this manner.
5.5.1 Cytosolic cAMP-binding proteins
Soluble extracts were prepared (as described in section 2.9.1) from tissue derived from
LR24, LR48 and L12 rats, for which PK-A activity, C-subunit quantification and Ca
mRNA data already existed. Tissue extracts derived from nursing rats (L12) were used
as controls. Both control and litter removed tissue extracts were run together in
grouped experiments, in which samples were equalised with respect to protein
concentration prior to photoaffinity labelling. Labelling was carried out as described
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Figure 5.4 Cytosolic cAMP-binding proteins in mammary tissue following litter
removal
Mammary tissue was sampled from rats as follows: L12, at day 12 of lactation;
LR24, 24h following removal of litter at day 10 of lactation; LR48, 48h following
litter removal. Extracts were prepared and labelled with the photoaffinity ligand 8-
azido-[32P]cAMP, as described in the section 2.9. Lanes a-c represent control and
litter removed samples run in a single experiment. Lanes d and e represent a separate
cAMP competition experiment in which samples were labelled both in the presence
and absence of radio-inert cAMP. Results are representative of data for not less than
4 animals.
in section 2.9.2.
Three major proteins were labelled in the cytosolic fractions of mammary tissue
sampled from LR24 and LR48 rats (Figure 5.4). These migrated on SDS-PAGE at the
same positions as cAMP-binding proteins identified in the L12 control rats i.e. RI, RII
and a 37-38kDa R-subunit degradation product (also described in section 4.6.1).
Labelling of all three bands was successfully competed out by radio-inert cAMP as
described in section 2.9.3 (Figure 5.4), and was absent when no u.v. irradiation was
applied to the samples (results not shown). In addition to these major cAMP-binding
proteins, numerous lower molecular weight bands were also labelled. However,
labelling of these was not competed out by radio-inert cAMP, allowing the conclusion
that they were not specific cAMP-binding proteins/peptides (Figure 5.4).
Litter removal appeared to have a marked effect upon the level of R-subunits in the
cytosolic compartment of rat mammary tissue. Levels of both RI and RII were shown
to be substantially diminished following 24h litter removal; levels were depleted by
approximately 50-60% with respect to those levels measured in L12 controls (Figure
5.5). The depression in total R-subunit (RI + RII) persisted until 48h litter removal,
although there was no further reduction in R-subunit levels (Figures 5.5 and 5.6). The
RILRI isoform ratio was only marginally depressed by litter removal (Figures 5.9),
with the decline in total R-subunit apparently brought about by decreasing levels of
both RI and RII, and there did not appear to be preferential down regulation of either
isoform.
The apparent loss of R-subunit following litter removal was accompanied by a dramatic



































L12 LR 24 LR 48
Figure 5.5. Cytosolic R-subunit composition of mammary tissue following litter
removal
Mammary tissue samples were those described in section 5.1. Extracts were prepared
and labelled with the photoaffinity ligand 8-azido-[32P]cAMP, as described in the
section 2.9. The above histograph shows data from a single experiment in which sets
of five L12, LR24 and LR48 animals, were equalised with respect to protein
concentration, photoaffinity labelled and run on the same SDS-PAGE gel. The relative
levels of cytosolic cAMP-binding proteins in control and litter removed samples were
determined after excision of radio-labelled bands and liquid scintillation counting to
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Figure 5.6 Cytosolic R- and C-subunit levels in rat mammary tissue following
litter removal
The above Figure represents combined data from two separate experiments;
immunoquantification of PK-A C-subunit, as described in section 5.3 and arbitrary
levels of R-subunits (RI + RII) as described in section 5.5. Results are means
(+ S.E.M.) for not less than 4 animals.
of R-subunit degradation (Weldon & Taylor, 1985). The level of 8-azido-[32P]cAMP
binding associated with this protein exceeded that of the L12 control samples, run in
the same experiment, by excess of ten fold, and levels of total R-subunit in the same
samples, by more than six-fold (Figure 5.5). Similar levels of this protein were also
apparent in samples from LR48 rats (Figure 5.5).
Therefore, as well as triggering C-subunit down-regulation (section 5.3), litter removal
was also shown to stimulate the rapid degradation of R-subunits (both RI and RII
isoforms); although there is some suggestion, comparing the two sets of data, that loss
of C-subunit protein mass was less dramatic than R-subunit degradation (Figure 5.6).
5.5.2 Particulate cAMP-binding proteins
Particulate samples were prepared by the re-suspension of pellet fractions following the
preparation of soluble, cytosolic extracts from mammary tissue samples, as described
in section 2.9.1. Accordingly particulate tissue extracts were derived from LR24, LR48
and L12 rats, for which PK-A activity, C-subunit quantification, Ca mRNA and
cytosolic R-subunit data already existed. Tissue extracts derived from nursing rats
(L12) were used as controls. Both control and litter removed (LR24 and LR48) tissue
extracts were run together in grouped experiments following equalisation for protein,
as described in section 2.9.2. Photoaffinity labelling revealed the presence of three
cAMP-binding proteins in the particulate compartment of LR24 and LR48 rat
mammary tissue. These migrated on SDS-PAGE gels at identical positions to cAMP-
binding proteins associated with control, cytosolic extracts run in the same experiment
(Figure 5.7) and were identified as being RI, RII and the 37-38kDa degradation product
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Figure 5.7 Particulate cAMP-binding proteins in rat mammary tissue following
litter removal
Mammary tissue was sampled from mid-lactating rats as described in section 5.1.
Extracts were prepared and labelled with the photoaffinity ligand 8-azido-[32P]cAMP
as described in the section 2.9. Results are representative of data for not less than 4
animals.
respectively. In competition experiments (described in section 2.9.3), all three protein
bands were successfully competed out by radio-inert cAMP, (results not shown). The
unspecific labelling of small proteins and peptides observed in cytosolic extracts was
absent from all particulate samples examined here.
As for the cytosolic compartment, litter removal led to a deterioration in the total level
of R-subunit (RI + RII); both LR24 and LR48 samples exhibited depleted levels of R-
subunit as compared to L12 controls. However, unlike the cytosolic compartment, the
decline in total R-subunit was brought about by the preferential down regulation of the
RI isoform (Figure 5.8). There was no corresponding decline in the level of the RII
isoform, thus litter removal was also shown to be accompanied by a substantial increase
in the RII:RI ratio (Figure 5.9).
Accompanying the decline in RI, was a large increase in the level of the 37-38kDa
cAMP-binding protein, which had previously been described (section 4.6.3) as absent
or present at very low concentrations, in the particulate fractions derived from nursing
rats, such as L12 controls examined in the same experiments (Figure 5.8). Levels of
the 37-38kDa cAMP-binding protein, as a proportion of total 8-azido[32P]cAMP
binding activity, did not appear to be as great as previously described for cytosolic
tissue extracts (section 5.5.1). The 37-38kDa protein represented approximately 5% of
the total 8-azido[32P]cAMP binding activity in the particulate fraction of L12 controls;
this rose to 25 and 30% for LR24 and LR48 samples respectively. Corresponding
values for cytosolic samples, derived from the same tissue, showed an increase from
22% for L12 controls to 83 and 76% for LR24 and LR48 samples respectively.
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Figure 5.8 Particulate R-subunit composition ofmammary tissue following litter
removal
The above Figure shows data from a single experiment in which particulate mammary
tissue extracts were prepared and labelled with the photoaffinity ligand 8-azido-
[32P]cAMP, as described in the section 2.9. The above histograph shows the relative
levels of cAMP-binding proteins in the particulate fractions of control and litter
removed samples. Values are means (+S.E.M.) for not less than four animals.
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Figure 5.9 The relative abundance of cytosolic and particulate R-subunit
isoforms
The above Figure represents a single experiment of paired design in which the relative
levels of the R-subunit isoforms RI and RII were measured for both cytosolic and
particulate fractions of the rat mammary tissue. Results are means (+ S.E.M.) for not
less than 4 animals.
5.6 Discussion
The significance of the suckling stimulus in maintaining the functional integrity of the
mammary gland and lactation has been demonstrated by others (Selye, 1934 and Flint
et al, 1981). Many studies have employed the technique of removing the litter at the
height of lactation to prevent milk removal and initiate involution (see Lascelles & Lee,
1987 for review). Although such an event is uncommon in nature, being limited to the
accidental loss of the offspring, this does allow involution to be initiated in a controlled
manner. The effects of abrupt weaning upon the expression of PK-A in the rat
mammary gland are discussed here.
Based upon tissue wet weight or DNA, 24h litter removal resulted in a rapid decline
in both total and expressed PK-A activities. The decline in expressed activity was more
marked, as compared to total activity with the result that the PK-A activity ratio also
fell following litter removal. Activity recovered slightly during the next 24h litter
removal, but did not return to those levels measured in nursing, control females.
Many independent studies have implicated the involvement of cAMP and PK-A in the
mediation of involution and apoptopic cell death, in a number of cell and tissue models.
The action of certain cAMP analogues, including 8-C1 cAMP have been found to
trigger apoptopic cell death in lymphoid cells (Dowd & Miesfeld, 1992) and increased
nuclear PK-A activity has been associated with early stages of involution in the mouse
mammary gland (Marti et al, 1994). Furthermore, total PK-A activity (expressed on
a tissue DNA basis) was found to be markedly suppressed during lactation in the rat
mammary gland (Gardner et al, 1994 and section 4.3.1). It is therefore possible that
suppression of PK-A activity is necessary in order to safeguard lactation. In the rat,
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lactation may be rescued by return of the pups up to, and including 24h from litter
removal (Flint et al, 1981). Therefore the initial suppression of PK-A activity (both
total and expressed) 24h from litter removal may be indicative of some physiological
mechanism, initiated to protect lactation following the temporary separation of mother
and offspring. Beyond 24h litter removal involutionary processes become irreversible,
at the same time pups fail to survive without their mother. It is of interest therefore,
that following 48h from litter removal a partial recovery of total and expressed PK-A
activity was observed; recovery of PK-A activity then, appeared to coincide with
mammary gland commitment to involution.
C-subunit protein mass was also shown to fall following litter removal but not in fixed
proportion to total PK-A activity, leading to a decline in the specific catalytic activity
of the C-subunit. Neither did C-subunit protein mass appear to be transcriptionally
regulated; levels of Ca mRNA remained relatively constant between lactating controls
and animals whose litters had been removed for 24 and 48h respectively. Maintenance
of C-subunit protein mass has previously been shown to come under transcriptional
regulation in the rat mammary gland throughout pregnancy and lactation; where the
specific catalytic activity of the C-subunit was also shown to remain constant (Gardner
et al, 1994 and section 4.5). Therefore, litter removal appeared to initiate regulatory
mechanisms other than those in place during mammary tissue development. The
abatement of C-subunit protein mass following litter removal may be achieved by the
stimulation of degradation pathways, specific for the PK-A C-subunit present within
rat mammary tissue. Deactivation of free C-subunit in rat mammary tissue has already
been described elsewhere in this thesis (section 3.4). Degradation of the PK-A C-
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subunit has been reported in other tissues, such as the identification of a protease
specific to C-subunit in brush border membranes isolated from rat small intestine
(Alhanaty & Shaltiel, 1979). A similar protease has also been described for rat renal
brush border (Schmitz et al, 1973; and Hopfer et al, 1973).
The apparent fall in C-subunit specific activity may be explained by the presence of a
specific PK-A inhibitor present within the mammary tissue. Inhibition of PK-A activity
has been described, in a variety of tissues, including the specific, heat-stable inhibitor
protein of PK-A, described in rabbit muscle by Walsh and colleges (Walsh et al, 1971).
There is also some evidence in the current literature, for the existence of "mute" C-
subunit molecules such as those described by Reed et al (1983) and Steinberg (1991),
or C-subunit with altered specific activities in small, distinct sub-cellular populations
(Clegg & Connor, 1991). The present result is indicative of divergence in the
regulation of C-subunit activity between lactating tissue and that undergoing
involutionary processes. Work discussed earlier in this thesis has already shown the
consistency of the intrinsic specific activity of mammary tissue C-subunit throughout
pregnancy and lactation (sections 3.3 and 4.4).
Several studies have established that hormones or cAMP itself are capable of regulating
the PK-A system, at least in part by altering the PK-A subunit concentration or by
transcriptional or post-transcriptional changes in the production or degradation of PK-A
subunits (Spaulding, 1993 and Garrel et al, 1995). Down-regulation of the C-subunit
and reduced catalytic activity might be expected in tissue which has experienced
elevated cAMP levels. In vitro cells exposed to high levels of cAMP for prolonged
periods show increased turnover of C-subunit or elevated levels of R-subunits both
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resulting in reduced catalytic activity (Spaulding, 1993).
PK-A deactivation may also be achieved by increasing the level of R-subunit relative
to C-subunit, the principle was recently confirmed by the identification of RIa (Boshart
et al, 1991 and Jones et al, 1991) as the extinguisher of cAMP-induced gene responses.
Three distinct cAMP-binding proteins were detected in soluble, cytosolic extracts
derived from rat mammary tissue which had undergone litter removal for 24 and 48h.
These migrated on SDS-PAGE gels at the same apparent molecular weights as the RI,
RII and a 37-38kDa protein present in L12 control samples run in the same
experiments.
Litter removal brought about a drastic decrease in the R-subunit levels measured in
soluble, cytosolic tissue extracts. Both R-subunit isoforms (RI and RII) appeared to be
equally effected. Greatest losses occurred between 0 and 24h litter removal, with
moderate losses of R-subunit occurring between 24 and 48h litter removal. In contrast,
levels of the 37-38kDa protein increased dramatically, between 0-24h; an observation
consistent with this protein being a product of R-subunit degradation. A similar protein
has been described by others (Handschin et al, 1983) and is thought to arise by the
hydrolysis of R-subunits at the susceptible "Hinge region" (Takio et al, 1980) which
is exposed only in the free subunits (Sugden et al, 1976., Potter & Taylor, 1979 and
Weldon & Taylor, 1985). Further studies have revealed that both types of R-subunits
are subject to proteolysis (Sugden et al, 1976., Weber & Hilz, 1978., 1979 and Corbin
et al, 1978), with the generation of 35-39kDa cAMP-binding products of RI and RII
respectively. These degradation products were unable to recombine with C-subunit to
form holoenzymes, leading to a cessation of biological activity (Weber & Hilz, 1979).
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Cleavage of released R-subunits at these protease sensitive sites might provide a signal
for farther degradation, which may eventually possibly lead to a loss of cAMP-binding
activity; no smaller, high affinity cAMP-binding proteins/peptides were found within
the mammary samples examined here.
The proteolytic cleavage of the R-subunit did not appear to be confined to mammary
involution. The 37-38kDa protein was also observed in pregnant and lactating rat
mammary tissue, albeit in smaller quantities, indicating that a basal level of R-subunit
degradation was present during mammary development (as described in section 4.6.1).
Increased degradation of R-subunit following litter removal may have been coincidental
with the activation of non-specific proteases following the onset of involution.
However, Northern blot studies have shown an inverse relationship between the
expression of proteases and their inhibitors in the mouse mammary gland following
litter removal (Strange et al, 1992); the first days of weaning were characterised by the
expression of certain protease inhibitors, while proteases were expressed more latterly
into involution. Therefore, it may also be possible that abrupt weaning was followed
by the increased expression of a protease, specific for the PK-A regulatory subunit.
Prior to litter removal C- and R-subunits appeared to be coordinately down-regulated.
However, 24 and 48h from litter removal the regulation of C- and R-subunits appeared
to diverge; the data suggests an increase in the C-:R-subunit ratio between 0-24h and
24-48h litter removal which would be expected to lead to an increase in the population
of free C-subunit within the tissue. This may account for the partial recovery of
expressed PK-A activity following 48h litter removal, but presents a possible paradox
between 0 and 24h litter removal where the C-:R-subunit ratio rises while the expressed
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activity decreases. Most tissues examined have been shown to contain equimolar
amounts of R- and C-subunits (Corbin et al, 1977; Hofmann et al, 1977). In the present
study, the ratio of C- and R-subunits was shown to remain relatively constant
throughout rat mammary development (see Chapter 4), although the molecular ratio of
these two subunits was not determined since the absolute amount of R-subunit was not
measured. Deviation from the usual 1:1 ratio has rarely been reported, and usually
entails over expression of R-subunit relative to C-subunit as first reported by Prashad
et al (1979) in neuroblastoma cells following prolonged treatment with dibutyryl
cAMP. More recently the C-:R-subunit ratio has been shown to decrease during the
pre-replicative phase of liver regeneration (Ekanger et al, 1989).
In the present study the particulate fraction of rat mammary tissue was also examined
for cAMP-binding proteins and shown to contain the same inventory of cAMP-binding
proteins as described previously, for soluble cytosolic extracts. Three cAMP-binding
proteins were present including RI, RII and the 37-38kDa protein. As for the cytosolic
compartment, there was a significant reduction in the level of total R-subunit (RI +
RII) following litter removal; R-subunit loss was greatest during the initial 24h period
of non-suckling, whereafter R-subunit levels remained low, but relatively stable.
However, unlike the cytosolic compartment there was no significant loss of the RII
isoform; the loss of the RI isoform was wholly responsible for the decrease observed
in total R-subunit. Therefore litter removal also led to a significant increase in the
RII:RI ratio.
Conversely, levels of the 37-38kDa protein increased following litter removal, most
notably between 0 and 24h; control mammary tissue (L12) contained very small or
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negligible quantities of this cAMP-binding protein. Hence, removal of the suckling
stimulus stimulated the down-regulation of R-subunit protein in both the cytosolic and
particulate compartments; and that down regulation was achieved, at least in part, by
an increase in the rate of proteolytic cleavage of intact R-subunits to form 37-38kDa
cAMP-binding protein fragments.
The extent of R-subunit degradation differed between cellular compartments. R-subunit
degradation appeared greatest in the cytosolic compartment, which also contained
higher levels of the 37-38kDa protein (expressed as a percentage of total 8-azido[32P]
cAMP-binding activity). There were further differences in relative degradation of the
two R-subunit isoforms, RI and RII. In the cytosolic compartment both isoforms were
equally down regulated with the resulting RITRI ratio remaining approximately
constant. Conversely there was no significant loss of RII from the particulate
compartment. Divergent turnover of PK-A subunits has been reported in rat liver, brain
and kidney (Weber & Hilz, 1986), in which type I holoenzyme was renewed much
faster than protein kinase II. The authors described the basic molecular mechanism
leading to this higher turnover of type I PK-A as being related to the greater instability
of free subunits compared to that of the holoenzyme. Since other studies have indicated
that RII is by far the most sensitive isoform to proteases, in vitro (Weber & Hilz,
1979), elevated turnover of RI may be an indicator of preferential activation of the type
I holoenzyme. A growing body of evidence has also shown that the type II PK-A
holoenzyme can be tethered at specific subcellular locations through interaction of its
R-subunits with an AKAP, or A-Kinase Anchoring Protein (Scott, 1991). The majority
of these proteins have been detected in particulate tissue fractions, implying attachment
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to membrane and skeletal components (see Scott and Carr 1992 for review). Although
specific mammary AKAPs have yet to be identified it remains a possibility that the RII
isoform is associated with similar proteins in the particulate compartment of rat
mammary tissue. Association with AKAPs may afford RII protection from the
proteolytic degradation, and help explain the difference between the two cellular
compartments discussed above. Evidence for similar proteins which will bind to, and
anchor the RI isoform has been insufficient to the effect that RI is generally regarded
as remaining "free" in solution.
If, as the data suggests, C-subunit was present in excess over R-subunit, then the
mechanism that normally maintains the stoichiometry between these two subunits was
disrupted following the onset of involution. Although the level of many proteins is
maintained by transcriptional regulation (as for PK-A C-subunit throughout rat
mammary development, section 4.5) regulation can also occur at the level of translation
and/or degradation of mRNA and at the level of protein degradation. It is therefore
possible that the two subunits were regulated coordinately at one level (e.g.
transcription) but regulated differently at another level e.g. translation or degradation.
C-subunit activity and therefore protein phosphorylation was also apparently subject
to further regulation, in that the specific activity of the enzyme was reduced following




Throughout the course of pregnancy, parturition and lactation, mammary tissue
progresses through a programme of proliferation and differentiation: the terminal
differentiation events enable expression of the tissue's physiological functions of
biosynthesis and secretion. The end of lactation sees a reductive remodelling process
termed involution during which the tissue returns to a less differentiated state such as
that observed prior to pregnancy. Such processes entail concerted modification of
expression of large numbers of genes. Since such pleiotropic transcriptional regulation
is a well documented function of PK-A (Montminy et al, 1990) the behaviour of this
kinase in mammary tissue was investigated here. The following discussion summarises
how PK-A activity and the expression of PK-A generic C-subunit and R-subunits (RI
and RII) were developmentally regulated throughout the pregnancy/lactation/involution
cycle of the rat mammary gland.
The expression of the Ca- and CP-subunit mRNA appeared to be coordinately
regulated throughout pregnancy and lactation, in that their ratio to one another did not
change. Ca appears to be expressed constitutively in most cells, however the
expression of CP is tissue specific (Showers & Maurer, 1986., Uhler et al, 1986 and
Hedin et al, 1989). Ca mRNA was shown to predominate over that of CP in rat
mammary tissue; this pattern of expression is characteristic of liver and kidney, but
unlike brain, where the abundance of the two mRNAs is roughly equal (Showers and
Maurer, 1986). Absolute levels of both the Ca and CP mRNAs were repressed during
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lactation; a pattern mirrored by both C-subunit protein and total PK-A activity levels,
suggesting that transcriptional processes were major determinants of Ca and CP
activity. The mechanism of this repression during lactation is as yet unknown; however
it is in sharp contrast with control of expression of milk protein genes, which are
thought to be positively regulated at the transition from pregnancy to lactation by
decreasing progesterone and increasing serum prolactin concentrations (for review see
Rillema, 19??). Whether the factors involved in the induction of milk protein gene
expression from mid-pregnancy to mid-lactation are also responsible for the repression
of the C-subunit expression remains open to further investigation.
In relation to putative tonic influences of PK-A on mammary growth and development,
it is likely that expressed activity is the most physiologically relevant of the catalytic
parameters determined, being indicative of cAMP dependent protein phosphorylation
events. It is therefore of interest that this remains relatively constant throughout mid-
pregnancy but approximately doubles during late-pregnancy, immediately preceding the
steep increase in the rate of DNA synthesis which persists throughout early/mid
lactation. This enhancement in expressed PK-A activity does not persist
correspondingly, but instead declines back to base line.
Several independent lines of evidence have suggested that PK-A is atypical in its
biochemical properties, at least in lactating rat mammary tissue (Clegg, 1988., Clegg
and Ottey, 1990., Takhar and Munday, 1984 and Bussmann et al, 1984). The present
work suggests that there are no changes to the intrinsic specific activity of C-subunit,
with respect to the substrate, Kemptide, between pregnancy and lactation. C-subunit
protein mass was shown to be closely paralled by total PK-A activity throughout
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pregnancy and lactation, thereby demonstrating the consistency of C-subunit specific
catalytic activity. However, it is possible that mammary tissue may contain a novel C-
subunit, not recognised by Northern Ca and C6 probes or by the C-subunit antibody
(As-365/ab-365). In this respect it is of interest that 15% of C-subunit appears to be
insensitive to immunotitration and immunoprecipitation by As-365 (see below). Such
C-subunit may exhibit abberrant sensitivity to inhibitors and deactivators, and/or
intrinsic differences in C-subunit acylation or autophosphorylation. For the purpose of
C-subunit immunoquantification a polyclonal antibody was raised against a synthetic
peptide representing residues 322-332 of the C-subunit of PK-A (denoted As-365). This
epitope lies close to the binding sites both for substrates peptide and adenine nucleotide,
explaining the ability of the antibody to inhibit the catalytic activity of PK-A C-subunit.
As-365 showed no discernable difference in its potency titre against mammary tissue
extracts or purified mammary C-subunit preparations derived from pregnant and
lactating animals (as revealed by immunoinhibition studies). Such preparations differed
markedly in their levels of C-subunit expression, supporting the above conclusion that
C-subunit specific activity is unaffected by the differentiation of mammary tissue
throughout pregnancy and lactation.
The absolute level of rat mammary tissue C-subunit protein found in the present study,
of approximately 2/^g/g tissue in lactating animals, is in agreement with that deduced
by Clegg & Connor (1991). However mammary C-subunit also possessed a specific
activity several-fold greater than the best values measured for the purified protein,
including those from lactating and pregnant sheep mammary tissue. Such findings may
be indicative of major activity losses as a result of C-subunit purification or an
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enhancement of C-subunit activity within mammary tissue extracts. Enhancement of C-
subunit activity has been described previously in lactating rat mammary tissue extracts
(Clegg & Ottey, 1990).
Immunoinhibition and immunoprecipitation studies using mammary tissue extracts and
purified C-subunit preparations (including a non-myristoylated recombinant C-subunit),
also revealed a sub-population of C-subunit molecules not recognised by the As-365.
The proportion of this residual activity appeared to be independent of the tissues
physiological state or tissue of origin. Such molecules may have all or part of the
epitope 322-332 occluded, either by some small molecule not removed by the
purification process, or by some form of post-translational or proteolytic modification.
Since both Ca nd CP isoenzymes are known to contain the amino acid sequence used
to raise As-365, it is unlikely that the residual activity was a consequence of the C-
subunit heterogeneity described above.
In the course of these, and further investigations mammary tissue was shown to contain
a deactivator of PK-A activity which did not share the same characteristics of the heat
stable inhibitor of PK-A (PKI) first described by Walsh and colleagues (Walsh et al,
1971). Deactivation of PK-A was found to be critically time and temperature
dependent; modest but significant protection was also provided by the presence of
MgATP. PK-A deactivation has been described in other rat tissues; a specific C-
subunit proteinases has been identified in brush border membranes isolated from rat
small intestine and kidney (Alhanaty & Shaltiel, 1979, Schmitz et al, 1973 and Hopfer
et al, 1973). However, Western blotting studies using As-365, revealed no evidence for
the degradation of the C-subunit, possibly due to proteolytic modification of residues
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322-332. The specific deactivation of C-subunit, by a proteinases or deactivating factor,
together with the prevention of its action by substrate and R-subunits, raise the
possibility it may have a distinct physiological (possibly regulatory) assignment within
rat mammary tissue.
Cho-Chung and co-workers have repeatedly demonstrated a predominance of the type
I R-subunit (RI) in tumour cells and have established a strong correlation between RI
and cellular proliferation (Cho-Chung, 1992). In contrast the preferential expression
of the type II PK-A has been shown to be induced by treatment of tumour cells with
cAMP analogues and is typical of terminally differentiated tissues (Cho-Chung et al,
1991). The present study revealed a pattern of RI expression, throughout normal rat
mammary development, which reflected the changes in the rate of cellular proliferation
in the tissue; levels increased throughout pregnancy to peak around parturition or early
lactation, after which, cell numbers have been shown to remain relatively constant
(Knight & Peaker, 1982a). RI therefore appeared to be a positive regulator of
mammary cell growth, however, an alternative explanation may be that the RI gene
generally responds more rapidly than that of RII in demand for increased R-subunit
synthesis e.g. in rat liver regeneration (Ekanger et al, 1989).
RI remained the predominant isoform in rat mammary tissue throughout pregnancy and
lactation, however, levels of the RII isoform (and consequently the RII:RI ratio)
increased throughout mammary development. A growing body of evidence has shown
that type II PK-A holoenzyme can be tethered at specific subcellular locations through
interaction of its R-subunits (RII) with A-kinase anchoring proteins (AKAPs). The
majority of AKAPs are located in the particulate, cellular fractions, implying
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attachment to membrane and skeletal components (Scott, 1991). R-subunit expression
was therefore examined in both cytosolic (described above) and particulate fractions of
rat mammary tissue. Not surprisingly a greater proportion of particulate R-subunit was
found to comprise of RII. As for the cytosolic compartment the RII:RI ratio also
increased throughout both pregnancy and lactation. The vast majority of R-subunit was
shown to be located in the cytosolic compartment of rat mammary tissue, this pattern
of compartmentalisation has been found for most tissues examined, with the exception
of the brain (Scott & Carr, 1992).
Also present in cytosolic extracts, but absent from all particulate samples examined,
was a cAMP-binding protein of 37-38kDa. This may have been one of a family of
protein fragments derived from R-subunits by proteolysis at the susceptible hinge-
region, as previously described by others (Weldon & Taylor, 1985). Unlike the
regulatory subunits this protein showed no discernable developmental trend in its
expression, and indicated that a basal level of R-subunit degradation was in operation
throughout rat mammary development.
The initiation of involution by removal of the suckling stimulus (litter removal) was
shown to have quite dramatic effects upon the expression of PK-A in rat mammary
tissue. Both total and expressed PK-A activities declined 24h after litter removal,
recovering somewhat over the next 24h. C-subunit protein mass also declined
markedly, however expression of Ca mRNA changed little over this same period
suggesting that a mechanism other than transcriptional processes were the major
determinants of Ca activity. Ca has already been shown to greatly exceed that of CP
mRNA throughout pregnancy and lactation in the rat mammary gland, it is therefore
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unlikely that a decrease in the level of CP mRNA was responsible for the decline in
total C-subunit protein mass. The decrease in C-subunit protein mass may therefore be
explained by a decrease in mRNA stability, translational events or by C-subunit
degradation; the latter presumably by a proteinases with particular efficiency against
C-subunit. C-subunit degradation has already been discussed above (Alhanaty &
Shaltiel, 1979).
The decline in total PK-A activity was greater than could be explained by the decrease
in C-subunit protein mass alone, suggesting that a decline in the specific activity of the
C-subunit had occurred. The specific activity of mammary tissue C-subunit has
previously been shown to remain consistent throughout pregnancy and lactation,
therefore PK-A activity appeared to be subject to further regulation in tissue undergoing
the process of involution. Deactivation of C-subunit within rat mammary tissue extracts
has already been described above (also see sections 3.4 and 3.5). C-subunit may also
have been subject to inhibition by a specific protein kinase inhibitor present within
mammary tissue. C-subunit has been shown to be highly susceptible to a class of
endogenous proteins the PKI's, as first described by Walsh and colleagues (Walsh et
al, 1971). The presence of "mute" C-subunits (Steinberg, 1991) or molecules with
altered specific catalytic activities such as those described by Clegg & Connor (1991)
might provide an explanation for the altered specific activities.
Many independent studies have implicated the involvement of cAMP and PK-A in the
mediation of involution and apoptopic cell death (Dowd & Miesfeld, 1992 and Marti
et al, 1994). In the rat involution is initiated by removal of the pups and the suckling
stimulus; however, lactation may still be rescued by return of the pups up to, and
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including 24h from litter removal (Flint et al, 1981). Therefore the initial suppression
of PK-A activity (both total and expressed) may be indicative of a physiological
mechanism, initiated to protect lactation following the temporary separation of mother
and offspring. The suppression of total PK-A activity (expressed on a tissue DNA
basis) in the rat mammary gland during lactation (Gardner et al, 1994) appears to
further imply a negative role for PK-A in lactational processes. Beyond 24h litter
removal the process of involution becomes irreversible, at the same time a partial
recovery of total and expressed PK-A activity was observed. Recovery of PK-A activity
then, appeared to coincide with mammary gland commitment to involution.
Litter removal was also shown to induce a drastic decrease in the level of R-subunit in
mammary tissue extracts. In contrast, the level of the 37-38kDa proteolytic fragment
(Potter & Taylor, 1979) dramatically increased. Increased degradation of R-subunit
may therefore be indicative of activation of a specific protease in mammary tissue as
already described for the C-subunit. The extent of R-subunit degradation differed
between cellular compartments; degradation appeared greatest in the cytosolic
compartment, which also contained higher levels of the 37-38kDa proteolytic fragment.
There were further differences in the relative degradation of R-subunit isoforms (RI and
RII). Both isoforms were equally down-regulated in the cytosolic compartment; hence,
the isoform ratio (RILRI) remained constant. Conversely there was no significant loss
of RII in the particulate compartment, presumably reflecting protection from proteolytic
degradation by association with AKAPs.
Prior to litter removal C- and R-subunits appeared to be coordinately regulated, in that
the ratio of C- and R-subunits remained relatively constant throughout rat mammary
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development; although the molecular ratio of these two subunits was not determined
since the absolute amount of R-subunit was not measured. However, following litter
removal R-subunit degradation appeared to exceed that of the C-subunit. Most tissues
examined have been shown to contain equimolar amounts of R- and C-subunits (Corbin
et al, 1977; Hofmann et al, 1977). Deviation from the usual 1:1 ratio has rarely been
reported, and usually entails over expression of R-subunit relative to C-subunit as that
first reported in neuroblastoma cells by Prashad et al (1979). If, as the data suggests,
C-subunit was present in excess over R-subunit, then the mechanism that normally
maintains the stoichiometry between these two subunits was disrupted following the
onset of involution.
Expression of PK-A activity, as well as generic C- and R-subunits appeared to be
intimately regulated throughout the pregnancy/lactation/involution cycle of the rat
mammary gland. In summary the above study showed that the level of C-subunit
protein mass, and therefore total PK-A activity was maintained by transcriptional
regulation throughout the course of pregnancy and lactation. Mammary tissue was also
shown to contain a mechanism for deactivation/degradation of free C-subunit. However
the specific catalytic activity of mammary C-subunit was unaffected by the
differentiation of the tissue throughout pregnancy and lactation. C- and R-subunits
appeared to be coordinately regulated throughout much of pregnancy and lactation
(although R-subunit transiently exceeded C-subunit around parturition). It is therefore
possible that the two subunits were regulated coordinately at one level (e.g.
transcription) but regulated differently at another level e.g. translation or degradation.
Levels of the two major R-subunit isoforms (RII and RI) were also developmentally
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regulated; levels of the RII isoform gradually increased throughout pregnancy and
lactation while RI levels were shown to peak round parturition or early lactation. The
involution ofmammary tissue brought about changes in the regulation of PK-A activity;
C-subunit protein mass and therefore total PK-A activity were no longer subject to
transcriptional regulation. Both C- and R-subunits were subject to degradation within
involuting mammary tissue, however R-subunit degradation appeared much greater,
thus the mechanism that normally maintains the stoichiometry between the C- and R-
subunits was also disrupted. C-subunit activity was further regulated, in that the
specific activity of the enzyme was reduced following the initiation of involution,
possibly by the action of a specific kinase inhibitor.
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